0001213900-19-015722.txt : 20190814 0001213900-19-015722.hdr.sgml : 20190814 20190814123636 ACCESSION NUMBER: 0001213900-19-015722 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Natur International Corp. CENTRAL INDEX KEY: 0001552845 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 455547692 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54917 FILM NUMBER: 191024665 BUSINESS ADDRESS: STREET 1: JACHTHAVENWEG 124 CITY: 1081 KJ AMSTERDAM STATE: P7 ZIP: 0000 BUSINESS PHONE: 011 31 20 578 7700 MAIL ADDRESS: STREET 1: JACHTHAVENWEG 124 CITY: 1081 KJ AMSTERDAM STATE: P7 ZIP: 0000 FORMER COMPANY: FORMER CONFORMED NAME: Future Healthcare of America DATE OF NAME CHANGE: 20120621 10-Q 1 f10q0619_naturinternational.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 000-54917

NATUR INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)

WYOMING		45-5547692
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Jachthavenweg 124

1081 KJ Amsterdam

The Netherlands

(Address of principal executive offices)

Registrant’s telephone number, including area code: 011 31 20 578 7700

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (1) Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☒
	Emerging Growth company ☐

If an emerging growth company, indicate by check mark whether the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Securities and Exchange Act of 1934:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered

As of August 13, 2019, there were 322,230,038 shares of common stock, par value $0.001, of the registrant issued and outstanding.

PART I - FINANCIAL INFORMATION

The Unaudited Consolidated Financial Statements of Natur International Corp., a Wyoming corporation (the “Company,” “Natur,” “we,” “our,” “us” and words of similar import) were prepared by management and commence on the following page, together with related notes. In the opinion of management, the Unaudited Consolidated Financial Statements fairly present the financial condition of the Company.

Natur International Corp.

Index to Unaudited Financial Statements

Consolidated Balance Sheets	2

Unaudited Consolidated Statements of Operations	3

Unaudited Consolidated Statements of Cash Flows	5

Notes to Unaudited Consolidated Financial Statements	6

NATUR INTERNATIONAL CORP.

CONSOLIDATED BALANCE SHEETS

	NOTES	(unaudited) June 30, 2019			December 31, 2018
ASSETS
Current Assets
Cash and cash equivalents			1,028,877			128,364
Accounts receivable			2,628			42,744
Related party receivable			-			1,833
Inventories			24,483			179,072
Other current assets	5		60,274			99,535
Current assets held for disposal	13		5,000			377,628
Total Current Assets			1,121,262			829,176

Non-Current Assets
Intangible asset			37,353			37,353
Fixed asset	4		58,685			523,510
Other asset			-			201,160
Non-current assets held for disposal	13		-			51,165
Total Non-Current Assets			96,038			813,188

TOTAL ASSETS			1,217,300			1,642,364

LIABILITIES AND MEMBERS’ DEFICIT

Current Liabilities
Accounts Payable			426,891			1,127,345
Accrued expenses & other contingent liabilities	6		106,387			583,161
Related party other liabilities	7		2,809,939			2,032,705
Related party other notes	8		2,984,017			1,072,849
Convertible note payable	9		1,202,849			1,600,710
Related party convertible note payable	10		-			11,671,743
Preferred Stock payable			2,064,736			-
Current liabilities held for disposal	13		170,469			887,126
Total Current Liabilities			9,765,288			18,975,639

TOTAL LIABILITIES			9,765,288			18,975,639

Stockholders’ Equity
Common stock, $0.001 par value, 750,000,000 and 200,000,000 shares authorized as of June 30, 2019 and December 31, 2018, respectively. 310,597,593 and 129,049,192 issued and outstanding as of June 30, 2019 and December 31, 2018, respectively.			310,597			129,049
Preferred stock A, $0.001 par value, 2,397.131 and 2,469.131 issued and outstanding as of June 30, 2019 and December 31, 2018, respectively. Convertible to common stock at a 1:33,000 ratio.			2			2
Preferred stock B, 100,000 shares authorized, Nil and 100,000 issued and outstanding as of June 30, 2019 and December 31, 2018, respectively. Convertible to common stock at a 1:1000 ratio.			-			100
Preferred stock C, $0.001 par value, Nil issued and outstanding as of June 30, 2019 and December 31, 2018, respectively. Convertible to common stock at a 1:1000 ratio.			-			-
Additional Paid in Capital			14,924,725			5,174,269
Total Shareholders’ deficit			(23,850,777	)		(22,299,570	)
Accumulated other comprehensive loss			67,465			(337,125	)
TOTAL EQUITY/(DEFICIT)			(8,547,988	)		(17,333,274	)

LIABILITIES AND MEMBERS’ DEFICIT			1,217,300			1,642,364

The accompanying notes are an integral part of these consolidated financial statements

NATUR INTERNATIONAL CORP.

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Three Months						For the Six Months
	June 30, 2019			June 30, 2018			June 30, 2019			June 30, 2018

REVENUE		8,134			414,716			72,553			942,433

COST OF GOODS SOLD - RELATED PARTY		2,679			224,682			33,560			425,036
COST OF GOODS SOLD		2,240			58,718			66,136			132,116
		4,919			283,400			99,696			557,152

GROSS MARGIN		3,215			131,316			(27,143	)		385,281

OPERATING EXPENSES
Wages & Salaries		108,335			349,298			373,064			792,679
Selling, General & Administrative		1,243,061			904,599			2,645,471			2,019,466
Amortization , depreciation and impairment		3,609			30,268			275,798			83,584

Total operating expenses		1,355,005			1,284,165			3,294,333			2,895,729

LOSS FROM OPERATIONS		(1,351,790	)		(1,152,849	)		(3,321,476	)		(2,510,448	)

Interest expense		862			34,413			40,095			63,261

LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES		(1,352,652	)		(1,187,262	)		(3,361,571	)		(2,573,709	)

Income taxes		-			-			-			-

INCOME FROM CONTINUING OPERATIONS		(1,352,652	)		(1,187,262	)		(3,361,571	)		(2,573,709	)

Discontinued operations (NOTE 13)
Gain (loss) on disposal of subsidiary		1,591,187			-			1,891,985			-
Loss from operations of discontinued Component		(42,211	)		(302,964	)		(81,621	)		(1,095,701	)

NET PROFIT (LOSS) AVAILABLE/ATTRIBUTE TO MEMBERS		196,324			(1,490,226	)		(1,551,207	)		(3,669,410	)

Basic earnings/(loss) per share		0.00			(0.01	)		(0.00	)		(0.03	)
Diluted earnings/(loss) per share		0.00			(0.01	)		(0.00	)		(0.03	)

COMPREHENSIVE INCOME

Net Profit (Loss)		196,324			(1,490,226	)		(1,551,207	)		(3,669,410	)
Other comprehensive income		50,677			-			404,590			-

COMPREHENSIVE PROFIT (LOSS)		247,001			(1,490,226	)		(1,146,617	)		(3,669,410	)

The accompanying notes are an integral part of these consolidated financial statements

NATUR INTERNATIONAL CORP.

UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICIT

	Common Stock				Preferred stock A					Preferred stock B						Preferred stock C
	Amount ($.001 par)		Number of Shares		Amount ($.001 par)		Number of Shares			Amount ($.001 par)			Number of Shares			Amount ($.001 par)			Number of Shares			Other Paid in Capital			Retained deficit			Accumulated OCI			Total
Balance at December 31, 2018		129,049		129,049,192		2		2,469.131			100			100,000			-			-			5,174,269			(22,299,570	)		(337,125	)		(17,333,275	)

Net Loss																										(1,747,531	)					(1,747,531	)
Share-based compensation																							403,162									403,162
Conversion of Preferred A to Common Stock		2,376		2,376,002		(-)		(72	)														(2,376	)								(-)
Accumulated other comprehensive gain/(loss)																													353,913			353,913
Balance at March 31, 2019		131,425		131,425,194		2		2,397.131			100			100,000			-			-			5,575,055			(24,047,101	)		16,788			(18,323,731	)
																																-
Net Profit																										196,324						196,324
Share-based compensation																							685,044									685,044
Debt Converted to Common Stock		340		340,000																			13,218									13,558
Conversion of Preferred B to Common Stock		100,000		100,000,000							(100	)		(100,000	)								(99,900	)								-
Issuance of Preferred C Stock																	79			78,832			8,830,061									8,830,140
Conversion of Preferred C to Common Stock		78,832		78,832,399													(79	)		(78,832	)		(78,753	)								-
Accumulated other comprehensive gain/(loss)																													50,677			50,677
Balance at June 30, 2019		310,597		310,597,593		2		2,397			-			-			-			-			14,924,725			(23,850,777	)		67,465			(8,547,988	)

	Common Stock		Preferred stock A		Preferred stock B		Preferred stock C
	Amount ($.001 par)	Number of Shares	Amount ($.001 par)	Number of Shares	Amount ($.001 par)	Number of Shares	Amount ($.001 par)	Number of Shares	Other Paid in Capital	Retained deficit		Accumulated OCI		Total
Balance at December 31, 2017	115,760	115,759,999	-	-	-	-	-	-	3,316,560	(15,250,748	)	(1,114,812	)	(12,933.240	)

Net Loss										(2,179,184	)			(2,179,184	)
Accumulated other comprehensive gain/(loss)												-		-
Balance at March 31, 2018	115,760	115,759,999	-	-	-	-	-	-	3,316,560	(17,429,932	)	(1,114,812	)	(15,112,424	)
														-
Net Profit										(1,490,226	)			(1,490,226	)
Accumulated other comprehensive gain/(loss)												-		-
Balance at June 30, 2018	115,760	115,759,999	-	-	-	-	-	-	3,316,560	(18,920,158	)	(1,114,812	)	(16,602,650

The accompanying notes are an integral part of these consolidated financial statements

NATUR INTERNATIONAL CORP.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Six Months
	June 30, 2019			June 30, 2018
CASH FLOW FROM OPERATING ACTIVITIES
Net Loss		(1,551,207	)		(3,669,410	)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization, depreciation and impairment		275,798			32,015
Share Based Compensation		1,088,206			-
Gain on Disposal of Subsidiaries		(1,891,985	)
Changes in:
- Accounts receivable		37,592			(252,278	)
- Related party receivable		24			(20,802	)
- Inventories		44,516			(436,965	)
- Other current assets		(1,124	)		33,911
- Accounts payable		(23,411	)		1,951,766
- Accrued expenses		(178,008	)		(416,304	)
- Accrued expenses - related parties		110,391			(124,643	)
Net cash used in operating activities		(2,089,208	)		(2,902,710	)
Net cash (used in) from operating activities - Discontinued operations		-			210,652

CASH FLOW FROM INVESTING ACTIVITIES
Cash paid for purchase of fixed assets		-			-
Cash received for sale of property and equipment		-			-
Net cash used in investing activities		-			-
Net cash used in investing activities – Discontinued operations		51,165			-

CASH FLOW FROM FINANCING ACTIVITIES
Related party loan additions		-			1,799,213
Related party loan repayments		-			(240,503	)
Cash received from subscription of Preferred Stock		2,064,736
Third party convertible note additions		560,915			52,266
Related party convertible loan additions		-			-
Net cash provided from financing activities		2,625,651			1,610,976
Net cash from financing activities - Discontinued Operations		-			-

Effect of foreign exchange rate changes on cash and cash equivalents		312,905			-

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		900,513			(1,081,082	)

CASH AND CASH EQUIVALENTS beginning of period		128,364			1,082,734
CASH AND CASH EQUIVALENTS end of period		1,028,877			1,652

NON-CASH TRANSACTIONS
Preferred stock C issued for debt conversion		79
Common stock issued for debt conversion		340
Preferred stock A conversion		2,376
Preferred stock C conversion		78,832
Preferred stock B conversion		100,000
Debt transferred from RP other liabilities to RP other notes payable		672,370

The accompanying notes are an integral part of these consolidated financial statements

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

Natur International Corp. was formerly named Future Healthcare of America. In November 2018, Natur Holding B.V. was acquired to continue the company as a provider of cold pressed juice beverages and healthy snacks. The original business of Future Healthcare of America, founded in 2012, was as a provider of home healthcare services, which had declined and is expected to be fully closed and liquidated in the third quarter of 2019.

The current name of the company is Natur International Corp., which was effected on January 7, 2019. The trading symbol for our common stock became NTRU as of that date and trades on The OTC Market.

Natur International Corp., is a Wyoming corporation, and operates its beverage business through a number of direct and indirect subsidiaries, of which the current principal one is Natur BPS B.V. (known by the trade name Natur Functionals), and is the successor to the business of Natur Holding B.V. (“we”, “our”, “the Company” or “Natur”). Our beverage business commenced in late 2015, with product distribution in Northern Europe. Currently, our operational headquarters is in Amsterdam, the Netherlands.

At the onset of 2019, our product line up centered on a range of cold pressed juices and healthy snacks. These products were sold either directly or through distribution partners in the Netherlands and the United Kingdom. Beginning in the fourth quarter of 2018, and throughout the first half of 2019, the Company focus shifted from dependence on the legacy fruit and vegetable juices and snacks toward innovating a new line of hemp-derived natural food and beverage products. The Company product value proposition is to provide affordable, culturally relevant, authentic, fresh fruit, vegetable and hemp-derived supplemented consumer products to democratize clean, healthy, eating and drinking, with plans to address the growing needs for products that address other personal needs in health, wellness and beauty care.

Through third party contract manufacturers, we apply patented technology to proprietary nutrient dense blends of fruit and vegetables, adding hemp-derived supplements. These are bottled or packed with technically advanced food and product safety measures and in some cases cold high-pressure processing to bring fresh tasting fruit, vegetable and hemp-derived supplemented blends to market through more than fifteen product types. These newly innovated products are brought to market, in Europe, through Natur’s distribution channels of direct-to-business, direct-to-consumer and through select distributors.

Natur operated as a private enterprise in the Netherlands from its founding in 2015 through November 13, 2018, when it was acquired as a wholly owned subsidiary in a share exchange transaction by Future Healthcare of America, pursuant to that certain Share Exchange Agreement, among the Company and the former shareholders of Natur Holding, B.V. (the “Share Exchange Transaction”). In connection with the Share Exchange Transaction, the former shareholders of Natur received the equivalent of 215,759,999 shares of the Common Stock (the “Common Stock”), which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the “Series B Preferred Stock”) representing 100,000,000 shares of Common Stock upon conversion. The Share Exchange Transaction was accounted for as a reverse capitalization with Natur Holding B.V. being treated as the accounting acquirer. As such, the historical information for all periods presented prior to the merger date relate to Natur Holding B.V. Subsequent to the Share Exchange Transaction consummation date, the information in this report relates to the consolidated entities of Natur, including Natur Holding B.V. and successor subsidiary and the former subsidiaries of Future Healthcare of America, the latter of which are currently in the process of being wound down and presented as discontinued operations.

In connection with the Share Exchange Transaction, net cash received was $2,000,000 and costs incurred were $399,381 including professional fees for legal, accounting services and finance commission. Immediately after the Share Exchange Transaction, the former Natur shareholders collectively owned the controlling position among the shareholders of the Company.

On May 1, 2019, Natur Holding B.V. filed a Petition in the Netherlands Court for the District of Amsterdam (“Petition”) for the liquidation of the company and the transfer of certain assets and retained liabilities to Natur BPS B.V., a wholly owned subsidiary of Natur International Corp., which operates under the trade name Natur Functionals. This court process allowed the historical business of the Company’s beverage business to be continued and eliminates a substantial amount of the liabilities of the Company. The Petition permits the Company to focus on activities that will drive growth and future profits. As a result of the Petition the control of Natur International Corp. over Natur Holding B.V. is compromised for financial reporting purposes, and its investment in it will be deconsolidated as of May 1, 2019.

The Series B Preferred Stock was automatically converted upon the Company increasing the number of shares of Common Stock of its authorized capital, which happened on June 26, 2019. At the same time the Series C Preferred Stock was automatically converted to 78,832,399 shares of Common Stock. As of June 30, 2019, the total number of outstanding shares amounted to 310,597,593 shares of Common Stock with an authorized share capital of 750,000,000 shares of common Stock.

During the first half of the 2019 fiscal year, in addition to pursuing the Petition to reorganize certain of its liabilities, the Company successfully has negotiated to convert a further $6,114,790 of debt into 149,516,865 shares of common stock to be issued in due course. More importantly, it has been conducting substantial fund-raising activities. It has obtained new funding through a series of securities purchase agreements that have been funded in the amount of $2,064,736 or are subject to signed commitments for funding in the amount of $3,283,904 that is expected to be completed during the third fiscal quarter of 2019. The securities to be sold will be a mix of several new series of preferred stock convertible into up to 96,289,473 shares of Common Stock and warrants exercisable for up to 177,404,377 shares of Common Stock.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS - continued

On June 30, 2019, the Company expressed its interest in pursuing a transaction with Share International Holding B.V. on a binding basis. The contemplated transaction would be an acquisition of Share International Holding B.V. (“SIH”) and related assets for the operation of its business by the issuance of shares of Natur. The terms of this potential acquisition have yet to be negotiated and finalized, and the overall transaction is subject to conditions precedent at this time. At the same time as the Company entered into the letter of intent, it lent to SIH the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%. The repayment obligation under the Note will be cancelled if no business arrangement is concluded due to a breach by the Company of any agreement for the business arrangement that is concluded in the future, either party to the note experiences a material adverse change, or the business arrangement is not approved by the shareholders or owners of the respective parties to the extent that approval is required. The note also has other standard default provisions under which the Company may declare a default. Also, at the same time as the foregoing letter of intent and loan were concluded, the board of directors of the Company appointed Mr. Paul Bartley as the Chief Executive Officer of the Company; Mr. Bartley is a principal of SIH.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation. The Company prepares its financial statements using the accrual basis of accounting in accordance with United States generally accepted accounting principles (“US GAAP”).

Consolidation - The financial statements presented reflect the accounts of Natur International Corp and its direct and indirect subsidiaries. All inter-company transactions have been eliminated in consolidation.

Use of Estimates in Financial Statement Preparation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents. Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable. Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for bad debts. The allowance for bad debts is recognized based on management’s estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Inventory. Inventory, consisting of raw materials, work in progress and finished goods, is valued at the lower of the inventory’s costs or net realizable value, using the first in, first out method to determine the cost. Management compares the cost of inventory with its net realizable value and an allowance is made to write down inventory to net realizable value, if lower.

Property and Equipment. Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:

Category		Estimated Useful lives
Building and improvements		5 years
Machines and installations		5 years
Furniture and fixtures		7 years
Hardware and software		3 years

Intangible Assets and Long-Lived Assets. The Company recognizes an acquired intangible asset apart from goodwill whenever the intangible asset arises from contractual or other legal rights, or when it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their useful lives. Impairment losses are recognized if the carrying amount of an intangible asset subject to amortization is not recoverable from expected future cash flows and its carrying amount exceeds its fair value.

The Company’s long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Long lived assets are evaluated on a yearly basis and no impairment losses were incurred during the six months ended June 30, 2019.

Related Party Transactions. The Board of Directors has adopted a Related Party Transaction Policy for the review of related person transactions. Under these policies and procedures, the management reviews related person transactions in which we are or will be a participant to determine if they are fair and beneficial to the Company. Financial transactions, arrangements, relationships or any series of similar transactions, arrangements or relationships in which a related person has or will have a material interest and that exceeds the lesser of: (i) $10,000, and (ii) one percent of the average of the Company’s total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review. Any member of the board who is a related person with respect to a transaction under review may not participate in the deliberation or vote requesting approval or ratification of the transaction. Transactions that are subject to the policy include any transaction, arrangement or relationship (including indebtedness or guarantees of indebtedness) in which the Company is a participant with a related person. The related person may have a direct or indirect material interest in the transaction. It is Company policy that the board shall approve any related party transaction before the commencement of the transaction. However, if the transaction is not identified before commencement, it must still be presented to the board for their review and ratification.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Revenue Recognition. Beginning on January 1, 2018, the Company recognizes revenue under ASC 606, Revenue from Contracts with Customers. The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. The following five steps are applied to achieve that core principle:

Step 1: Identify the contract with the customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognize revenue when the company satisfies a performance obligation

The Company’s performance obligations are satisfied at the point in time when products are received by the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company’s contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of product.

The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon delivery to the customer. The Company’s performance obligations are satisfied at that time.

Share-Based Payment Arrangements. The Company measures the cost of employee services received in exchange for an award of equity instruments (share-based payments, or SBP) based on the grant-date fair value of the award. That cost is recognized over the period during which an employee is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model. The Company adopted ASU 2018-07 in the first quarter of 2019 which aligns the accounting for share-based payment awards issued to employees and non-employees.

The fair value of each option granted during the period ended June 30, 2019 was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table:

	2019			2018
Expected dividend yield		0	%		-
Expected option term (years)		6			-
Expected volatility		382	%		-
Risk-free interest rate		3	%		-

The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company’s common stock. The assumed discount rate was the default risk-free six-year interest rate in the Netherlands.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Revenues do not include sales or other taxes collected from customers.

The Company’s products are sold and distributed through various channels, which include selling directly to retail stores and other outlets such as food markets, institutional accounts and independent outlets. The Company typically collects payment from customers within 30 days from the date of sale. The following table presents our continued revenues disaggregated by geographical region for the six-month period ended June 30, 2019:

	June 30, 2019		June 30, 2018
Netherlands		72,553		942,433
France		-		-
Iceland		-		-
Total		72,553		942,433

The Company sells its products and extends credit, generally without requiring collateral, based on an ongoing evaluation of the customer’s business prospects and financial condition. The Company evaluates the collectability of its trade accounts receivable based on a number of factors, including the Company’s historic collections pattern and changes to a specific customer’s ability to meet its financial obligations. The Company has established an allowance for doubtful accounts to adjust the recorded receivable to the estimated amount the Company believes will ultimately be collected.

The nature of the Company’s contracts does not give rise to variable consideration, such as prospective and retrospective rebates.

The Company experiences customer returns primarily as a result of damaged or out-of-date product. At any given time, the Company estimates less than 1% of sales could be at risk for return by customers. As the company do not deem this amount to be material no provision was recorded for the period ended 30 June, 2019. Returned product is recognized as a reduction of net sales.

Recent Accounting Pronouncements

Compensation—Stock Compensation: On June 20, 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting, which aligns the accounting for share-based payment awards issued to employees and nonemployees. Under ASU No. 2018-07, the existing employee guidance will apply to nonemployee share-based transactions (as long as the transaction is not effectively a form of financing), with the exception of specific guidance related to the attribution of compensation cost. The cost of nonemployee awards will continue to be recorded as if the grantor had paid cash for the goods or services. In addition, the contractual term will be able to be used in lieu of an expected term in the option-pricing model for nonemployee awards. The adoption had no impact on the Company’s historic financial statements.

Leases: In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”. This update requires the recognition of lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous guidance. The accounting for finance leases (capital leases) was substantially unchanged. The original guidance required application on a modified retrospective basis with adjustments to the earliest comparative period presented. In August 2018, the FASB issued ASU No. 2018-11, “Targeted Improvements to ASC 842,” which included an option to not restate comparative periods in transition and elect to use the effective date of ASU No. 2016-02 as the date of initial application, which the Company elected. As a result, the consolidated balance sheet prior to January 1, 2019 was not restated, and continues to be reported under previous guidance that did not require the recognition of operating lease liabilities and corresponding lease assets on the consolidated balance sheet. As a result of the adoption of ASU No. 2016-02 on January 1, 2019, the Company recorded operating lease right-of-use assets of $580,310 and operating lease liabilities of $578,007.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Foreign Currency Translation. The Company follows Section 830-10-45 of the FASB Accounting Standards Codification (“Section 830-10-45”) for foreign currency translation to translate the financial statements from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity’s functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash.

The financial records of the Company are maintained in its local currency, the euro (“EUR”), which is the functional currency. Assets and liabilities are translated from the local currency into the reporting currency, U.S. dollars, at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Foreign currency translation gain (loss) resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining accumulated other comprehensive income in the consolidated statement of stockholders’ equity.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - continued

Unless otherwise noted, the rate presented below per U.S. $1.00 was the midpoint of the interbank rate as quoted by OANDA Corporation (www.oanda.com) contained in its consolidated financial statements. Translation of amounts from EUR into U.S. dollars has been made at the following exchange rates for the respective periods:

	June 30, 2019		December 31, 2018
Balance Sheets		0.8849		0.8734
Statements of operations and comprehensive income (loss)		0.8895		0.8464
Equity		0.9037		0.9037

Cost of Revenues. Cost of revenue includes all direct expenses incurred to produce the revenue for the period. This includes, but is not limited to, costs for finished products, pick packing costs, storage costs and transportation costs. Cost of revenues are recorded in the same period as the resulting revenue.

Employee Benefits. Wages, salaries, bonuses and social security contributions are recognized as an expense in the year in which the associated services are rendered by employees. For any unused portion of vacation leave, an accrual is recorded for carry over to the following year.

Income Taxes. The Company is subject to US corporation tax. The US combined federal and state corporate tax rate is 23%. The company’s United States net operating losses totaled $3,483,928 as of December 31, 2017 and begin to expire in tax years 2032 and following. Net losses from US operating totaled $157,386 for 2018 and may be carried forward indefinitely. The company is subject to US Internal Revenue Code rules limiting the use of US net operating losses after the merger with Future Health Care of America during 2018 (described in Note 17). This limitation has no effect on the Company’s financial statements because the Company has recognized no deferred tax asset with respect to its net operating loss carryforwards. The NOLs are the cumulative NOL’s per the Company’s 2017 federal income tax return. The 382 limit will not be factored in until the company has income and the limit is therefore applicable.

Natur BPS B.V., the Dutch subsidiary of Natur International Corp is structured as a Dutch limited liability company. Tax on the result is calculated based on the result before tax in the profit and loss account, considering losses available for set-off from previous years (to the extent that they have not already been included in the deferred tax assets) and exempt profit components and after the addition of non-deductible costs. Due account is also taken of changes which occur in the deferred tax assets and deferred tax liabilities in respect of changes in the applicable tax rate.

The corporate tax rate for profits above $238,812 (or €200,000) amounts to 25%. Below that amount the rate is 20%. Future profits can be carried back to prior year losses for a maximum of 9 years for the full amount of losses incurred.

In the financial statements of group companies, a tax charge is calculated on the basis of the accounting result. The corporate income tax that is due by these group companies is charged into the current accounts of the company.

Because of the compensable losses no deferred taxes are included in the financial statements. From incorporation of the company only the Corporation Tax return of 2015/2016 has been filed. All years are still subject to examination.

Fair Value of Financial Instruments. The carrying value of short-term instruments, including cash, accounts payable and accrued expenses, and short-term notes approximate fair value due to the relatively short period to maturity for these instruments. The long-term debt approximate fair value since the related rates of interest approximate current market rates.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs.

The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.

Income /(Loss) Per Share - The Company computes income (loss) per share in accordance with Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260 Earnings Per Share, which requires the Company to present basic earnings per share and diluted earnings per share when the effect is dilutive (see Note 12).

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 – GOING CONCERN

The Company considered its going concern disclosure requirements in accordance with ASC 240-40-50. We have had material operating losses, working capital deficit and have not yet created positive cash flows. These factors raise substantial doubt as to our ability to continue as a going concern. The Company concluded, in spite of the decreased cash flow from operations, both the elimination of certain debt and the successful raising of new capital and obtaining new capital commitments during the second quarter of 2019, that it has materially improved its capital so as to continue as going concern. The Company implemented a plan in the second quarter of 2019 to further structurally improve the conditions for its continuing as a going concern; (i) the Company implemented certain cost savings, primarily to its overhead requirements, (ii) the Company will continue to generate additional revenue (and positive cash flows from operations) partly related to the Company’s expansion into new product lines during 2019 and partly related to the Company sales initiatives already implemented; and (iii) undertook a reorganization and restructuring program to reduce its debt that has now been completed. The corporate restructuring through the Petition in May 2019 is further disclosed in Note 13 to these financial statements. These actions have had an overall positive impact on the cost-basis of the organization. Notwithstanding the foregoing, the Company will continue to need additional capital from investors to fund its larger business plan and maintain the continuity and growth of its current operations. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.

NOTE 4 – FIXED ASSETS

Property, equipment and intangible assets at June 30, 2019, and December 31, 2018, consisted of the following:

	June 30,			December 31,
	2019			2018
Building and improvements		-			491,847
Machines and installations		-			65,886
Furniture and fixtures		60,117			200,508
Hardware and software		-			80,163
		60,117			838,404

Less: Accumulated Depreciation & Amortization		(1,432	)		(314,894	)
		58,685			523,510

NOTE 5 – OTHER CURRENT ASSETS

Other current assets at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Value Added Tax receivable		34,878		67,388
Prepaid expenses		25,396		32,054
Other Receivables		-		93
		60,274		99,535

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 – ACCRUED EXPENSES & OTHER CONTINGENT LIABILITIES

Accrued expenses & other contingent liabilities at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Taxes payable		21,628		352,423
Invoices to be received		26,018		3,972
Holiday Allowance Payable		2,558		24,642
Other accrued expenses & other contingent liabilities		56,183		202,124
		106,387		583,161

NOTE 7 – RELATED PARTY OTHER LIABILITIES

Related party other liabilities at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

NL Life Sciences B.V.		2,088,917		563,118
STB Family Offices SARL		227,323		200,234
STB Family Offices B.V.		-		661,432
Stichting Thank You Nature		-		16,913
Flare Media B.V.		-		25,458
AMC		193,632		325,382
Management & Board Fees		278,092		142,154
Yoomoo Limited		-		98,014
TriDutch Holding B.V.		21,975		-
		2,809,939		2,032,705

For the outstanding amount relating to AMC this transaction relates to the purchase of bottled juices for resale. Total purchases relating to goods sold for the six-month period ended June 30, 2019 and the six-month period ended June 30, 2018 was $41,130, and $797,770, respectively.

For the related party balance liability held from NL Life Sciences, STB Family Offices SARL and TriDutch Holding B.V there is no repayment schedule in place. No interest is being charged. For the related party liability held with Flare Media B.V., STB Family Office B.V. in May 2019 the debt was fully transferred to NL Life Sciences B.V. as part of a debt restructuring. This balance will be converted into equity in the third quarter of 2019.

The other loans consist of the procurement of goods and consulting fees for the management team that have accrued from previous periods. No interest is being charged.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 8 – RELATED PARTY OTHER NOTES

Loan from other related parties at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Efficiency Life Fund		2,984,017		400,750
TriDutch Holding B.V.		-		672,099
		2,984,017		1,072,849

For the loan from TriDutch Holding B.V., in May 2019 the debt was fully transferred to NL Life Sciences B.V. as part of a debt restructuring.

For the loan from Efficiency Life Fund there is a repayment schedule in place to repay the loan in 10 installments from July 2019 to April 2022 and the debt therefore transferred from a related party liability to a loan.

NOTE 9 – CONVERTIBLE NOTE PAYABLE

Convertible loans payable at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Convertible loan 1		636,614		629,750
Convertible loan 2		-		970,960
Convertible loan 3		566,235		-
		1,202,849		1,600,710

Convertible Loan 1

Party for loan 1 had granted a loan facility in the principle amount of $581,058 or €500,000 with the right, but not the obligation to convert the outstanding loan amounts into shares in the capital of Natur at a company valuation of $17.4 million or €15 million for a term from December 19, 2017, till the maturity date of December 31, 2018, at an interest rate of 10% per annum. In July 2019 the amount was fully converted to common stock of the company.

Convertible Loan 2

On October 20, 2017, an amount of $929,692 or €800,000 was advanced to the Company for a loan agreement that was drafted but never signed. An interest rate of 5% per annum is calculated and the loan has a maturity date of February 28, 2018. Repeated attempts at correspondence was made between the Company and the lender’s attorney in April and May 2019 to discuss converting the balance to Common Stock of the Company on the bankruptcy of Natur Holding B.V. as no response was received the amount remains in Natur Holding B.V. who’s estate is being managed independently by a court issued Curator.

Convertible Loan 3

Natur Holding B.V., the principle subsidiary of Natur International Corp, entered into a loan agreement with Dam! Holding B.V., under which Natur Holding may borrow up to US$560,915 or €500,000. The final terms of the agreement were concluded on February 18, 2019.The full drawdown of US$560,915 was made in three tranches throughout January and February 2019. It is the company’s intention to fully convert this to common stock in the third quarter of 2019.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10 – RELATED PARTY CONVERTIBLE NOTE PAYABLE

Related party convertible note payable at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Convertible loan Efficiency Life Fund		-		11,671,743

As at June 26, 2019 $8,830,140 of the balance was converted Into Series Preferred C stock, this stock then converted to Common stock after the increase in authorized share capital of NTRU . The remainder of the balance is currently being held as loan with the company as described and shown in note 8.

NOTE 11 – OPTIONS & WARRANTS

On November 13, 2018, the Company closed a subscription agreement and debt conversion agreement with Alpha Capital Anstalt wherein the Company granted the following warrants to purchase:

-	A total of 33,000,000 shares of common stock, at $0.0606060 per share, exercisable for four years.

-	A total of 6,000,000 shares of common stock, at $0.15 per share, exercisable for four years.

A summary of the status of the warrants granted is presented below for the three months ended:

	June 30, 2019				December 31, 2018
	Shares		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
Outstanding at beginning of period		39,000,000	$	0.074		-	$	-
Granted		-		-		39,000,000		0.074
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding at end of period		39,000,000	$	0.074		39,000,000	$	0.074

On January 16, 2019, the Company completed compensatory arrangements with three board members of Natur International Corp. with the following terms:

Mr. Anthony Joel Bay, through La Bay Ventures Inc., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary. The option provides for cashless exercise and may be registered for resale at the election of the Company. If the service agreement is terminated for a breach thereof, all vested and unvested options will terminate, but if the service agreement is otherwise terminated, then only then vested options will continue to be exercisable for the full term.

Mr. Rudolf Derk Huisman, through Pas Beheer B.V., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary. The option provides for cashless exercise and may be registered for resale at the election of the Company If the service agreement is terminated for a breach thereof, all vested and unvested options will terminate, but if the service agreement is otherwise terminated, then only then vested options will continue to be exercisable for the full term.

Ms. Ellen Berkers, through Montrose Executive Management, will be issued an aggregate of 5,800,000 share of options to purchase common stock of the Company as part of her termination arrangement dated May 30, 2019. The option granted by the Company provides for the right to exercise the shares at $.030303 per share at any time from April 1, 2022 until March 31, 2025. The option provides for cashless exercise and may be registered for resale at the election of the Company.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 11 – OPTIONS & WARRANTS - continued

Mr. Robert A. Paladino, through Cavalier Aire LLC., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of NTRU. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary. The option provides for cashless exercise and may be registered for resale at the election of the Company. If the service agreement is terminated for a breach thereof, all vested and unvested options will terminate, but if the service agreement is otherwise terminated, then only then vested options will continue to be exercisable for the full term.

A summary of the status of the share options is presented below for the six months ended:

	June 30, 2019				December 31, 2018
	Shares		Weighted Average Fair Value		Shares		Weighted Average Fair Value
Outstanding at beginning of period		-	$	-		-	$	-
Vested		9,459,688		0.071		-		-
Unvested		18,298,275
Exercised		-		0.071		-		-
Expired		-		-		-		-
Outstanding at end of period		27,757,963	$	0.071		-	$	-

The fair value of all stock options outstanding at 30 June, 2019 is $1,970,813 at a weighted average fair value of $0.071 per option.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 12 – LOSS PER SHARE

At June 30, 2019, the Company had 310,597,593 shares issues and outstanding at a par value of $.001. The Company also has 2,397.130 preferred A shares issued and outstanding. Alpha Capital Anstalt has two outstanding warrants issued on November 13, 2018, each with 4-year terms. The first warrant has an exercise price of $0.060606 for 36,000,000 shares and the second warrant is exercisable for 6,000,000 shares at a $0.15 exercise price. The Company has reserved 16,240,000 shares of Common Stock for management incentive awards. At December 31, 2018, the Company had 129,049,192 shares of common stock issued and outstanding.

NOTE 13 – DISCONTINUED OPERATIONS AND ASSETS/LIABILITIES HELD FOR DISPOSAL

Effective November 30, 2018, the Company closed the London office and shops as part of the restructuring plan. Functionally the operations were shut down before December 31, 2018, and therefore we have qualified it as discontinued operations the sale of assets is in process. The existing support functions were transferred to the headquarters in Amsterdam as part of the centralization of support staff initiative.

As of March 22, 2019, the company Naturalicious UK Limited was put into liquidation and the matters are being dealt with by a qualified administration firm in the United Kingdom. A board meeting was held on March 22, 2019, and it was agreed to liquidate the company. Currently the rights and obligations of the company are handled by the administration firm and the legal obligation over the liabilities are extinguished. As we no longer have any rights or obligations to the indirect subsidiary, it has been removed from the consolidation and the net liability position of the company is released and recognized as a gain on disposal.

Effective August 31, 2018, the Company offices in Casper, Wyoming were closed at the termination of its health care operations.. The increase in costs coupled with a decrease in business activity, led to the decision to close the Casper, Wyoming operations. In closing the office, the Company transitioned its clients to new service providers, and terminated employees as the transition happened. The month to month lease was terminated with the landlord on August 31, 2018.

In line with the objective to secure the continuity of the Company, it was decided late 2018 to extend the product line with added functional extracts (Nutrigenomics, hemp-derived extracts). For this, the Company established Natur BPS B.V. (formerly Natur CBD B.V.) as a sister company of Natur Holding B.V. at March 13, 2019, wholly owned by Natur International Corp. Based on global developments and following the success of companies in the USA and Canada, the Company defined new growth objectives with complementary products based on hemp-derived extracts as a new revenue model. Additional funding was sought in the market, but it became apparent that the willingness of new investors to provide the company with funding in debt or equity was dependent on the restructuring of the existing debt on the balance sheet of the Company. As most of this debt is held on the balance sheet of Natur Holding B.V., it was decided to develop a restructuring plan to:

Establish an asset transfer from Natur Holding B.V. to Natur CBD B.V., optimizing the proceeds for these assets and subsequently liquidate Natur Holding B.V.;

Continue the business in Natur CBD B.V. with an extended portfolio of functional products, including food and beverages infused with hemp-derived extracts and deliver the objectives as set by the Board

Expeditiously seek new funding in the form of (long-term) or convertible debt or equity. Discussions with Third parties are on-going.

In May 2019 we reached agreements with most of the debtholders to convert their debt to equity and effective from May 1, 2019, the asset transfer between Natur Holding B.V. and its sister company Natur BPS B.V was executed and Natur Holding B.V. and its wholly owned subsidiaries were declared bankrupt by the Court in Amsterdam, the Netherlands. The total debt that was converted to shares of common stock to be issued is $ 6,754,575.

In June we reached agreement with private investors for the sale of preferred stock and warrants. At June 30, 2019, agreements were signed for a total of $2,064,756 against 65,621.283 of to be issued shares of several series of preferred stock.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 13 – DISCONTINUED OPERATIONS AND ASSETS/LIABILITIES HELD FOR DISPOSAL - continued

The following table presents the carrying amounts of the major classes of assets and liabilities included in our discontinued operations as presented on our Unaudited Consolidated Balance Sheet as of June 30, 2019.

NATUR INTERNATIONAL CORP

UNAUDITED BALANCE SHEET OF DISCONTINUED OPERATIONS

	For the Six Months		December 31, 2018
Current assets
Cash and cash equivalents		-		-
Related party receivable		-		201,907
Accounts receivable		-		124,016
Inventories		-		-
Other current assets		-		51,705
Total current assets		-		377,628

Fixed Assets
Tangible fixed assets		-		27,547
Financial Fixed Assets		-		23,618
Total fixed assets		-		51,165

TOTAL ASSETS		-		428,793

Short term debt
Accounts Payable		36,894		643,616
Accrued expenses & other contingent liabilities		133,575		243,510
Total short-term debt		170,469		887,126

NATUR INTERNATIONAL CORP

UNAUDITED INCOME STATEMENT OF DISCONTINUED OPERATIONS

	For the Three Months			For the Six Months
	For the Six Months			December 31, 2018

REVENUE		-			-

COST OF GOODS SOLD		-			-

GROSS MARGIN		-			-

OPERATING EXPENSES
Wages & Salaries		-			-
Selling, General & Administrative		(42,211	)		(81,621	)
Amortization & depreciation		-			-

Total operating expenses		(42,211	)		(81,621	)

LOSS FROM OPERATIONS		42,211			81,621

Interest expense		-			-

LOSS FROM DISCONTINUED OPERATIONS		42,211			81,621

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 14 – SUBSEQUENT EVENTS

In July 2019 the Company reached agreement with certain non-US private investors to invest in total $1,765,605 to acquire 46,947.368 of the Series G Preferred Stock. These preferred shares have registration rights.

On July 25, 2019 the Company entered into a Purchase and Recapitalization Agreement (“Recapitalization Agreement”) with DRBG Holdco, LLC, a Delaware limited liability company, Temple Turmeric, Inc., a Delaware corporation, Daniel Sullivan, Tim Quick, and TQ Holdings LLC, a New Hampshire limited liability company to acquire the business of Temple. Under the Recapitalization Agreement the Company acquired 15,121,984 shares of Series A Preferred Stock of Temple from DRBG for a nominal amount and acquired from TQH a promissory note in the principal amount of $100,000, plus all accrued and unpaid interest. As part of the transaction Temple issued to DRBG a warrant to acquire a percentage of the Temple equity. The Temple board of directors will have three of the five directors appointed by the Company pursuant to the terms of the Series A Shares. The Series A Shares represent an approximate 52% of the equity of Temple, on a fully diluted basis.

Under the Recapitalization Agreement the Company will provide working capital to Temple in the amount of not less than $150,000 but up to $250,000. The Company will acquire additional equity ownership of Temple for this investment based on a valuation of Temple of $1,000,000. This further investment will increase the controlling position of the Company in combination with its ownership of the Series A Shares.

The Temple warrant is exercisable for the greater of 1,493,735 shares of common stock of Temple or 2.5% of the equity of Temple on a fully diluted basis. The exercise price per share is the par value of the common stock to be acquired upon exercise of the Temple warrant. The exercise period is ten years, but not later than the earlier of the consummation of the initial public offering by Temple or a sale transaction of Temple, as defined in the Warrant. The Temple warrant has a cashless conversion right and has typical anti-dilution rights for dividends, reverse splits and changes in the capitalization of Temple.

On July 19, 2019, the board of directors of the Company appointed Mr. Paul Bartley as the Chief Executive Officer of the Company and appointed him to be a director of the Company, filling one of the existing vacancies on the Board of Directors. On June 30, 2019, the Company lent to Share International Holding B.V. a company of which Mr. Bartley is a principal, the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%. SIH requested the loan to finance the costs relating to the conclusion of the merger such as extensive travel, third party consultancy fees and legal costs. Natur International Corp. was willing to provide the loan pending the outcome of the merger discussions.

The repayment obligation under the note will be cancelled if no business arrangement is concluded due to a breach by the Company of any agreement for the business arrangement that is concluded in the future, either party to the note experiences a material adverse change, or the business arrangement is not approved by the shareholders or owners of the respective parties to the extent that approval is required. The note also has other standard default provisions under which the Company may declare a default.

On July 29, 2019, $639,784 of an outstanding loan facility in the principle amount of $581,058 or €500,000 plus accrued interest, at an interest rate of 10% per annum, was converted to common stock of the company. On this date the debt was converted and 11,632,445 of common stock was issued to the borrower.

NATUR INTERNATIONAL CORP.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 15 – RECAPITALIZATION

As discussed in Note 1 – Organization and nature of business, effective November 13, 2018, Future Healthcare of America entered into a reverse capitalization transaction with Natur Holding B.V. In conjunction with the transaction the Company was recapitalized, resulting in the capital structure outlined below. The main purpose of the transaction was to raise additional capital for the purposes of growth. The historical number of common shares of Nature Holding B.V. presented in our financial statements were converted to post-acquisition shares on a 1 to 112 basis.

The following shares of common stock were issued in connection with the reverse capitalization transaction. Natur shareholders had a controlling voting percentage of 94% subsequent to the transaction:

-	115,759,999 shares of common stock were issued to the Natur shareholders.

-	2,023,562 shares of common stock were issued to two of the former management of the Company for their cancellation and release of accrued salaries

-	2,469,131 shares of Series A Preferred Stock were issued for a cash capital investment of $2,000,000 and debt forgiveness of $469,131. The shares of Series A Preferred Stock will convert at a ratio of 1 share to 33,000 common shares.

-	100,000 shares of Series B Preferred Stock were issued to the Natur Holding B.V. shareholders. These shares convert at a ratio of 1 share to 1,000 common shares.

NOTE 16 – STOCKHOLDERS’ DEFICIT

On November 13, 2018, Future Healthcare of America completed a transactions pursuant to the Share Exchange Agreement discussed in Note 1. In connection with the Share Exchange Transaction, the Company issued the equivalent of 215,759,999 shares of the Common Stock to the former shareholders of Nature Holding B.V., which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the “Series B Preferred Stock”) representing 100,000,000 shares of Common Stock upon conversion. The Series B Preferred Stock converted automatically into the Common Stock on June 26, 2019, when the Company increased its authorized capital in sufficient amount to permit the conversion of the Series B Preferred Stock. At closing the number of common shares, issued and outstanding was 322,230,038. Per the OTC listing the shares were officially converted on the July 2, 2019.

On September 21, 2018, Parent Company also executed a Securities Purchase Agreement (the “SPA”) by which it agreed to privately issue and sell to Alpha Capital Anstalt (the “Alpha”) 2,469.131 shares of non-voting, convertible Series A Preferred Stock, each share convertible into approximately 33,000 shares of Common Stock, based on a per common share conversion rate of $.030303. Alpha also purchased two warrants, one pursuant to the SPA that is exercisable for 33,000,000 shares of Common Stock at $.060606 per share and another one pursuant to a debt cancellation agreement exercisable for 6,000,000 shares of Common Stock at $.15 per share. The aggregate purchase price for the Series A Preferred Stock and the warrant for 33,333,000 shares of common stock was $2,000,000 in cash and conversion of $469,131 of outstanding debt. The other warrant was issued for conversion of outstanding interest due Alpha under a prior loan agreement to Future Healthcare of America. Prior to the acquisition of Natur Holding, B.V., Alpha also had cancelled approximately $651,000 of debt principle and interest due from the Company. These transactions eliminated $1,420,000 of debt principle and interest of the Company and improved its balance sheet. As part of the SPA transaction, Alpha has also agreed to reimburse up to $100,000 of the liabilities of Parent Company existing at the closing date, which has not yet been paid.

On March 19, 2019, the holder of the Series A Preferred Stock converted 72 of such shares with a stated value of $72,000 for 2,376,002 shares of common stock. The applicable conversion price per common share was $0.030303. The Company did not receive any payment on this conversion, having received the consideration for the Series A Preferred Shares on November 12, 2018. There are remaining an aggregate of 2,397.131 shares of Series A Preferred Stock issued and outstanding. The shares of common stock issued on conversion are registered for resale by the holder.

On April 4, 2019, the Company filed an Articles of Amendment in the State of Wyoming to create a new class of Series C Preferred Stock, which was returned as of April 9, 2019. The Series C Preferred Stock was converted into 78,832,399 shares of Common Stock on June 26, 2019. Per the OTC listing the shares were officially converted on the July 2, 2019.

In June 2019, the Company has entered into a series of agreements under which it will be required to issue the following different series of preferred stock, subject to certain conditions precedent.

Series Preferred Stock D: 15,789.473 preferred shares, conversion to common shares at a ratio of 1:1,000. price per share of $31.70, no voting rights and a warrant reflecting the right to buy 20,000,000 shares at an exercise price of $0.06

Series Preferred Stock E: 56,443.551 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $30,40, no voting rights and a warrant reflecting the right to buy 56,443,551 shares at an exercise price of $0.0304

Series Preferred Sock F: 49,342.105 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share $0.0304, registration rights, and warrant reflecting the right to buy 740,130,158 shares at an exercise price of $0.0304.

Series Preferred Sock G: 46,947.368 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $0.038, registration rights and a warrant reflecting the right to buy 46,947,368 shares at an exercise price of $0.076.

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

General

Safe Harbor Statement.

Statements made in this Form 10-Q which are not purely historical are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and business of the Company, including, without limitation, our ability to gain a larger share of the markets in which we offer our beverage and other products, our ability to retain our business relationships, our ability to raise capital and our ability to consolidate our business operations, acquisitions and grow our product offerings to meet consumer demands, Statements preceded by, followed by or that include the words “may”, “would”, “could”, “should”, “expects”, “projects”, “anticipates”, “believes”, “estimates”, “plans”, “intends”, “targets”, “tend” or similar expressions indicate forward-looking statements.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond the Company’s control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following, in addition to those contained in the Company’s reports on file with the Securities and Exchange Commission: general economic or industry conditions in the national and local communities in which the Company conducts business and sells its products, changes in the legislation or regulatory requirements that affect our products and their composition and the locations through and to which they can be transported and sold, the development of products that may be superior to those offered by the Company, competition in our product segments, changes in the quality or composition of the Company’s products, our ability to develop new products, our ability to raise capital, conditions in the securities markets that may affect the price and trading of our securities held by investors, changes in accounting principles, and other governmental, regulatory and technical factors affecting the Company’s operations.

Accordingly, results actually achieved may differ materially from expected results in these statements. Forward-looking statements speak only as of the date they are made. The Company does not undertake, and specifically disclaims, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

New Vision & Mission

The Company is committing to meet the demands of the burgeoning market for healthy food & beverage products beyond our award-winning fruit and vegetable juices and snacks. The Company is preparing for launch of a wider range of foods and beverages that are effectively functional. With consumers in increasing numbers eating more frequently, eating socially and being focused on the wellness derived from their choices, we are offering choices that can boost their immune system, support a sense of equilibrium in a stressful life, help to resist foods that are not healthy, and more.

The Company brings the forces of nature, existing naturally and organically, as functional supplements in our branded foods and beverages. The first of nature’s superfoods to join our line is hemp. We are preparing for the launch of our line of juices and snacks infused with hemp-derived extracts that are intended to offer improvement in quality of life. The human body’s endo-cannabinoid system is starved for sources of external cannabinoids. When fed, this system fires up the forces of immunity, pain management, heart health, a sense of equilibrium and much more. The Forces of Nature, from the industrial hemp plant, in their purest form, provide the best source for these important cannabinoids. These hemp-derived extracts are the non-psychoactive cannabinoid in the hemp plant that, in increasing numbers, is gain consumer fans for its potential role in treating many common health issues, including pain, inflammation, anxiety, depression, acne and heart disease.

Anticipating growing demand, Natur is developing collaborations in hemp cultivation, extraction and innovation – with growers, greenhouses, research and development scientists driving new products in the fields of hemp-derived medication, edibles and beverages, human and animal topicals and wellness products.

Business Highlights

During the quarter ended June 30, 2019, the Company focused its efforts on the restructuring of its business in the Netherlands and the restructuring of the debt, at the same time the first steps were set to activate the new business plan. Discussions with potential merger partners and private investors took considerable time during this quarter

For the quarter, while sales revenues were considerably lower year over year, operating losses were also lower. Contributing to negative margins was the reduction of inventories through liquidation.

Results of Operations and Financial Condition

Three Months Ended 30 June, 2019 versus Three Months Ended 30 June 2018

During the three months ended June 30, 2019, Natur recorded revenues of $8,134, a 98% decrease over revenues of $414,716 for the same period in 2018. The decrease in 2019 is attributed to the decision the Company made to discontinue selling to less profitable customers while developing its new culturally relevant product lines. It should be noted that in Q2 2018, revenues were generated by two large customers. Both of these customers proved to be less beneficial to the business than planned and by the beginning of Q1 2019 sales to these customers were discontinued.

With the lower revenues in the quarter, cost of goods sold included unleveraged warehousing, inventory reduction and product discard costs and totaled $4,919, a 99% decrease as compared to $283,400 in the comparable period of 2018. Natur posted a gross profit of $3,215 during the second quarter 2019, versus a gross loss of $131,316 for the second quarter of 2018.

Six Months Ended 30 June, 2019 versus Six Months Ended 30 June 2018

During the six months ended June 30, 2019, Natur recorded revenues of $72,553, a 92% decrease over revenues of $942,433 for the same period in 2018. The decrease in 2019 is attributed to the decision the company made to discontinue selling to less profitable customers while developing its new culturally relevant product lines. It should be noted that in first half of 2018, the introduction of two large customers generated initial opening orders, filling the supply chain. Both of these customers proved to be less beneficial to the business than planned and by the beginning of Q1 2019 sales to these customers were discontinued.

With the lower revenues in the six-month period, cost of goods sold included unleveraged warehousing, inventory reduction and product discard costs and totaled $99,696, an 82% decrease as compared to $557,152 in the comparable period of 2018. Natur posted a gross loss of $27,143 during the first half of 2019, versus a gross profit of $385,281 for the first half of 2018.

Natur continued to make year over year improvements in some controllable costs while recording total operating expenses of $3,294,333 during the first half of 2019, a 14% increase as compared to operating expenses of $2,895,729 in the same period of 2018. Wages & Salaries showed a strong improvement, totaling $373,064 in the first half of 2019 versus $792,679 in the first half of 2018, a decrease of 53% driven by significantly streamlined head-count compared to 2018. An additional strong contributing factor is the discontinuation of retail store activities in both the UK and the Netherlands. Selling, General & Administrative costs increased to $2,645,471 from $2,019,466 when comparing the first half of 2019 versus 2018, or 31%. This was driven mainly by an increase in the overall costs incurred by the business due to the administration costs of maintaining a public listing such as legal, board and accountancy fees. The Company also introduced a stock option scheme in 2019 with no similar such costs in the first half of 2018 with costs totaling $1,088,206 for 2019 . Amortization depreciation and impairment costs increased to $275,798 from $83,584 when comparing the first half of 2019 versus 2018, or 230%. This was driven mainly by the Company taking a prudent measure to write down all assets in the retail stores (approximately $200,000) to Nil. As the Company could not comfortably assume we would receive any proceeds for these assets it will therefore only take gains on disposal in future periods should they be realized. These assets are now with the Curator pursuant to the Petition who is dealing with the liquidation of Natur Holding B.V.

Natur’s net loss available to common shareholders was $1,551,207 for the first half of 2019. This represents a 58% decrease from our net loss of $3,669,410 in the first half of 2018. The decrease in the loss was partially offset due to the liquidation of the UK business and a number of the subsidiaries in the Netherlands which allowed a gain on disposal of $1,891,985 to be realized.

Three Months Ended 30 June, 2019 versus Three Months Ended 31 March 2019

During the three months ended June 30, 2019, Natur recorded revenues of $8,134, an 87% decrease over revenues of $64,419 for the preceding period. The decrease against the quarters was driven by the fact that the companies focus for the quarter was on restructuring and seeking funding that would allow the business to continue as a going concern. The focus moving forward into the second half of the year is to engage revenues as part of the Company’s new strategic focus.

For the quarter ended June 30, 2019, cost of goods sold totaled $4,919, a 91% decrease as compared to $94,777 in the preceding period of 2019. This reflects the costs associated with the overall reduction of revenue and due to the reduction in sales the Company had experienced higher marginal costs for our warehousing in the first quarter which have now been largely reduced. We also experienced higher disposal costs due to the perishable nature of our products in the first quarter of 2019. Natur posted a gross profit of $3,215 during the second quarter 2019, versus a gross loss of $30,358 for the preceding quarter of 2019.

Natur recorded total operating expenses of $1,355,005 during the second quarter of 2019, a 30% decrease as compared to operating expenses of $1,939,328 in the preceding period. Wages & Salaries totaled $108,335 in the second quarter of 2019 versus $264,729 in the preceding quarter a decrease of 59% driven by significantly streamlined head-count compared to the first quarter. An additional strong contributing factor is the discontinuation of retail store activities in both the UK and the Netherlands. Selling, General & Administrative costs decreased to $1,243,061 from $1,402,410 when comparing the preceding quarter, or 11%. This was driven mainly by a decrease in the overall costs incurred by the business due to the administration costs of maintaining a public listing as processes have been strengthened and we have undertaken less advisory work in the quarter. The was slightly offset by the fact that the Company also introduced a stock option scheme in 2019 with higher costs in the second quarter due to the termination agreement with Ms. Ellen Berkers. Amortization depreciation & impairment costs decreased to $3,609 from $272,189 when comparing the second quarter of 2019 versus the first quarter of 2019, or 99%. This was driven mainly by the Company taking a prudent measure to write down all assets in the retail stores (roughly $200k) to Nil in the first quarter. As the Company could not comfortably assume we would receive any proceeds for these assets it will therefore only take gains on disposal in future periods should they be realized. These assets are now with the Curator pursuant to the Petition who is dealing with the liquidation of the company.

Natur’s net profit available to common shareholders was $196,324 for the second quarter of 2019. This represents a strong improvement from our net loss of $1,747,531 in the first quarter of 2019. The gain was partially by the corporate restructuring and the decision to close the UK business and a number of the company’s subsidiaries in the Netherlands which allowed a gain on disposal of $1,891,985 to be realized.

Restructuring Activities

Debt restructuring - Effective June 30, 2019 the Company and most of its debtholders have agreed and executed contracts to settle the amounts owed by the Company to the holders under individual the debt agreements, including principle, interest expenses, penalties and other charges of whatsoever nature, all in an amount equal to $6,754,575 in exchange for and in consideration of the issuance to by the Company of an aggregate of 161,149,309 shares of Common Stock.

Corporate restructuring - In line with the objective to secure the continuity of the Company, it was decided in late 2018 to extend the product line with the addition of functional extracts (Nutrigenomics, hemp-derived extracts). For this, the Company established Natur CBC B.V. at March 13, 2019, wholly owned by Natur International Corp. Based on global developments and following the success of companies in the USA and Canada, the Company defined new growth objectives with complementary products based on hemp-derived extracts as a new revenue model. Additional funding was sought in the market, but it became apparent that the willingness of new investors to provide the company with funding in debt or equity was dependent on the restructuring of the existing debt of the Company. As most of this debt exists at the level of Natur Holding B.V., it was decided to develop a restructuring plan to: establish an asset transfer from Natur Holding B.V. to Natur CBD B.V., optimizing the proceeds for these assets and subsequently liquidate Natur Holding B.V. and continue the business in Natur CBD B.V. with an extended portfolio of functional products, including food and beverages infused with hemp-derived extracts and deliver the objectives as set by the Board.

In May 2019 we reached agreements with most of the debtholders to convert their debt to equity and effectively May 1, 2019 the asset transfer between Natur Holding B.V. and its sister company Natur Functionals B.V. was executed and Natur Holding B.V. and its wholly owned subsidiaries were declared bankrupt by the Court in Amsterdam, the Netherlands. The total Debt that was converted to Shares to be issued is $6,754,575.

In June we reached agreement with private investors for the sale of Preferred Stock and Warrants. At June 30, 2019 agreements were signed for a total of $2,064,756 against 65,621.283 of to be issued Preferred Shares.

Accounting Policies

ASC 842: In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)”. This update requires the recognition of lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous guidance. The accounting for finance leases (capital leases) was substantially unchanged. The original guidance required application on a modified retrospective basis with adjustments to the earliest comparative period presented. In August 2018, the FASB issued ASU No. 2018-11, “Targeted Improvements to ASC 842,” which included an option to not restate comparative periods in transition and elect to use the effective date of ASU No. 2016-02 as the date of initial application, which the Company elected. As a result, the consolidated balance sheet prior to January 1, 2019 was not restated, and continues to be reported under previous guidance that did not require the recognition of operating lease liabilities and corresponding lease assets on the consolidated balance sheet. As a result of the adoption of ASU No. 2016-02 on January 1, 2019, the Company recorded operating lease right-of-use assets of $580,310 and operating lease liabilities of $578,007. The adoption of ASU No. 2016-02 had an immaterial impact on the Company’s condensed consolidated statement of income and consolidated statement of cash flows for the six-month period ended June 30, 2019. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which allowed the Company to carry forward the historical lease classification, not reassess prior conclusions related to expired or existing contracts that are or that contain leases, and not reassess the accounting for initial direct costs.

Quantitative and Qualitative Disclosures About Market Risk.

Not required for smaller reporting companies.

Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), which we refer to as disclosure controls, are controls and procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. There are inherent limitations to the effectiveness of any control system. A control system, no matter how well conceived and operated, can provide only reasonable assurance that its objectives are met. No evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

As of June 30, 2019, an evaluation was carried out under the supervision and with the participation of our management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that, as of such date, the design and operation of these disclosure controls were ineffective to accomplish their objectives at the reasonable assurance level.

(b) Changes in Internal Control over Financial Reporting

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), occurred during the fiscal quarter ended June, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting

PART II - OTHER INFORMATION

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes included in Part I, Item 1 of this Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. See “Special Note Regarding Forward-Looking Statements.” Our actual results may differ materially from those described below. You should read the “Risk Factors” section of this Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Certain figures, such as interest rates and other percentages included in this section have been rounded for ease of presentation. Percentage figures included in this section have not in all cases been calculated on the basis of such rounded figures but on the basis of such amounts prior to rounding. For this reason, percentage amounts in this section may vary slightly from those obtained by performing the same calculations using the figures in our consolidated financial statements or in the associated text. Certain other amounts that appear in this section may similarly not sum due to rounding.

ITEM 1 – LEGAL PROCEEDINGS

On June 17, 2016 and June 30, 2016 two complaints were filed, one with the Federal Equal Employment Opportunity Commission (“EEOC”) and one with the Wyoming State Department of Labor against the Company, alleging discrimination on the basis of sex and disability. The complaints did not seek any specific monetary relief. The complaints were mediated by the Wyoming State Department of Labor, and the U.S. Equal Employment Opportunity Commission. The Wyoming State Department of Labor issued a notice of dismissal for one of the complaints. After reviewing the facts and circumstances, the Company believes the claims made are weak, at best, and the Company has retained counsel and intends to continue a vigorous defense. On March 6, 2018, a complaint was filed with the Wyoming Court of Natrona County, alleging violation of the Wyoming Fair Employment Practices Act of 1965 for discrimination based upon sex, disability and retaliation. The complaint does not seek any specific monetary relief. At this time, management cannot reasonably estimate the cost to defend or the outcome of the complaints.

On June 1, 2018, The U.S. EEOC decided that Interim Healthcare of Wyoming violated the Wage discrimination laws (Title VII of the Civil Rights Act of 1964) by paying a male employee more than female employees. The EEOC initially claimed that back wages for these individuals plus liquidated damages total $43,593. On September 19, 2018, the Company attended a Conciliation meeting, at which the EEOC presented a revised settlement of $133,575 for back wages plus liquidated damages. The Company and the EEOC did not agree to a resolution. On September 28, 2018, the EEOC filed in the U.S. District Court for the District of Wyoming a complaint claiming Interim Healthcare of Wyoming violated the Wage discrimination laws (Title VII of the Civil Rights Act of 1964) by paying a male employee more than female employees. It is too early to provide an educated opinion on the chances of a favorable outcome in this matter. There was a wage disparity present at Interim such that a male RN nurse employee was earning $1-$2 more per hour than all other RN nurse employees who were female. Interim employed approximately 6 female RN nurses, and this wage disparity existed for approximately 1 year of operation. We have asserted that this wage disparity was the result of market factors and not illegal gender discrimination, however whether we will be able to marshal sufficient evidence to overcome the presumption that arises from the admitted wage disparity. The Company recorded an accrual totaling $133,575 related to this matter in the period ended December 31, 2018.

ITEM 1A – RISK FACTORS

Not required for smaller reporting companies.

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None, not applicable.

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

None, not applicable.

ITEM 4 – MINE SAFETY DISCLOSURES

None, not applicable.

ITEM 5 – OTHER INFORMATION

ITEM 6 – EXHIBITS

Exhibit No.		Description

31.1		302 Certification of Paul Bartley

31.2		302 Certification of Ruud Huisman

32		906 Certification.

101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation
101.DEF		XBRL Taxonomy Extension Definition
101.LAB		XBRL Taxonomy Extension Labels
101.PRE		XBRL Taxonomy Extension Presentation Linkbase

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NATUR INTERNATIONAL CORP.

Date: 8/14/19	By:	/s/ Paul Bartley
		Paul Bartley
		Chief Executive Officer

Date: 8/14/19		/s/ Rudolf D. Huisman
		Ruud Huisman
		Chief Financial Officer

EX-31.1 2 f10q0619ex31-1_naturintl.htm 302 CERTIFICATION OF PAUL BARTLEY

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Paul Bartley, certify that:

1. I have reviewed this report on Form 10-Q of the issuer;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4. The issuer's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the issuer's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the issuer's internal control over financial reporting that occurred during the issuer's most recent fiscal quarter (the issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the issuer's internal control over financial reporting; and

5. The issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuer's auditors and the audit committee of the issuer's board of directors (or persons performing the equivalent functions);

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.


Date: 8/14/19	By:	/s/ Paul Bartley
		Paul Bartley Chief Executive Officer

EX-31.2 3 f10q0619ex31-2_naturintl.htm 302 CERTIFICATION OF RUUD HUISMAN

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rudolf D. Huisman, certify that:

1. I have reviewed this report on Form 10-Q of the issuer;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer's internal control over financial reporting.


Date: 8/14/19	By:	/s/ Rudolf D. Huisman
		Rudolf D. Huisman Chief Financial Officer

EX-32 4 f10q0619ex32_naturintl.htm 906 CERTIFICATION.

Exhibit 32

CERTIFICATION PURSUANT TO SECTION 1350,

CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q for the period ended June 30, 2019 (the “Report”) of Natur International Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, we, Paul Bartley, the Chief Executive Officer and Rudolf D. Huismn, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

	By:	/s/ Paul Bartley
Date: August 14, 2019		Name: Paul Bartley, Chief Executive Officer

	By:	/s/ Rudolf D. Huisman
Date: August 14, 2019		Name: Rudolf D. Huisman, Chief Financial Officer

EX-101.INS 5 ntru-20190630.xml XBRL INSTANCE FILE 0001552845 2017-12-31 0001552845 2018-06-30 0001552845 2018-01-01 2018-06-30 0001552845 ntru:AlphaCapitalAnstaltMember 2018-09-01 2018-09-21 0001552845 us-gaap:CommonStockMember 2017-12-31 0001552845 us-gaap:CommonStockMember 2018-12-31 0001552845 us-gaap:RetainedEarningsMember 2017-12-31 0001552845 us-gaap:RetainedEarningsMember 2018-12-31 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001552845 ntru:BalanceSheetsMember 2018-12-31 0001552845 ntru:OperationsAndComprehensiveIncomeLossMember 2018-12-31 0001552845 us-gaap:EquityMember 2018-12-31 0001552845 2018-01-01 2018-12-31 0001552845 ntru:NLLifeSciencesBvMember 2018-12-31 0001552845 ntru:AmcMember 2018-12-31 0001552845 srt:ManagementMember 2018-12-31 0001552845 2018-12-31 0001552845 ntru:ConvertibleDebtOneMember 2018-12-31 0001552845 ntru:ConvertibleDebtTwoMember 2018-12-31 0001552845 ntru:ConvertibleDebtTwoMember 2017-10-02 2017-10-20 0001552845 ntru:ConvertibleDebtTwoMember 2017-10-20 0001552845 ntru:ConvertibleDebtTwoMember ntru:EuroMember 2017-10-02 2017-10-20 0001552845 ntru:EfficiencyLifeFundMember 2018-12-31 0001552845 ntru:TriDutchHoldingBvMember 2018-12-31 0001552845 ntru:STBFamilyOfficesSarlMember 2018-12-31 0001552845 ntru:STBFamilyOfficesBvMember 2018-12-31 0001552845 ntru:StichtingThankYouNatureMember 2018-12-31 0001552845 ntru:FllareMediaBvMember 2018-12-31 0001552845 ntru:YoomooLimitedMember 2018-12-31 0001552845 us-gaap:LongTermDebtMember 2018-01-01 2018-12-31 0001552845 us-gaap:LongTermDebtMember 2018-12-31 0001552845 us-gaap:LongTermDebtMember ntru:EURMember 2018-01-01 2018-12-31 0001552845 us-gaap:OtherAdditionalCapitalMember 2017-12-31 0001552845 us-gaap:OtherAdditionalCapitalMember 2018-12-31 0001552845 2018-11-01 2018-11-13 0001552845 2018-11-13 0001552845 us-gaap:SeriesBPreferredStockMember 2018-11-01 2018-11-13 0001552845 country:US 2018-01-01 2018-12-31 0001552845 country:US 2017-01-01 2017-12-31 0001552845 us-gaap:LongTermDebtMember ntru:EURMember 2018-12-31 0001552845 ntru:NaturShareholdersMember 2018-11-13 0001552845 us-gaap:PreferredClassAMember 2018-11-13 0001552845 us-gaap:PreferredClassBMember 2018-11-13 0001552845 us-gaap:PreferredClassAMember 2018-11-01 2018-11-13 0001552845 us-gaap:PreferredClassBMember 2018-11-01 2018-11-13 0001552845 us-gaap:PreferredClassAMember 2018-12-31 0001552845 us-gaap:PreferredClassBMember 2018-12-31 0001552845 us-gaap:PreferredClassAMember 2018-01-01 2018-12-31 0001552845 us-gaap:PreferredClassBMember 2018-01-01 2018-12-31 0001552845 us-gaap:ParentMember 2018-11-01 2018-11-13 0001552845 2019-01-01 2019-06-30 0001552845 2019-06-30 0001552845 us-gaap:PreferredClassAMember 2019-06-30 0001552845 us-gaap:PreferredClassBMember 2019-06-30 0001552845 2018-01-01 2018-03-31 0001552845 us-gaap:CommonStockMember 2019-06-30 0001552845 us-gaap:PreferredClassAMember 2019-01-01 2019-06-30 0001552845 us-gaap:PreferredClassBMember 2019-01-01 2019-06-30 0001552845 us-gaap:OtherAdditionalCapitalMember 2019-06-30 0001552845 us-gaap:RetainedEarningsMember 2019-06-30 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001552845 us-gaap:BuildingImprovementsMember 2019-01-01 2019-06-30 0001552845 us-gaap:MachineryAndEquipmentMember 2019-01-01 2019-06-30 0001552845 us-gaap:FurnitureAndFixturesMember 2019-01-01 2019-06-30 0001552845 us-gaap:SoftwareDevelopmentMember 2019-01-01 2019-06-30 0001552845 country:NL 2019-01-01 2019-06-30 0001552845 country:FR 2019-01-01 2019-06-30 0001552845 country:IS 2019-01-01 2019-06-30 0001552845 ntru:NLLifeSciencesBvMember 2019-06-30 0001552845 srt:ManagementMember 2019-06-30 0001552845 ntru:STBFamilyOfficesSarlMember 2019-06-30 0001552845 ntru:STBFamilyOfficesBvMember 2019-06-30 0001552845 ntru:StichtingThankYouNatureMember 2019-06-30 0001552845 ntru:FllareMediaBvMember 2019-06-30 0001552845 ntru:YoomooLimitedMember 2019-06-30 0001552845 ntru:AmcMember 2019-06-30 0001552845 ntru:DynamicHealthBvMember 2019-06-30 0001552845 ntru:DynamicHealthBvMember 2018-12-31 0001552845 ntru:NLLifeSciencesBvMember ntru:STBFamilyOfficesMember 2019-01-01 2019-06-30 0001552845 ntru:EfficiencyLifeFundMember 2019-06-30 0001552845 ntru:TriDutchHoldingBvMember 2019-06-30 0001552845 ntru:ConvertibleDebtOneMember 2019-06-30 0001552845 ntru:ConvertibleDebtTwoMember 2019-06-30 0001552845 ntru:ConvertibleDebtThreeMember 2018-12-31 0001552845 ntru:ConvertibleDebtThreeMember 2019-06-30 0001552845 us-gaap:WarrantMember 2018-11-01 2018-11-13 0001552845 ntru:WarrantOneMember 2018-11-01 2018-11-13 0001552845 us-gaap:WarrantMember 2018-11-13 0001552845 ntru:WarrantOneMember 2018-11-13 0001552845 2018-03-31 0001552845 2019-02-20 2019-03-19 0001552845 ntru:ConvertibleDebtThreeMember 2019-02-18 0001552845 us-gaap:ShareBasedCompensationAwardTrancheThreeMember ntru:ConvertibleDebtThreeMember 2019-02-18 0001552845 us-gaap:StockOptionMember ntru:MrAnthonyJoelBayMember 2019-01-01 2019-01-16 0001552845 us-gaap:StockOptionMember ntru:MrRudolfDerkHuismanMember 2019-01-01 2019-01-16 0001552845 us-gaap:StockOptionMember ntru:MrRobertAPaladinoMember 2019-01-01 2019-01-16 0001552845 ntru:LeaseMember 2019-06-30 0001552845 2019-04-01 2019-06-30 0001552845 2018-04-01 2018-06-30 0001552845 us-gaap:SeriesCPreferredStockMember 2019-06-30 0001552845 us-gaap:SeriesCPreferredStockMember 2018-12-31 0001552845 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001552845 us-gaap:CommonStockMember 2019-03-31 0001552845 us-gaap:OtherAdditionalCapitalMember 2019-01-01 2019-03-31 0001552845 us-gaap:OtherAdditionalCapitalMember 2019-03-31 0001552845 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001552845 us-gaap:RetainedEarningsMember 2019-03-31 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001552845 us-gaap:PreferredClassAMember 2019-01-01 2019-03-31 0001552845 us-gaap:PreferredClassAMember 2019-03-31 0001552845 us-gaap:PreferredClassBMember 2019-03-31 0001552845 2019-01-01 2019-03-31 0001552845 2019-03-31 0001552845 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001552845 us-gaap:OtherAdditionalCapitalMember 2019-04-01 2019-06-30 0001552845 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001552845 us-gaap:PreferredClassAMember 2019-04-01 2019-06-30 0001552845 us-gaap:PreferredClassBMember 2019-04-01 2019-06-30 0001552845 us-gaap:SeriesCPreferredStockMember 2019-03-31 0001552845 us-gaap:SeriesCPreferredStockMember 2019-01-01 2019-06-30 0001552845 us-gaap:SeriesCPreferredStockMember 2019-04-01 2019-06-30 0001552845 ntru:BalanceSheetsMember 2019-06-30 0001552845 ntru:OperationsAndComprehensiveIncomeLossMember 2019-06-30 0001552845 us-gaap:EquityMember 2019-06-30 0001552845 ntru:NLLifeSciencesBvMember ntru:STBFamilyOfficesMember 2018-01-01 2018-06-30 0001552845 us-gaap:SeriesCPreferredStockMember 2018-01-01 2018-12-31 0001552845 ntru:ConvertibleDebtThreeMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember ntru:EuroMember 2019-02-18 0001552845 us-gaap:SeriesCPreferredStockMember 2019-06-01 2019-06-28 0001552845 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-06-30 0001552845 us-gaap:SubsequentEventMember ntru:NonUSPrivateInvestorsMember 2019-07-01 2019-07-31 0001552845 us-gaap:SubsequentEventMember 2019-07-01 2019-07-24 0001552845 us-gaap:SubsequentEventMember 2019-07-01 2019-07-09 0001552845 us-gaap:BuildingMember 2019-06-30 0001552845 us-gaap:BuildingMember 2018-12-31 0001552845 us-gaap:SoftwareDevelopmentMember 2019-06-30 0001552845 us-gaap:SoftwareDevelopmentMember 2018-12-31 0001552845 us-gaap:MachineryAndEquipmentMember 2018-12-31 0001552845 us-gaap:MachineryAndEquipmentMember 2019-06-30 0001552845 us-gaap:FurnitureAndFixturesMember 2019-06-30 0001552845 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001552845 us-gaap:ConvertibleDebtMember 2019-01-01 2019-06-30 0001552845 us-gaap:ConvertibleDebtMember 2019-06-30 0001552845 country:NL 2018-01-01 2018-06-30 0001552845 country:FR 2018-01-01 2018-06-30 0001552845 country:IS 2018-01-01 2018-06-30 0001552845 2019-04-01 2019-04-30 0001552845 2019-05-01 2019-05-31 0001552845 2019-06-01 2019-06-26 0001552845 us-gaap:StockOptionMember ntru:MsEllenBerkersMember 2019-01-01 2019-01-16 0001552845 2019-08-13 0001552845 us-gaap:OtherAdditionalCapitalMember 2018-03-31 0001552845 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001552845 us-gaap:CommonStockMember 2018-03-31 0001552845 us-gaap:RetainedEarningsMember 2018-03-31 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001552845 us-gaap:OtherAdditionalCapitalMember 2018-06-30 0001552845 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001552845 us-gaap:RetainedEarningsMember 2018-06-30 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001552845 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001552845 us-gaap:CommonStockMember 2018-06-30 0001552845 us-gaap:SubsequentEventMember 2019-07-01 2019-07-29 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure iso4217:EUR

-3669410

-1551207

196324

-1490226

2018-02-28

2018-12-31

1082734

1652

128364

1028877

99535

60274

523510

58685

51165

1072849

400750

672099

2984017

1600710

629750

970960

1202849

636614

566235

67388

34878

32054

25396

563118

325382

142154

2032705

200234

661432

16913

25458

98014

2809939

2088917

278092

227323

193632

21975

352423

21628

3972 26018 24642 2558

202124

56183

583161

106387

17400000 15000000

0.05

0.10

1799213

929692

800000

377628

5000

11671743

581058

500000

560915

500000

Natur International Corp. 0001552845 2019-06-30 Non-accelerated Filer true --12-31 Q2 2019 false 10-Q

1642364

1217300

813188

96038

37353

829176

1121262

179072

24483

42744

2628

18975639

9765288

18975639

9765288

11671743

2032705

2809939

583161

106387

1127345

426891

1642364

1217300

-337125

67465

-22299570

-23850777

5174269

14924725

129049

310597

-2510448

157386

3483928

-3321476

-1351790

-1152849

942433

72553

8134

414716

942433

0.23

2032-03-31

469131

2000000

The shares of Series A Preferred Stock will convert at a ratio of 1 share to 33,000 common shares. These shares convert at a ratio of 1 share to 1,000 common shares.

128364

1028877

-1081082

900513

312905

1610976

2625651

210652

-2902710

-2089208

1951766

-23411

-33911

1124

436965

-44516

20802

-24

252278

-37592

100

-416304

-178008

-124643

110391

false

In part as 100,000 shares of voting.

2376002

-72

2000000

399381

215759999

115760000

65621.283

P5Y

P7Y

P3Y

0.8734

0.8464

0.9037

0.8849

0.8895

0.9037

0.074 0.074 0.074

39000000

39000000 P4Y P4Y

33000000

6000000

0.0606060

0.15

129049192

2023562

115759999

310597593

0.001

51705

124016

201907

23618

27547

428793

243510

133575

643616

36894

81621

42211

-81621

-42211

81621

42211

The holder of the Series A Preferred Stock converted 72 of such shares with a stated value of $72,000 for 2,376,002 shares of common stock. The applicable conversion price per common share was $0.030303. The Company did not receive any payment on this conversion, having received the consideration for the Series A Preferred Shares on November 12, 2018. There are remaining an aggregate of 2,397.131 shares of Series A Preferred Stock issued and outstanding. The shares of common stock issued on conversion are registered for resale by the holder.

The historical number of common shares of Nature Holding B.V. presented in our financial statements were converted to post-acquisition shares on a 1 to 112 basis.

In connection with the Share Exchange Transaction, the Company issued the equivalent of 215,759,999 shares of the Common Stock to the former shareholders of Nature Holding B.V., which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the "Series B Preferred Stock") representing 100,000,000 shares of Common Stock upon conversion. The Series B Preferred Stock converted automatically into the Common Stock on June 26, 2019, when the Company increased its authorized capital in sufficient amount to permit the conversion of the Series B Preferred Stock.

578007

200000000

750000000

129049192

310597593

310597594

0.001

100000

2469131

100000

2469131

100000

2397131

2469131

100000

2397131

81621 42211 false

1088206

P0Y

P6Y

0.00

3.82

0.00

0.03

27757963

9459688

18298275

0.071

The fair value of all stock options outstanding at 30 June, 2019 is $1,970,813 at a weighted average fair value of $0.071 per option.

Through La Bay Ventures Inc., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary.

Through Pas Beheer B.V., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary.

Through Cavalier Aire LLC., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of NTRU. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary.

The Company entered into the letter of intent, it lent to SIH the sum $250,000 under a promissory note, due January 4, 2020.

Through Montrose Executive Management, will be issued an aggregate of 5,800,000 share of options to purchase common stock of the Company as part of her termination arrangement dated May 30, 2019. The option granted by the Company provides for the right to exercise the shares at $.030303 per share at any time from April 1, 2022 until March 31, 2025.

201160

false (i) $10,000, and (ii) one percent of the average of the Company's total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review.

580310

887126

170469

000-54917 Yes P7 Yes

887126

170469

-3669410

-1146617

247001

-1490226

404590

50677

-0.03

-0.00

0.00

-0.01

-1095701

-81621

-42211

-302964

1891985

1591187

-2573709

-3361571

-1352652

-1187262

-2573709

-3361571

-1352652

-1187262

63261

40095

862

34413

2895729

3294333

1355005

1284165

83584

275798

3609

30268

2019466

2645471

1243061

904599

792679

373064

108335

349298

385281

-27143

3215

131316

557152

99696

4919

283400

132116 66136 2240 58718 425036 33560 2679 224682

-2179184

196324

-1490226

-1747531

196324

-2179184

-1490226

685044

403162

685044

2376

-2376

-12933240

-16602650

115760

129049

-15250748

-22299570

-1114812

-337125

-17333274

3316560

5174269

-8547988

310597

14924725

-23850777

67465

-15112424

131425

5575055

-24047101

16788

100

-18323730

3316560

115760

-17429932

-1114812

3316560

-18920158

-1114812

115760

115759999

129049192

2469131

100000

2397

310597593

131425194

2397131

100000

115759999

13558

340

13218

340000

100000 -99900 -100 100000000 -100000 78832 -78753 -79 78832399 -78832

50677

353913

50677

32015

275798

52266

560915

-240503

NOTE 6 – ACCRUED EXPENSES & OTHER CONTINGENT LIABILITIES   Accrued expenses & other contingent liabilities at June 30, 2019 and December 31, 2018 consisted of the following:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Taxes payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21,628</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">352,423</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Invoices to be received</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,972</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Holiday Allowance Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,642</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses & other contingent liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,183</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">202,124</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">106,387</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">583,161</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Taxes payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21,628</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">352,423</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Invoices to be received</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,018</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,972</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Holiday Allowance Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,642</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other accrued expenses & other contingent liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,183</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">202,124</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">106,387</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">583,161</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table>

41130

797770

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> June 30, 2019</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font: 10pt Times New Roman, Times, Serif">Outstanding at beginning of period</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Outstanding at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr></table>

1:33,000 1:1000 1:33,000 1:1000 1:1000 1:1000

2064756

Basis of presentation. The Company prepares its financial statements using the accrual basis of accounting in accordance with United States generally accepted accounting principles ("US GAAP").

Use of Estimates in Financial Statement Preparation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents. Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable. Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for bad debts. The allowance for bad debts is recognized based on management's estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances.

Inventory. Inventory, consisting of raw materials, work in progress and finished goods, is valued at the lower of the inventory's costs or net realizable value, using the first in, first out method to determine the cost. Management compares the cost of inventory with its net realizable value and an allowance is made to write down inventory to net realizable value, if lower.

Property and Equipment. Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="width: 50%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Category</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated Useful lives</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Building and improvements</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">5 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Machines and installations</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">7 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Hardware and software</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">3 years</td></tr></table>

Intangible Assets, and Long-Lived Assets. The Company recognizes an acquired intangible asset apart from goodwill whenever the intangible asset arises from contractual or other legal rights, or when it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their useful lives. Impairment losses are recognized if the carrying amount of an intangible asset subject to amortization is not recoverable from expected future cash flows and its carrying amount exceeds its fair value.   The Company's long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Long lived assets are evaluated on a yearly basis and no impairment losses were incurred during the six months ended June 30, 2019.

Related Party Transactions. The Board of Directors has adopted a Related Party Transaction Policy for the review of related person transactions. Under these policies and procedures, the management reviews related person transactions in which we are or will be a participant to determine if they are fair and beneficial to the Company. Financial transactions, arrangements, relationships or any series of similar transactions, arrangements or relationships in which a related person has or will have a material interest and that exceeds the lesser of: (i) $10,000, and (ii) one percent of the average of the Company's total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review. Any member of the board who is a related person with respect to a transaction under review may not participate in the deliberation or vote requesting approval or ratification of the transaction. Transactions that are subject to the policy include any transaction, arrangement or relationship (including indebtedness or guarantees of indebtedness) in which the Company is a participant with a related person. The related person may have a direct or indirect material interest in the transaction. It is Company policy that the board shall approve any related party transaction before the commencement of the transaction. However, if the transaction is not identified before commencement, it must still be presented to the board for their review and ratification.

Revenue Recognition. Beginning on January 1, 2018, the Company recognizes revenue under ASC 606, Revenue from Contracts with Customers. The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. The following five steps are applied to achieve that core principle:   Step 1: Identify the contract with the customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when the company satisfies a performance obligation   The Company's performance obligations are satisfied at the point in time when products are received by the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company's contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of product.   The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon delivery to the customer. The Company's performance obligations are satisfied at that time.

Foreign Currency Translation. The Company follows Section 830-10-45 of the FASB Accounting Standards Codification ("Section 830-10-45") for foreign currency translation to translate the financial statements from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity's functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash.   The financial records of the Company are maintained in its local currency, the euro ("EUR"), which is the functional currency. Assets and liabilities are translated from the local currency into the reporting currency, U.S. dollars, at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Foreign currency translation gain (loss) resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining accumulated other comprehensive income in the consolidated statement of stockholders' equity.   Unless otherwise noted, the rate presented below per U.S. $1.00 was the midpoint of the interbank rate as quoted by OANDA Corporation (www.oanda.com) contained in its consolidated financial statements. Translation of amounts from EUR into U.S. dollars has been made at the following exchange rates for the respective periods:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Balance Sheets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.8849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.8734</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Statements of operations and comprehensive income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.8895</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.8464</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.9037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.9037</td><td style="text-align: left"> </td></tr></table>

Cost of Revenues. Cost of revenue includes all direct expenses incurred to produce the revenue for the period. This includes, but is not limited to, costs for finished products, pick packing costs, storage costs and transportation costs. Cost of revenues are recorded in the same period as the resulting revenue.

Employee Benefits. Wages, salaries, bonuses and social security contributions are recognized as an expense in the year in which the associated services are rendered by employees. For any unused portion of vacation leave, an accrual is recorded for carry over to the following year.

Fair Value of Financial Instruments. The carrying value of short-term instruments, including cash, accounts payable and accrued expenses, and short-term notes approximate fair value due to the relatively short period to maturity for these instruments. The long-term debt approximate fair value since the related rates of interest approximate current market rates.   Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs.   The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"><td style="width: 50%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Category</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated Useful lives</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Building and improvements</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">5 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Machines and installations</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">7 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Hardware and software</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">3 years</td></tr></table>

1833

838404

60117

491847

80163

65886

60117

200508

314894

1432

523510

58685

6114790

0.10

Consolidation - The financial statements presented reflect the accounts of Natur International Corp and its direct and indirect subsidiaries. All inter-company transactions have been eliminated in consolidation.

Share-Based Payment Arrangements. The Company measures the cost of employee services received in exchange for an award of equity instruments (share-based payments, or SBP) based on the grant-date fair value of the award. That cost is recognized over the period during which an employee is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model. The Company adopted ASU 2018-07 in the first quarter of 2019 which aligns the accounting for share-based payment awards issued to employees and non-employees.   The fair value of each option granted during the period ended June 30, 2019 was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Expected dividend yield</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected option term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">382</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table>   The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company's common stock. The assumed discount rate was the default risk-free six-year interest rate in the Netherlands.   Revenues do not include sales or other taxes collected from customers.   The Company's products are sold and distributed through various channels, which include selling directly to retail stores and other outlets such as food markets, institutional accounts and independent outlets. The Company typically collects payment from customers within 30 days from the date of sale. The following table presents our continued revenues disaggregated by geographical region for the six-month period ended June 30, 2019:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2018</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Netherlands</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">72,553</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">942,433</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>France</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Iceland</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">72,553</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">942,433</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table>   The Company sells its products and extends credit, generally without requiring collateral, based on an ongoing evaluation of the customer's business prospects and financial condition. The Company evaluates the collectability of its trade accounts receivable based on a number of factors, including the Company's historic collections pattern and changes to a specific customer's ability to meet its financial obligations. The Company has established an allowance for doubtful accounts to adjust the recorded receivable to the estimated amount the Company believes will ultimately be collected.   The nature of the Company's contracts does not give rise to variable consideration, such as prospective and retrospective rebates.   The Company experiences customer returns primarily as a result of damaged or out-of-date product. At any given time, the Company estimates less than 1% of sales could be at risk for return by customers. As the company do not deem this amount to be material no provision was recorded for the period ended 30 June, 2019. Returned product is recognized as a reduction of net sales.

Recent Accounting Pronouncements   Compensation—Stock Compensation: On June 20, 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting, which aligns the accounting for share-based payment awards issued to employees and nonemployees. Under ASU No. 2018-07, the existing employee guidance will apply to nonemployee share-based transactions (as long as the transaction is not effectively a form of financing), with the exception of specific guidance related to the attribution of compensation cost. The cost of nonemployee awards will continue to be recorded as if the grantor had paid cash for the goods or services. In addition, the contractual term will be able to be used in lieu of an expected term in the option-pricing model for nonemployee awards. The adoption had no impact on the Company's historic financial statements.   Leases: In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)". This update requires the recognition of lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous guidance. The accounting for finance leases (capital leases) was substantially unchanged. The original guidance required application on a modified retrospective basis with adjustments to the earliest comparative period presented. In August 2018, the FASB issued ASU No. 2018-11, "Targeted Improvements to ASC 842," which included an option to not restate comparative periods in transition and elect to use the effective date of ASU No. 2016-02 as the date of initial application, which the Company elected. As a result, the consolidated balance sheet prior to January 1, 2019 was not restated, and continues to be reported under previous guidance that did not require the recognition of operating lease liabilities and corresponding lease assets on the consolidated balance sheet. As a result of the adoption of ASU No. 2016-02 on January 1, 2019, the Company recorded operating lease right-of-use assets of $580,310 and operating lease liabilities of $578,007.

Income /(Loss) Per Share - The Company computes income (loss) per share in accordance with Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 260 Earnings Per Share, which requires the Company to present basic earnings per share and diluted earnings per share when the effect is dilutive (see Note 12).

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><tr style="vertical-align: bottom"><td></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2018</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Netherlands</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">72,553</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">942,433</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>France</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Iceland</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">72,553</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">942,433</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table>

The Company lent to Share International Holding B.V. a company of which Mr. Bartley is a principal, the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%.

78832399

-0.03

0.00

-0.01

8830140 8830061 79 78832 2064736 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><tr style="vertical-align: bottom"><td></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Efficiency Life Fund</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,984,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">400,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">TriDutch Holding B.V.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">672,099</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,984,017</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,072,849</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table> 100000000 78832399 149516865

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Basis of presentation. The Company prepares its financial statements using the accrual basis of accounting in accordance with United States generally accepted accounting principles ("US GAAP").   Consolidation - The financial statements presented reflect the accounts of Natur International Corp and its direct and indirect subsidiaries. All inter-company transactions have been eliminated in consolidation.   Use of Estimates in Financial Statement Preparation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Cash and Cash Equivalents. Cash equivalents include all highly liquid investments with original maturities of three months or less.   Accounts Receivable. Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for bad debts. The allowance for bad debts is recognized based on management's estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances.   Inventory. Inventory, consisting of raw materials, work in progress and finished goods, is valued at the lower of the inventory's costs or net realizable value, using the first in, first out method to determine the cost. Management compares the cost of inventory with its net realizable value and an allowance is made to write down inventory to net realizable value, if lower.   Property and Equipment. Property and equipment are valued at cost. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="width: 50%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">Category</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated Useful lives</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Building and improvements</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">5 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Machines and installations</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">5 years</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">7 years</td></tr> <tr style="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Hardware and software</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">3 years</td></tr> </table>   Intangible Assets and Long-Lived Assets. The Company recognizes an acquired intangible asset apart from goodwill whenever the intangible asset arises from contractual or other legal rights, or when it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their useful lives. Impairment losses are recognized if the carrying amount of an intangible asset subject to amortization is not recoverable from expected future cash flows and its carrying amount exceeds its fair value.   The Company's long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Long lived assets are evaluated on a yearly basis and no impairment losses were incurred during the six months ended June 30, 2019.   Related Party Transactions. The Board of Directors has adopted a Related Party Transaction Policy for the review of related person transactions. Under these policies and procedures, the management reviews related person transactions in which we are or will be a participant to determine if they are fair and beneficial to the Company. Financial transactions, arrangements, relationships or any series of similar transactions, arrangements or relationships in which a related person has or will have a material interest and that exceeds the lesser of: (i) $10,000, and (ii) one percent of the average of the Company's total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review. Any member of the board who is a related person with respect to a transaction under review may not participate in the deliberation or vote requesting approval or ratification of the transaction. Transactions that are subject to the policy include any transaction, arrangement or relationship (including indebtedness or guarantees of indebtedness) in which the Company is a participant with a related person. The related person may have a direct or indirect material interest in the transaction. It is Company policy that the board shall approve any related party transaction before the commencement of the transaction. However, if the transaction is not identified before commencement, it must still be presented to the board for their review and ratification.   Revenue Recognition. Beginning on January 1, 2018, the Company recognizes revenue under ASC 606, Revenue from Contracts with Customers. The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. The following five steps are applied to achieve that core principle:   Step 1: Identify the contract with the customer Step 2: Identify the performance obligations in the contract Step 3: Determine the transaction price Step 4: Allocate the transaction price to the performance obligations in the contract Step 5: Recognize revenue when the company satisfies a performance obligation   The Company's performance obligations are satisfied at the point in time when products are received by the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company's contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of product.   The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon delivery to the customer. The Company's performance obligations are satisfied at that time.   Share-Based Payment Arrangements. The Company measures the cost of employee services received in exchange for an award of equity instruments (share-based payments, or SBP) based on the grant-date fair value of the award. That cost is recognized over the period during which an employee is required to provide service in exchange for the SBP award—the requisite service period (vesting period). For SBP awards subject to conditions, compensation is not recognized until the performance condition is probable of occurrence. The grant-date fair value of share options is estimated using the Black-Scholes-Merton option-pricing model. The Company adopted ASU 2018-07 in the first quarter of 2019 which aligns the accounting for share-based payment awards issued to employees and non-employees.   The fair value of each option granted during the period ended June 30, 2019 was estimated on the date of grant using the Black-Scholes-Merton option-pricing model with the weighted average assumptions in the following table:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Expected dividend yield</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected option term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">382</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table>   The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company's common stock. The assumed discount rate was the default risk-free six-year interest rate in the Netherlands.    Revenues do not include sales or other taxes collected from customers.   The Company's products are sold and distributed through various channels, which include selling directly to retail stores and other outlets such as food markets, institutional accounts and independent outlets. The Company typically collects payment from customers within 30 days from the date of sale. The following table presents our continued revenues disaggregated by geographical region for the six-month period ended June 30, 2019:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2018</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Netherlands</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">72,553</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">942,433</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>France</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Iceland</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">72,553</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">942,433</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table>   The Company sells its products and extends credit, generally without requiring collateral, based on an ongoing evaluation of the customer's business prospects and financial condition. The Company evaluates the collectability of its trade accounts receivable based on a number of factors, including the Company's historic collections pattern and changes to a specific customer's ability to meet its financial obligations. The Company has established an allowance for doubtful accounts to adjust the recorded receivable to the estimated amount the Company believes will ultimately be collected.   The nature of the Company's contracts does not give rise to variable consideration, such as prospective and retrospective rebates.   The Company experiences customer returns primarily as a result of damaged or out-of-date product. At any given time, the Company estimates less than 1% of sales could be at risk for return by customers. As the company do not deem this amount to be material no provision was recorded for the period ended 30 June, 2019. Returned product is recognized as a reduction of net sales.   Recent Accounting Pronouncements   Compensation—Stock Compensation: On June 20, 2018, the FASB issued ASU No. 2018-07, Compensation—Stock Compensation (Topic 718) - Improvements to Nonemployee Share-Based Payment Accounting, which aligns the accounting for share-based payment awards issued to employees and nonemployees. Under ASU No. 2018-07, the existing employee guidance will apply to nonemployee share-based transactions (as long as the transaction is not effectively a form of financing), with the exception of specific guidance related to the attribution of compensation cost. The cost of nonemployee awards will continue to be recorded as if the grantor had paid cash for the goods or services. In addition, the contractual term will be able to be used in lieu of an expected term in the option-pricing model for nonemployee awards. The adoption had no impact on the Company's historic financial statements.   Leases: In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)". This update requires the recognition of lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous guidance. The accounting for finance leases (capital leases) was substantially unchanged. The original guidance required application on a modified retrospective basis with adjustments to the earliest comparative period presented. In August 2018, the FASB issued ASU No. 2018-11, "Targeted Improvements to ASC 842," which included an option to not restate comparative periods in transition and elect to use the effective date of ASU No. 2016-02 as the date of initial application, which the Company elected. As a result, the consolidated balance sheet prior to January 1, 2019 was not restated, and continues to be reported under previous guidance that did not require the recognition of operating lease liabilities and corresponding lease assets on the consolidated balance sheet. As a result of the adoption of ASU No. 2016-02 on January 1, 2019, the Company recorded operating lease right-of-use assets of $580,310 and operating lease liabilities of $578,007.    Foreign Currency Translation. The Company follows Section 830-10-45 of the FASB Accounting Standards Codification ("Section 830-10-45") for foreign currency translation to translate the financial statements from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity's functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash.   The financial records of the Company are maintained in its local currency, the euro ("EUR"), which is the functional currency. Assets and liabilities are translated from the local currency into the reporting currency, U.S. dollars, at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Foreign currency translation gain (loss) resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining accumulated other comprehensive income in the consolidated statement of stockholders' equity.   Unless otherwise noted, the rate presented below per U.S. $1.00 was the midpoint of the interbank rate as quoted by OANDA Corporation (www.oanda.com) contained in its consolidated financial statements. Translation of amounts from EUR into U.S. dollars has been made at the following exchange rates for the respective periods:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Balance Sheets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.8849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.8734</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Statements of operations and comprehensive income (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.8895</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.8464</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.9037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.9037</td><td style="text-align: left"> </td></tr> </table>   Cost of Revenues. Cost of revenue includes all direct expenses incurred to produce the revenue for the period. This includes, but is not limited to, costs for finished products, pick packing costs, storage costs and transportation costs. Cost of revenues are recorded in the same period as the resulting revenue.   Employee Benefits. Wages, salaries, bonuses and social security contributions are recognized as an expense in the year in which the associated services are rendered by employees. For any unused portion of vacation leave, an accrual is recorded for carry over to the following year.   Income Taxes. The Company is subject to US corporation tax. The US combined federal and state corporate tax rate is 23%. The company's United States net operating losses totaled $3,483,928 as of December 31, 2017 and begin to expire in tax years 2032 and following. Net losses from US operating totaled $157,386 for 2018 and may be carried forward indefinitely. The company is subject to US Internal Revenue Code rules limiting the use of US net operating losses after the merger with Future Health Care of America during 2018 (described in Note 17). This limitation has no effect on the Company's financial statements because the Company has recognized no deferred tax asset with respect to its net operating loss carryforwards. The NOLs are the cumulative NOL's per the Company's 2017 federal income tax return. The 382 limit will not be factored in until the company has income and the limit is therefore applicable.   Natur BPS B.V., the Dutch subsidiary of Natur International Corp is structured as a Dutch limited liability company. Tax on the result is calculated based on the result before tax in the profit and loss account, considering losses available for set-off from previous years (to the extent that they have not already been included in the deferred tax assets) and exempt profit components and after the addition of non-deductible costs. Due account is also taken of changes which occur in the deferred tax assets and deferred tax liabilities in respect of changes in the applicable tax rate.   The corporate tax rate for profits above $238,812 (or €200,000) amounts to 25%. Below that amount the rate is 20%. Future profits can be carried back to prior year losses for a maximum of 9 years for the full amount of losses incurred.   In the financial statements of group companies, a tax charge is calculated on the basis of the accounting result. The corporate income tax that is due by these group companies is charged into the current accounts of the company.   Because of the compensable losses no deferred taxes are included in the financial statements. From incorporation of the company only the Corporation Tax return of 2015/2016 has been filed. All years are still subject to examination.   Fair Value of Financial Instruments. The carrying value of short-term instruments, including cash, accounts payable and accrued expenses, and short-term notes approximate fair value due to the relatively short period to maturity for these instruments. The long-term debt approximate fair value since the related rates of interest approximate current market rates.   Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs.   The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.   Income /(Loss) Per Share - The Company computes income (loss) per share in accordance with Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 260 Earnings Per Share, which requires the Company to present basic earnings per share and diluted earnings per share when the effect is dilutive (see Note 12).

NOTE 12 – LOSS PER SHARE   At June 30, 2019, the Company had 310,597,593 shares issues and outstanding at a par value of $.001. The Company also has 2,397.130 preferred A shares issued and outstanding. Alpha Capital Anstalt has two outstanding warrants issued on November 13, 2018, each with 4-year terms. The first warrant has an exercise price of $0.060606 for 36,000,000 shares and the second warrant is exercisable for 6,000,000 shares at a $0.15 exercise price. The Company has reserved 16,240,000  shares of Common Stock for management incentive awards. At December 31, 2018, the Company had 129,049,192 shares of common stock issued and outstanding.

Alpha Capital Anstalt has two outstanding warrants issued on November 13, 2018, each with 4-year terms. The first warrant has an exercise price of $0.060606 for 36,000,000 shares and the second warrant is exercisable for 6,000,000 shares at a $0.15 exercise price. The Company has reserved 16,240,000 shares of Common Stock for management incentive awards.

The Company reached agreement with certain non-US private investors to invest in total $1,765,605 to acquire 46,947.368 of the Series G Preferred Stock. NOTE 15 – RECAPITALIZATION  As discussed in Note 1 – Organization and nature of business, effective November 13, 2018, Future Healthcare of America entered into a reverse capitalization transaction with Natur Holding B.V. In conjunction with the transaction the Company was recapitalized, resulting in the capital structure outlined below. The main purpose of the transaction was to raise additional capital for the purposes of growth. The historical number of common shares of Nature Holding B.V. presented in our financial statements were converted to post-acquisition shares on a 1 to 112 basis. The following shares of common stock were issued in connection with the reverse capitalization transaction. Natur shareholders had a controlling voting percentage of 94% subsequent to the transaction:    <table cellpadding="0" cellspacing="0" border="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt">-</td> <td style="font-size: 10pt">115,759,999 shares of common stock were issued to the Natur shareholders.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt">-</td> <td style="font-size: 10pt">2,023,562 shares of common stock were issued to two of the  former management of the Company for their cancellation and release of accrued salaries</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt">-</td> <td style="font-size: 10pt">2,469,131 shares of Series A Preferred Stock were issued for a cash capital investment of $2,000,000 and debt forgiveness of $469,131. The shares of Series A Preferred Stock will convert at a ratio of 1 share to 33,000 common shares.</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt">-</td> <td style="font-size: 10pt">100,000 shares of Series B Preferred Stock were issued to the Natur Holding B.V. shareholders. These shares convert at a ratio of 1 share to 1,000 common shares.</td></tr></table> Parent Company also executed a Securities Purchase Agreement (the "SPA") by which it agreed to privately issue and sell to Alpha Capital Anstalt (the "Alpha") 2,469.131 shares of non-voting, convertible Series A Preferred Stock, each share convertible into approximately 33,000 shares of Common Stock, based on a per common share conversion rate of $.030303. Alpha also purchased two warrants, one pursuant to the SPA that is exercisable for 33,000,000 shares of Common Stock at $.060606 per share and another one pursuant to a debt cancellation agreement exercisable for 6,000,000 shares of Common Stock at $.15 per share. The aggregate purchase price for the Series A Preferred Stock and the warrant for 33,333,000 shares of common stock was $2,000,000 in cash and conversion of $469,131 of outstanding debt. The other warrant was issued for conversion of outstanding interest due Alpha under a prior loan agreement to Future Healthcare of America. Prior to the acquisition of Natur Holding, B.V., Alpha also had cancelled approximately $651,000 of debt principle and interest due from the Company.

Transactions eliminated $1,420,000 of debt principle and interest of the Company and improved its balance sheet. As part of the SPA transaction, Alpha has also agreed to reimburse up to $100,000 of the liabilities of Parent Company existing at the closing date, which has not yet been paid.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">NL Life Sciences B.V.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,088,917</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">563,118</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">STB Family Offices SARL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">227,323</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,234</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">STB Family Offices B.V.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">661,432</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stichting Thank You Nature</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,913</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Flare Media B.V.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,458</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>AMC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,632</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">325,382</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Management & Board Fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">278,092</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">142,154</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Yoomoo Limited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">98,014</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">TriDutch Holding B.V.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,975</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,809,939</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,032,705</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible loan 1</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">636,614</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">629,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible loan 2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">970,960</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Convertible loan 3</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">566,235</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,202,849</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,600,710</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><tr style="vertical-align: bottom"><td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at beginning of period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">       -</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">       -</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%">Vested</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">9,459,688</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.071</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,298,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.071</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt">Outstanding at end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">27,757,963</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.071</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr></table>

322230038 79

NOTE 3 – GOING CONCERN   The Company considered its going concern disclosure requirements in accordance with ASC 240-40-50. We have had material operating losses, working capital deficit and have not yet created positive cash flows. These factors raise substantial doubt as to our ability to continue as a going concern. The Company concluded, in spite of the decreased cash flow from operations, both the elimination of certain debt and the successful raising of new capital and obtaining new capital commitments during the second quarter of 2019, that it has materially improved its capital so as to continue as going concern. The Company implemented a plan in the second quarter of 2019 to further structurally improve the conditions for its continuing as a going concern; (i) the Company implemented certain cost savings, primarily to its overhead requirements, (ii) the Company will continue to generate additional revenue (and positive cash flows from operations) partly related to the Company’s expansion into new product lines during 2019 and partly related to the Company sales initiatives already implemented; and (iii) undertook a reorganization and restructuring program to reduce its debt that has now been completed. The corporate restructuring through the Petition in May 2019 is further disclosed in Note 13 to these financial statements. These actions have had an overall positive impact on the cost-basis of the organization. Notwithstanding the foregoing, the Company will continue to need additional capital from investors to fund its larger business plan and maintain the continuity and growth of its current operations. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.

NOTE 4 – FIXED ASSETS    Property, equipment and intangible assets at June 30, 2019, and December 31, 2018, consisted of the following:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Building and improvements</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">491,847</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Machines and installations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,886</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,508</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Hardware and software</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">80,163</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">838,404</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Depreciation & Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(314,894</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">58,685</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">523,510</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr></table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Building and improvements</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">491,847</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Machines and installations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">65,886</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,508</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Hardware and software</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">80,163</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,117</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">838,404</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Accumulated Depreciation & Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(314,894</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">58,685</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">523,510</td></tr></table>

NOTE 8 – RELATED PARTY OTHER NOTES   Loan from other related parties at June 30, 2019 and December 31, 2018 consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">June 30, 2019</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2018</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%">Efficiency Life Fund</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">2,984,017</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right">400,750</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>TriDutch Holding B.V.</td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">672,099</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right">2,984,017</td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right">1,072,849</td> <td> </td></tr> </table>   For the loan from TriDutch Holding B.V., in May 2019 the debt was fully transferred to NL Life Sciences B.V. as part of a debt restructuring.   For the loan from Efficiency Life Fund there is a repayment schedule in place to repay the loan in 10 installments from July 2019 to April 2022 and the debt therefore transferred from a related party liability to a loan. For the loan from Efficiency Life Fund there is a repayment schedule in place to repay the loan in 10 installments from July 2019 to April 2022 and the debt therefore transferred from a related party liability to a loan. NOTE 10 – RELATED PARTY CONVERTIBLE NOTE PAYABLE   Related party convertible note payable at June 30, 2019 and December 31, 2018 consisted of the following:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Convertible loan Efficiency Life Fund</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">          -</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,671,743</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table>   As at June 26, 2019 $8,830,140  of the balance was converted Into Series Preferred C stock, this stock then converted to Common stock after the increase in authorized share capital of NTRU . The remainder of the balance is currently being held as loan with the company as described and shown in note 8. NOTE 11 – OPTIONS & WARRANTS   On November 13, 2018, the Company closed a subscription agreement and debt conversion agreement with Alpha Capital Anstalt wherein the Company granted the following warrants to purchase:   <table cellpadding="0" cellspacing="0" border="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.25in">-</td> <td>A total of 33,000,000 shares of common stock, at $0.0606060 per share, exercisable for four years.</td></tr> </table> <table cellpadding="0" cellspacing="0" border="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 0.25in">-</td> <td>A total of 6,000,000 shares of common stock, at $0.15 per share, exercisable for four years.</td></tr> </table>   A summary of the status of the warrants granted is presented below for the three months ended:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> June 30, 2019</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font: 10pt Times New Roman, Times, Serif">Outstanding at beginning of period</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Outstanding at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">39,000,000</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.074</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>    On January 16, 2019, the Company completed compensatory arrangements with three board members of Natur International Corp. with the following terms:   Mr. Anthony Joel Bay, through La Bay Ventures Inc., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary. The option provides for cashless exercise and may be registered for resale at the election of the Company. If the service agreement is terminated for a breach thereof, all vested and unvested options will terminate, but if the service agreement is otherwise terminated, then only then vested options will continue to be exercisable for the full term.   Mr. Rudolf Derk Huisman, through Pas Beheer B.V., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary. The option provides for cashless exercise and may be registered for resale at the election of the Company If the service agreement is terminated for a breach thereof, all vested and unvested options will terminate, but if the service agreement is otherwise terminated, then only then vested options will continue to be exercisable for the full term.   Ms. Ellen Berkers, through Montrose Executive Management, will be issued an aggregate of 5,800,000 share of options to purchase common stock of the Company as part of her termination arrangement dated May 30, 2019. The option granted by the Company provides for the right to exercise the shares at $.030303 per share at any time from April 1, 2022 until March 31, 2025. The option provides for cashless exercise and may be registered for resale at the election of the Company.    Mr. Robert A. Paladino, through Cavalier Aire LLC., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of NTRU. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary. The option provides for cashless exercise and may be registered for resale at the election of the Company. If the service agreement is terminated for a breach thereof, all vested and unvested options will terminate, but if the service agreement is otherwise terminated, then only then vested options will continue to be exercisable for the full term.   A summary of the status of the share options is presented below for the six months ended:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at beginning of period</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">       -</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">       -</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%">Vested</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">9,459,688</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.071</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Unvested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,298,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.071</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt">Outstanding at end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">27,757,963</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.071</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>    The fair value of all stock options outstanding at 30 June, 2019 is $1,970,813 at a weighted average fair value of $0.071 per option.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif">Current assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Related party receivable</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">201,907</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">124,016</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">Inventories</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">51,705</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total current assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">377,628</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Fixed Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Tangible fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,547</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Financial Fixed Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">23,618</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Total fixed assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">51,165</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">TOTAL ASSETS</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">428,793</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Short term debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accounts Payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">36,894</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">643,616</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Accrued expenses & other contingent liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">133,575</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">243,510</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total short-term debt</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">170,469</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">887,126</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">REVENUE</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">COST OF GOODS SOLD</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">GROSS MARGIN</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">OPERATING EXPENSES</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Wages & Salaries</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Selling, General & Administrative</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(42,211</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(81,621</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Amortization & depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Total operating expenses</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(42,211</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(81,621</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">LOSS FROM OPERATIONS</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">42,211</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">81,621</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">LOSS FROM DISCONTINUED OPERATIONS</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">42,211</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">81,621</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr></table>

$639,784 of an outstanding loan facility in the principle amount of $581,058 or €500,000 plus accrued interest, at an interest rate of 10% per annum, was converted to common stock of the company. On this date the debt was converted and 11,632,445 of common stock was issued to the borrower.

51165

2064736 340 2376 78832 100000 672370

NOTE 5 – OTHER CURRENT ASSETS   Other current assets at June 30, 2019 and December 31, 2018 consisted of the following:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Value Added Tax receivable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">34,878</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">67,388</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,396</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,054</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Receivables</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">93</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">60,274</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">99,535</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr></table>

NOTE 9 – CONVERTIBLE NOTE PAYABLE   Convertible loans payable at June 30, 2019 and December 31, 2018 consisted of the following:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible loan 1</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">636,614</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">629,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible loan 2</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">970,960</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Convertible loan 3</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">566,235</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,202,849</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,600,710</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table>   Convertible Loan 1   Party for loan 1 had granted a loan facility in the principle amount of $581,058 or €500,000 with the right, but not the obligation to convert the outstanding loan amounts into shares in the capital of Natur at a company valuation of $17.4 million or €15 million for a term from December 19, 2017, till the maturity date of December 31, 2018, at an interest rate of 10% per annum. In July 2019 the amount was fully converted to common stock of the company.   Convertible Loan 2   On October 20, 2017, an amount of $929,692 or €800,000 was advanced to the Company for a loan agreement that was drafted but never signed. An interest rate of 5% per annum is calculated and the loan has a maturity date of February 28, 2018. Repeated attempts at correspondence was made between the Company and the lender’s attorney in April and May 2019 to discuss converting the balance to Common Stock of the Company on the bankruptcy of Natur Holding B.V. as no response was received the amount remains in Natur Holding B.V. who’s estate is being managed independently by a court issued Curator.   Convertible Loan 3   Natur Holding B.V., the principle subsidiary of Natur International Corp, entered into a loan agreement with Dam! Holding B.V., under which Natur Holding may borrow up to US$560,915 or €500,000. The final terms of the agreement were concluded on February 18, 2019.The full drawdown of US$560,915 was made in three tranches throughout January and February 2019. It is the company’s intention to fully convert this to common stock in the third quarter of 2019.

8830140

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS   Natur International Corp. was formerly named Future Healthcare of America. In November 2018, Natur Holding B.V. was acquired to continue the company as a provider of cold pressed juice beverages and healthy snacks. The original business of Future Healthcare of America, founded in 2012, was as a provider of home healthcare services, which had declined and is expected to be fully closed and liquidated in the third quarter of 2019.   The current name of the company is Natur International Corp., which was effected on January 7, 2019. The trading symbol for our common stock became NTRU as of that date and trades on The OTC Market.   Natur International Corp., is a Wyoming corporation, and operates its beverage business through a number of direct and indirect subsidiaries, of which the current principal one is Natur BPS B.V. (known by the trade name Natur Functionals), and is the successor to the business of Natur Holding B.V. ("we", "our", "the Company" or "Natur"). Our beverage business commenced in late 2015, with product distribution in Northern Europe. Currently, our operational headquarters is in Amsterdam, the Netherlands.   At the onset of 2019, our product line up centered on a range of cold pressed juices and healthy snacks. These products were sold either directly or through distribution partners in the Netherlands and the United Kingdom. Beginning in the fourth quarter of 2018, and throughout the first half of 2019, the Company focus shifted from dependence on the legacy fruit and vegetable juices and snacks toward innovating a new line of hemp-derived natural food and beverage products. The Company product value proposition is to provide affordable, culturally relevant, authentic, fresh fruit, vegetable and hemp-derived supplemented consumer products to democratize clean, healthy, eating and drinking, with plans to address the growing needs for products that address other personal needs in health, wellness and beauty care.   Through third party contract manufacturers, we apply patented technology to proprietary nutrient dense blends of fruit and vegetables, adding hemp-derived supplements. These are bottled or packed with technically advanced food and product safety measures and in some cases cold high-pressure processing to bring fresh tasting fruit, vegetable and hemp-derived supplemented blends to market through more than fifteen product types. These newly innovated products are brought to market, in Europe, through Natur's distribution channels of direct-to-business, direct-to-consumer and through select distributors.   Natur operated as a private enterprise in the Netherlands from its founding in 2015 through November 13, 2018, when it was acquired as a wholly owned subsidiary in a share exchange transaction by Future Healthcare of America, pursuant to that certain Share Exchange Agreement, among the Company and the former shareholders of Natur Holding, B.V. (the "Share Exchange Transaction"). In connection with the Share Exchange Transaction, the former shareholders of Natur received the equivalent of 215,759,999 shares of the Common Stock (the "Common Stock"), which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the "Series B Preferred Stock") representing 100,000,000 shares of Common Stock upon conversion. The Share Exchange Transaction was accounted for as a reverse capitalization with Natur Holding B.V. being treated as the accounting acquirer. As such, the historical information for all periods presented prior to the merger date relate to Natur Holding B.V. Subsequent to the Share Exchange Transaction consummation date, the information in this report relates to the consolidated entities of Natur, including Natur Holding B.V. and successor subsidiary and the former subsidiaries of Future Healthcare of America, the latter of which are currently in the process of being wound down and presented as discontinued operations.   In connection with the Share Exchange Transaction, net cash received was $2,000,000 and costs incurred were $399,381 including professional fees for legal, accounting services and finance commission. Immediately after the Share Exchange Transaction, the former Natur shareholders collectively owned the controlling position among the shareholders of the Company.   On May 1, 2019, Natur Holding B.V. filed a Petition in the Netherlands Court for the District of Amsterdam ("Petition") for the liquidation of the company and the transfer of certain assets and retained liabilities to Natur BPS B.V., a wholly owned subsidiary of Natur International Corp., which operates under the trade name Natur Functionals. This court process allowed the historical business of the Company's beverage business to be continued and eliminates a substantial amount of the liabilities of the Company. The Petition permits the Company to focus on activities that will drive growth and future profits. As a result of the Petition the control of Natur International Corp. over Natur Holding B.V. is compromised for financial reporting purposes, and its investment in it will be deconsolidated as of May 1, 2019.   The Series B Preferred Stock was automatically converted upon the Company increasing the number of shares of Common Stock of its authorized capital, which happened on June 26, 2019. At the same time the Series C Preferred Stock was automatically converted to 78,832,399 shares of Common Stock. As of June 30, 2019, the total number of outstanding shares amounted to 310,597,593 shares of Common Stock with an authorized share capital of 750,000,000 shares of common Stock.    During the first half of the 2019 fiscal year, in addition to pursuing the Petition to reorganize certain of its liabilities, the Company successfully has negotiated to convert a further $6,114,790 of debt into 149,516,865 shares of common stock to be issued in due course. More importantly, it has been conducting substantial fund-raising activities. It has obtained new funding through a series of securities purchase agreements that have been funded in the amount of $2,064,736 or are subject to signed commitments for funding in the amount of $3,283,904 that is expected to be completed during the third fiscal quarter of 2019. The securities to be sold will be a mix of several new series of preferred stock convertible into up to 96,289,473 shares of Common Stock and warrants exercisable for up to 177,404,377 shares of Common Stock.     On June 30, 2019, the Company expressed its interest in pursuing a transaction with Share International Holding B.V. on a binding basis. The contemplated transaction would be an acquisition of Share International Holding B.V. ("SIH") and related assets for the operation of its business by the issuance of shares of Natur. The terms of this potential acquisition have yet to be negotiated and finalized, and the overall transaction is subject to conditions precedent at this time. At the same time as the Company entered into the letter of intent, it lent to SIH the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%. The repayment obligation under the Note will be cancelled if no business arrangement is concluded due to a breach by the Company of any agreement for the business arrangement that is concluded in the future, either party to the note experiences a material adverse change, or the business arrangement is not approved by the shareholders or owners of the respective parties to the extent that approval is required. The note also has other standard default provisions under which the Company may declare a default. Also, at the same time as the foregoing letter of intent and loan were concluded, the board of directors of the Company appointed Mr. Paul Bartley as the Chief Executive Officer of the Company; Mr. Bartley is a principal of SIH.

New funding through a series of securities purchase agreements that have been funded in the amount of $2,064,736 or are subject to signed commitments for funding in the amount of $3,283,904 that is expected to be completed during the third fiscal quarter of 2019. The securities to be sold will be a mix of several new series of preferred stock convertible into up to 96,289,473 shares of Common Stock and warrants exercisable for up to 177,404,377 shares of Common Stock. NOTE 7 – RELATED PARTY OTHER LIABILITIES   Related party other liabilities at June 30, 2019 and December 31, 2018 consisted of the following:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">NL Life Sciences B.V.</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,088,917</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">563,118</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">STB Family Offices SARL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">227,323</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,234</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">STB Family Offices B.V.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">661,432</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stichting Thank You Nature</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,913</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Flare Media B.V.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,458</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>AMC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">193,632</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">325,382</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Management & Board Fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">278,092</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">142,154</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Yoomoo Limited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">98,014</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">TriDutch Holding B.V.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,975</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,809,939</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,032,705</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table>   For the outstanding amount relating to AMC this transaction relates to the purchase of bottled juices for resale. Total purchases relating to goods sold for the six-month period ended June 30, 2019 and the six-month period ended June 30, 2018 was $41,130, and $797,770, respectively.   For the related party balance liability held from NL Life Sciences, STB Family Offices SARL and TriDutch Holding B.V there is no repayment schedule in place. No interest is being charged. For the related party liability held with Flare Media B.V., STB Family Office B.V. in May 2019 the debt was fully transferred to NL Life Sciences B.V. as part of a debt restructuring. This balance will be converted into equity in the third quarter of 2019.   The other loans consist of the procurement of goods and consulting fees for the management team that have accrued from previous periods. No interest is being charged.

NOTE 13 – DISCONTINUED OPERATIONS AND ASSETS/LIABILITIES HELD FOR DISPOSAL    Effective November 30, 2018, the Company closed the London office and shops as part of the restructuring plan. Functionally the operations were shut down before December 31, 2018, and therefore we have qualified it as discontinued operations the sale of assets is in process. The existing support functions were transferred to the headquarters in Amsterdam as part of the centralization of support staff initiative.   As of March 22, 2019, the company Naturalicious UK Limited was put into liquidation and the matters are being dealt with by a qualified administration firm in the United Kingdom. A board meeting was held on March 22, 2019, and it was agreed to liquidate the company. Currently the rights and obligations of the company are handled by the administration firm and the legal obligation over the liabilities are extinguished. As we no longer have any rights or obligations to the indirect subsidiary, it has been removed from the consolidation and the net liability position of the company is released and recognized as a gain on disposal.   Effective August 31, 2018, the Company offices in Casper, Wyoming were closed at the termination of its health care operations.. The increase in costs coupled with a decrease in business activity, led to the decision to close the Casper, Wyoming operations. In closing the office, the Company transitioned its clients to new service providers, and terminated employees as the transition happened. The month to month lease was terminated with the landlord on August 31, 2018.    In line with the objective to secure the continuity of the Company, it was decided late 2018 to extend the product line with added functional extracts (Nutrigenomics, hemp-derived extracts). For this, the Company established Natur BPS B.V. (formerly Natur CBD B.V.) as a sister company of Natur Holding B.V. at March 13, 2019, wholly owned by Natur International Corp. Based on global developments and following the success of companies in the USA and Canada, the Company defined new growth objectives with complementary products based on hemp-derived extracts as a new revenue model. Additional funding was sought in the market, but it became apparent that the willingness of new investors to provide the company with funding in debt or equity was dependent on the restructuring of the existing debt on the balance sheet of the Company. As most of this debt is held on the balance sheet of Natur Holding B.V., it was decided to develop a restructuring plan to:    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"> </td> <td style="width: 24px; font-size: 10pt">A.</td> <td style="font-size: 10pt">Establish an asset transfer from Natur Holding B.V. to Natur CBD B.V., optimizing the proceeds for these assets and subsequently liquidate Natur Holding B.V.;</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">B.</td> <td>Continue the business in Natur CBD B.V. with an extended portfolio of functional products, including food and beverages infused with hemp-derived extracts and deliver the objectives as set by the Board</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">C.</td> <td>Expeditiously seek new funding in the form of (long-term) or convertible debt or equity. Discussions with Third parties are on-going. </td></tr> </table>   In May 2019 we reached agreements with most of the debtholders to convert their debt to equity and effective from May 1, 2019, the asset transfer between Natur Holding B.V. and its sister company Natur BPS B.V was executed and Natur Holding B.V. and its wholly owned subsidiaries were declared bankrupt by the Court in Amsterdam, the Netherlands. The total debt that was converted to shares of common stock to be issued is $ 6,754,575.   In June we reached agreement with private investors for the sale of preferred stock and warrants. At June 30, 2019, agreements were signed for a total of $2,064,756 against 65,621.283 of to be issued shares of several series of preferred stock.   The following table presents the carrying amounts of the major classes of assets and liabilities included in our discontinued operations as presented on our Unaudited Consolidated Balance Sheet as of June 30, 2019.   NATUR INTERNATIONAL CORP UNAUDITED BALANCE SHEET OF DISCONTINUED OPERATIONS   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif">Current assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Related party receivable</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">201,907</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">124,016</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">Inventories</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">51,705</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total current assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">377,628</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Fixed Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Tangible fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,547</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Financial Fixed Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">23,618</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Total fixed assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">51,165</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">TOTAL ASSETS</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">428,793</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Short term debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Accounts Payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">36,894</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">643,616</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Accrued expenses & other contingent liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">133,575</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">243,510</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Total short-term debt</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">170,469</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">887,126</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>   NATUR INTERNATIONAL CORP UNAUDITED INCOME STATEMENT OF DISCONTINUED OPERATIONS   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">REVENUE</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">COST OF GOODS SOLD</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">GROSS MARGIN</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">OPERATING EXPENSES</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Wages & Salaries</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Selling, General & Administrative</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(42,211</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(81,621</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Amortization & depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Total operating expenses</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(42,211</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">(81,621</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">LOSS FROM OPERATIONS</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">42,211</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">81,621</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Interest expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">LOSS FROM DISCONTINUED OPERATIONS</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">42,211</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">81,621</td><td style="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr></table>

NOTE 14 – SUBSEQUENT EVENTS    In July 2019 the Company reached agreement with certain non-US private investors to invest in total $1,765,605 to acquire 46,947.368 of the Series G Preferred Stock. These preferred shares have registration rights.   On July 25, 2019 the Company entered into a Purchase and Recapitalization Agreement ("Recapitalization Agreement") with DRBG Holdco, LLC, a Delaware limited liability company, Temple Turmeric, Inc., a Delaware corporation, Daniel Sullivan, Tim Quick, and TQ Holdings LLC, a New Hampshire limited liability company to acquire the business of Temple. Under the Recapitalization Agreement the Company acquired 15,121,984 shares of Series A Preferred Stock of Temple from DRBG for a nominal amount and acquired from TQH a promissory note in the principal amount of $100,000, plus all accrued and unpaid interest. As part of the transaction Temple issued to DRBG a warrant to acquire a percentage of the Temple equity. The Temple board of directors will have three of the five directors appointed by the Company pursuant to the terms of the Series A Shares. The Series A Shares represent an approximate 52% of the equity of Temple, on a fully diluted basis.   Under the Recapitalization Agreement the Company will provide working capital to Temple in the amount of not less than $150,000 but up to $250,000. The Company will acquire additional equity ownership of Temple for this investment based on a valuation of Temple of $1,000,000. This further investment will increase the controlling position of the Company in combination with its ownership of the Series A Shares.   The Temple warrant is exercisable for the greater of 1,493,735 shares of common stock of Temple or 2.5% of the equity of Temple on a fully diluted basis. The exercise price per share is the par value of the common stock to be acquired upon exercise of the Temple warrant. The exercise period is ten years, but not later than the earlier of the consummation of the initial public offering by Temple or a sale transaction of Temple, as defined in the Warrant. The Temple warrant has a cashless conversion right and has typical anti-dilution rights for dividends, reverse splits and changes in the capitalization of Temple.   On July 19, 2019, the board of directors of the Company appointed Mr. Paul Bartley as the Chief Executive Officer of the Company and appointed him to be a director of the Company, filling one of the existing vacancies on the Board of Directors. On June 30, 2019, the Company lent to Share International Holding B.V. a company of which Mr. Bartley is a principal, the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%. SIH requested the loan to finance the costs relating to the conclusion of the merger such as extensive travel, third party consultancy fees and legal costs. Natur International Corp. was willing to provide the loan pending the outcome of the merger discussions.   The repayment obligation under the note will be cancelled if no business arrangement is concluded due to a breach by the Company of any agreement for the business arrangement that is concluded in the future, either party to the note experiences a material adverse change, or the business arrangement is not approved by the shareholders or owners of the respective parties to the extent that approval is required. The note also has other standard default provisions under which the Company may declare a default.   On July 29, 2019, $639,784 of an outstanding loan facility in the principle amount of $581,058 or €500,000 plus accrued interest, at an interest rate of 10% per annum, was converted to common stock of the company. On this date the debt was converted and 11,632,445 of common stock was issued to the borrower.

NOTE 16 – STOCKHOLDERS' DEFICIT  On November 13, 2018, Future Healthcare of America completed a transactions pursuant to the Share Exchange Agreement discussed in Note 1. In connection with the Share Exchange Transaction, the Company issued the equivalent of 215,759,999 shares of the Common Stock to the former shareholders of Nature Holding B.V., which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the "Series B Preferred Stock") representing 100,000,000 shares of Common Stock upon conversion. The Series B Preferred Stock converted automatically into the Common Stock on June 26, 2019, when the Company increased its authorized capital in sufficient amount to permit the conversion of the Series B Preferred Stock. At closing the number of common shares, issued and outstanding was 322,230,038. Per the OTC listing the shares were officially converted on the July 2, 2019.   On September 21, 2018, Parent Company also executed a Securities Purchase Agreement (the "SPA") by which it agreed to privately issue and sell to Alpha Capital Anstalt (the "Alpha") 2,469.131 shares of non-voting, convertible Series A Preferred Stock, each share convertible into approximately 33,000 shares of Common Stock, based on a per common share conversion rate of $.030303. Alpha also purchased two warrants, one pursuant to the SPA that is exercisable for 33,000,000 shares of Common Stock at $.060606 per share and another one pursuant to a debt cancellation agreement exercisable for 6,000,000 shares of Common Stock at $.15 per share. The aggregate purchase price for the Series A Preferred Stock and the warrant for 33,333,000 shares of common stock was $2,000,000 in cash and conversion of $469,131 of outstanding debt. The other warrant was issued for conversion of outstanding interest due Alpha under a prior loan agreement to Future Healthcare of America. Prior to the acquisition of Natur Holding, B.V., Alpha also had cancelled approximately $651,000 of debt principle and interest due from the Company. These transactions eliminated $1,420,000 of debt principle and interest of the Company and improved its balance sheet. As part of the SPA transaction, Alpha has also agreed to reimburse up to $100,000 of the liabilities of Parent Company existing at the closing date, which has not yet been paid.    On March 19, 2019, the holder of the Series A Preferred Stock converted 72 of such shares with a stated value of $72,000 for 2,376,002 shares of common stock. The applicable conversion price per common share was $0.030303. The Company did not receive any payment on this conversion, having received the consideration for the Series A Preferred Shares on November 12, 2018. There are remaining an aggregate of 2,397.131 shares of Series A Preferred Stock issued and outstanding. The shares of common stock issued on conversion are registered for resale by the holder.   On April 4, 2019, the Company filed an Articles of Amendment in the State of Wyoming to create a new class of Series C Preferred Stock, which was returned as of April 9, 2019. The Series C Preferred Stock was converted into 78,832,399 shares of Common Stock on June 26, 2019. Per the OTC listing the shares were officially converted on the July 2, 2019.   In June 2019, the Company has entered into a series of agreements under which it will be required to issue the following different series of preferred stock, subject to certain conditions precedent.   <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; text-align: left; font-size: 10pt">·</td> <td style="text-align: left; font-size: 10pt">Series Preferred Stock D: 15,789.473 preferred shares, conversion to common shares at a ratio of 1:1,000. price per share of $31.70, no voting rights and a warrant reflecting the right to buy 20,000,000 shares at an exercise price of $0.06</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td style="text-align: left">Series Preferred Stock E: 56,443.551 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $30,40, no voting rights and a warrant reflecting the right to buy 56,443,551 shares at an exercise price of $0.0304</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; text-align: left; font-size: 10pt">·</td> <td style="text-align: left; font-size: 10pt">Series Preferred Sock F: 49,342.105 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share $0.0304, registration rights, and warrant reflecting the right to buy 740,130,158 shares at an exercise price of $0.0304.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">·</td><td>Series Preferred Sock G: 46,947.368 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $0.038, registration rights and a warrant reflecting the right to buy 46,947,368 shares at an exercise price of $0.076.</td></tr></table>

· Series Preferred Stock D: 15,789.473 preferred shares, conversion to common shares at a ratio of 1:1,000. price per share of $31.70, no voting rights and a warrant reflecting the right to buy 20,000,000 shares at an exercise price of $0.06 · Series Preferred Stock E: 56,443.551 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $30,40, no voting rights and a warrant reflecting the right to buy 56,443,551 shares at an exercise price of $0.0304 · Series Preferred Sock F: 49,342.105 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share $0.0304, registration rights, and warrant reflecting the right to buy 740,130,158 shares at an exercise price of $0.0304. · Series Preferred Sock G: 46,947.368 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $0.038, registration rights and a warrant reflecting the right to buy 46,947,368 shares at an exercise price of $0.076.

EX-101.SCH 6 ntru-20190630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Unaudited Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Unaudited Consolidated Statements of Shareholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Unaudited Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Nature of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Fixed Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Other Current Assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Accrued Expenses & Other Contingent Liabilities link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Related Party Other Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party Other Notes link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Convertible Note Payable link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Convertible Note Payable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Options & Warrants link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Discontinued Operations and Assets/Liabilities Held for Disposal link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Recapitalization link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Fixed Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Accrued Expenses & Other Contingent Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Related Party Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Related Party Other Notes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Convertible Note Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Related Party Convertible Note Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Options & Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Organization and Nature of Business (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Summary of Significant Accounting Policies (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Fixed Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Accrued Expenses & Other Contingent Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Related Party Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Related Party Other Liabilities (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Related Party Other Notes (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Related Party Other Notes (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Convertible Note Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Convertible Note Payable (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Related Party Convertible Note Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Related Party Convertible Note Payable (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Options & Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Options & Warrants (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Options & Warrants (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Details Textual) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Recapitalization (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Stockholders' Deficit (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ntru-20190630_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ntru-20190630_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ntru-20190630_lab.xml XBRL LABEL FILE Debt Instrument [Axis] Alpha Capital Anstalt [Member] Equity Components [Axis] Common Stock Retained Earnings / Accumulated Deficit Other Comprehensive Income / Loss Balance Sheet Location [Axis] Balance Sheets [Member] Income Statement Location [Axis] Operations and comprehensive income (loss) [Member] Trading Activity By Type [Axis] Equity [Member] Related Party [Axis] NL Life Sciences B.V. [Member] AMC [Member] Management [Member] Short-term Debt, Type [Axis] Convertible loan 1 [Member] Convertible loan 2 [Member] Type of Currency [Axis] Euro [Member] Efficiency Life Fund TriDutch Holding B.V. [Member] STB Family Offices SARL [Member] STB Family Offices B,V [Member] Stichting Thank You Nature [Member] Flare Media B.V [Member] Yoomoo Limited [Member] Extinguishment of Debt [Axis] Long-term Debt [Member] Extinguishment Of Debt [Axis] Currency [Axis] EUR [Member] Other Paid-In Capital Class of Stock [Axis] Series B Preferred Stock [Member] Geographical [Axis] United States [Member] Natur Shareholders [Member] Preferred Class A [Member] Preferred Class B [Member] Parent Company [Member] Property, Plant and Equipment, Type [Axis] Building Improvements [Member] Machinery And EquipmentMember [Member] Furniture And Fixtures [Member] Software Development [Member] Netherlands [Member] France [Member] Iceland [Member] Dynamic Health B.V. [Member] Related Party Transaction [Axis] STB Family Offices [Member] Convertible loan 3 [Member] Class of Warrant or Right [Axis] Warrant [Member] Warrant One [Member] Vesting [Axis] Three tranches [Member] Derivative Instrument [Axis] Stock Option [Member] Mr. Anthony Joel Bay [Member] Mr. Rudolf Derk Huisman [Member] Mr. Robert A. Paladino [Member] Lease Arrangement, Type [Axis] Leases [Member] Preferred Class C [Member] Preferred Class C [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Title of Individual [Axis] non-US private investors [Member] Building [Member] Machines and installations [Member] Furniture and Fixtures [Member] Convertible Debt [Member] Ms. Ellen Berkers [Member] Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Amendment Flag Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Current Reporting Status Entity Filer Category Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Ex Transition Period Entity Common Stock, Shares Outstanding Entity File Number Entity Interactive Data Current Entity Incorporation State Country Code Statement [Table] Statement [Line Items] Preferred stock A Preferred stock B Preferred stock C ASSETS Current Assets Cash and cash equivalents Accounts receivable Related party receivable Inventories Other current assets Current assets held for disposal Total Current Assets Non-Current Assets Intangible asset Fixed assets Other asset Non-current assets held for disposal Total Non-Current Assets TOTAL ASSETS LIABILITIES AND MEMBER' DEFICIT Current Liabilities Accounts Payable Accrued expenses & other contingent liabilities Related party other liabilities Related party other notes Convertible note payable Related party convertible note payable Preferred Stock payable Current liabilities held for disposal Total Current Liabilities TOTAL LIABILITIES Stockholders' Equity Common stock, $0.001 par value, 750,000,000 and 200,000,000 shares authorized as of June 30, 2019 and December 31, 2018, respectively. 310,597,593 and 129,049,192 issued and outstanding as of June 30, 2019 and December 31, 2018, respectively. Preferred stock Additional Paid in Capital Total Shareholders' deficit Accumulated other comprehensive loss TOTAL EQUITY/(DEFICIT) LIABILITIES AND MEMBERS' DEFICIT Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Convertible to common stock Income Statement [Abstract] REVENUE COST OF GOODS SOLD - RELATED PARTY COST OF GOODS SOLD COST OF GOODS SOLD, TOTAL GROSS MARGIN OPERATING EXPENSES Wages & Salaries Selling, General & Administrative Amortization , depreciation and impairment Total operating expenses LOSS FROM OPERATIONS Interest expense LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES Income taxes INCOME FROM CONTINUING OPERATIONS Discontinued operations (NOTE 13) Gain (loss) on disposal of subsidiary Loss from operations of discontinued Component NET PROFIT (LOSS) AVAILABLE/ATTRIBUTE TO MEMBERS Basic earnings/(loss) per share Diluted earnings/(loss) per share COMPREHENSIVE INCOME Net Profit (Loss) Other comprehensive income COMPREHENSIVE PROFIT (LOSS) Other Paid in Capital Retained deficit Accumulated OCI Balance Balance, Shares Net Profit (Loss) Share-based compensation Debt Converted to Common Stock Debt Converted to Common Stock, Shares Conversion of Preferred A to Common Stock Conversion of Preferred A to Common Stock, Shares Conversion of Preferred B to Common Stock Conversion of Preferred B to Common Stock, Shares Issuance of Preferred C Preferred Stock Issuance of Preferred C Preferred Stock, shares Conversion of Preferred C to Common Stock Conversion of Preferred C to Common Stock, Shares Accumulated other comprehensive gain/(loss) Balance Balance, Shares Statement of Cash Flows [Abstract] CASH FLOW FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities Amortization, depreciation and impairment Share Based Compensation EX-101.PRE 10 ntru-20190630_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2019	Aug. 13, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	Natur International Corp.
Entity Central Index Key	0001552845
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2019
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		322,230,038
Entity File Number	000-54917
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	P7

XML 12 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 1,028,877	$ 128,364
Accounts receivable	2,628	42,744
Related party receivable		1,833
Inventories	24,483	179,072
Other current assets	60,274	99,535
Current assets held for disposal	5,000	377,628
Total Current Assets	1,121,262	829,176
Non-Current Assets
Intangible asset	37,353	37,353
Fixed assets	58,685	523,510
Other asset		201,160
Non-current assets held for disposal		51,165
Total Non-Current Assets	96,038	813,188
TOTAL ASSETS	1,217,300	1,642,364
Current Liabilities
Accounts Payable	426,891	1,127,345
Accrued expenses & other contingent liabilities	106,387	583,161
Related party other liabilities	2,809,939	2,032,705
Related party other notes	2,984,017	1,072,849
Convertible note payable	1,202,849	1,600,710
Related party convertible note payable		11,671,743
Preferred Stock payable	2,064,736
Current liabilities held for disposal	170,469	887,126
Total Current Liabilities	9,765,288	18,975,639
TOTAL LIABILITIES	9,765,288	18,975,639
Stockholders' Equity
Common stock, $0.001 par value, 750,000,000 and 200,000,000 shares authorized as of June 30, 2019 and December 31, 2018, respectively. 310,597,593 and 129,049,192 issued and outstanding as of June 30, 2019 and December 31, 2018, respectively.	310,597	129,049
Additional Paid in Capital	14,924,725	5,174,269
Total Shareholders' deficit	(23,850,777)	(22,299,570)
Accumulated other comprehensive loss	67,465	(337,125)
TOTAL EQUITY/(DEFICIT)	(8,547,988)	(17,333,274)
LIABILITIES AND MEMBERS' DEFICIT	1,217,300	1,642,364
Preferred stock A
Stockholders' Equity
Preferred stock	2	2
Preferred stock B
Stockholders' Equity
Preferred stock		100
Preferred stock C
Stockholders' Equity
Preferred stock

XML 13 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	200,000,000
Common stock, shares issued	310,597,593	129,049,192
Common stock, shares outstanding	310,597,593	129,049,192
Preferred stock A
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	2,397,131	2,469,131
Preferred stock, shares outstanding	2,397,131	2,469,131
Convertible to common stock	1:33,000	1:33,000
Preferred stock B
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued		100,000
Preferred stock, shares outstanding		100,000
Convertible to common stock	1:1000	1:1000
Preferred stock C
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Convertible to common stock	1:1000	1:1000

XML 14 R4.htm IDEA: XBRL DOCUMENT

Unaudited Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
REVENUE	$ 8,134	$ 414,716	$ 72,553	$ 942,433
COST OF GOODS SOLD - RELATED PARTY	2,679	224,682	33,560	425,036
COST OF GOODS SOLD	2,240	58,718	66,136	132,116
COST OF GOODS SOLD, TOTAL	4,919	283,400	99,696	557,152
GROSS MARGIN	3,215	131,316	(27,143)	385,281
OPERATING EXPENSES
Wages & Salaries	108,335	349,298	373,064	792,679
Selling, General & Administrative	1,243,061	904,599	2,645,471	2,019,466
Amortization , depreciation and impairment	3,609	30,268	275,798	83,584
Total operating expenses	1,355,005	1,284,165	3,294,333	2,895,729
LOSS FROM OPERATIONS	(1,351,790)	(1,152,849)	(3,321,476)	(2,510,448)
Interest expense	862	34,413	40,095	63,261
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(1,352,652)	(1,187,262)	(3,361,571)	(2,573,709)
Income taxes
INCOME FROM CONTINUING OPERATIONS	(1,352,652)	(1,187,262)	(3,361,571)	(2,573,709)
Discontinued operations (NOTE 13)
Gain (loss) on disposal of subsidiary	1,591,187		1,891,985
Loss from operations of discontinued Component	(42,211)	(302,964)	(81,621)	(1,095,701)
NET PROFIT (LOSS) AVAILABLE/ATTRIBUTE TO MEMBERS	$ 196,324	$ (1,490,226)	$ (1,551,207)	$ (3,669,410)
Basic earnings/(loss) per share	$ 0.00	$ (0.01)	$ (0.00)	$ (0.03)
Diluted earnings/(loss) per share	$ 0.00	$ (0.01)	$ 0.00	$ (0.03)
COMPREHENSIVE INCOME
Net Profit (Loss)	$ 196,324	$ (1,490,226)	$ (1,551,207)	$ (3,669,410)
Other comprehensive income	50,677		404,590
COMPREHENSIVE PROFIT (LOSS)	$ 247,001	$ (1,490,226)	$ (1,146,617)	$ (3,669,410)

XML 15 R5.htm IDEA: XBRL DOCUMENT

Unaudited Consolidated Statements of Shareholders’ Deficit - USD ($)	Common Stock	Other Paid in Capital	Retained deficit	Accumulated OCI	Preferred stock A	Preferred stock B	Preferred stock C	Total
Balance at Dec. 31, 2017	$ 115,760	$ 3,316,560	$ (15,250,748)	$ (1,114,812)				$ (12,933,240)
Balance, Shares at Dec. 31, 2017	115,759,999
Net Profit (Loss)			(2,179,184)					(2,179,184)
Accumulated other comprehensive gain/(loss)
Balance at Mar. 31, 2018	$ 115,760	3,316,560	(17,429,932)	(1,114,812)				(15,112,424)
Balance, Shares at Mar. 31, 2018	115,759,999
Net Profit (Loss)			(1,490,226)					(1,490,226)
Accumulated other comprehensive gain/(loss)
Balance at Jun. 30, 2018	$ 115,760	3,316,560	(18,920,158)	(1,114,812)				(16,602,650)
Balance, Shares at Jun. 30, 2018	115,759,999
Balance at Dec. 31, 2018	$ 129,049	5,174,269	(22,299,570)	(337,125)				(17,333,274)
Balance, Shares at Dec. 31, 2018	129,049,192				2,469,131	100,000
Net Profit (Loss)			(1,747,531)					(1,747,531)
Share-based compensation		403,162						403,162
Conversion of Preferred A to Common Stock	$ 2,376	(2,376)
Conversion of Preferred A to Common Stock, Shares	2,376,002				(72)
Accumulated other comprehensive gain/(loss)				353,913				353,913
Balance at Mar. 31, 2019	$ 131,425	5,575,055	(24,047,101)	16,788	$ 2	$ 100		(18,323,730)
Balance, Shares at Mar. 31, 2019	131,425,194				2,397,131	100,000
Net Profit (Loss)			196,324					196,324
Share-based compensation		685,044						685,044
Debt Converted to Common Stock	$ 340	13,218						13,558
Debt Converted to Common Stock, Shares	340,000
Conversion of Preferred B to Common Stock	$ 100,000	(99,900)				$ (100)
Conversion of Preferred B to Common Stock, Shares	100,000,000					(100,000)
Issuance of Preferred C Preferred Stock		8,830,061					$ 79	8,830,140
Issuance of Preferred C Preferred Stock, shares							78,832
Conversion of Preferred C to Common Stock	$ 78,832	(78,753)					$ (79)
Conversion of Preferred C to Common Stock, Shares	78,832,399						(78,832)
Accumulated other comprehensive gain/(loss)				50,677				50,677
Balance at Jun. 30, 2019	$ 310,597	$ 14,924,725	$ (23,850,777)	$ 67,465				$ (8,547,988)
Balance, Shares at Jun. 30, 2019	310,597,593				2,397

XML 16 R6.htm IDEA: XBRL DOCUMENT

Unaudited Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
CASH FLOW FROM OPERATING ACTIVITIES
Net Loss	$ (1,551,207)	$ (3,669,410)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization, depreciation and impairment	275,798	32,015
Share Based Compensation	1,088,206
Gain on Disposal of Subsidiaries	(1,891,985)
Changes in:
- Accounts receivable	37,592	(252,278)
- Related party receivable	24	(20,802)
- Inventories	44,516	(436,965)
- Other current assets	(1,124)	33,911
- Accounts payable	(23,411)	1,951,766
- Accrued expenses	(178,008)	(416,304)
- Accrued expenses - related parties	110,391	(124,643)
Net cash used in operating activities	(2,089,208)	(2,902,710)
Net cash (used in) from operating activities - Discontinued operations		210,652
CASH FLOW FROM INVESTING ACTIVITIES
Cash paid for purchase of fixed assets
Cash received for sale of property and equipment
Net cash used in investing activities
Net cash used in investing activities - Discontinued operations	51,165
CASH FLOW FROM FINANCING ACTIVITIES
Related party loan additions		1,799,213
Related party loan repayments		(240,503)
Cash received from subscription of Preferred Stock	2,064,736
Third party convertible note additions	560,915	52,266
Related party convertible loan additions
Net cash provided from financing activities	2,625,651	1,610,976
Net cash from financing activities - Discontinued Operations
Effect of foreign exchange rate changes on cash and cash equivalents	312,905
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	900,513	(1,081,082)
CASH AND CASH EQUIVALENTS beginning of period	128,364	1,082,734
CASH AND CASH EQUIVALENTS end of period	1,028,877	$ 1,652
NON-CASH TRANSACTIONS
Preferred stock C issued for debt conversion	79
Common stock issued for debt conversion	340
Preferred stock A conversion	2,376
Preferred stock C conversion	78,832
Preferred stock B conversion	100,000
Debt transferred from RP other liabilities to RP other notes payable	$ 672,370

XML 17 R7.htm IDEA: XBRL DOCUMENT

Organization and Nature of Business

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION AND NATURE OF BUSINESS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

The current name of the company is Natur International Corp., which was effected on January 7, 2019. The trading symbol for our common stock became NTRU as of that date and trades on The OTC Market.

Natur International Corp., is a Wyoming corporation, and operates its beverage business through a number of direct and indirect subsidiaries, of which the current principal one is Natur BPS B.V. (known by the trade name Natur Functionals), and is the successor to the business of Natur Holding B.V. ("we", "our", "the Company" or "Natur"). Our beverage business commenced in late 2015, with product distribution in Northern Europe. Currently, our operational headquarters is in Amsterdam, the Netherlands.

Through third party contract manufacturers, we apply patented technology to proprietary nutrient dense blends of fruit and vegetables, adding hemp-derived supplements. These are bottled or packed with technically advanced food and product safety measures and in some cases cold high-pressure processing to bring fresh tasting fruit, vegetable and hemp-derived supplemented blends to market through more than fifteen product types. These newly innovated products are brought to market, in Europe, through Natur's distribution channels of direct-to-business, direct-to-consumer and through select distributors.

Natur operated as a private enterprise in the Netherlands from its founding in 2015 through November 13, 2018, when it was acquired as a wholly owned subsidiary in a share exchange transaction by Future Healthcare of America, pursuant to that certain Share Exchange Agreement, among the Company and the former shareholders of Natur Holding, B.V. (the "Share Exchange Transaction"). In connection with the Share Exchange Transaction, the former shareholders of Natur received the equivalent of 215,759,999 shares of the Common Stock (the "Common Stock"), which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the "Series B Preferred Stock") representing 100,000,000 shares of Common Stock upon conversion. The Share Exchange Transaction was accounted for as a reverse capitalization with Natur Holding B.V. being treated as the accounting acquirer. As such, the historical information for all periods presented prior to the merger date relate to Natur Holding B.V. Subsequent to the Share Exchange Transaction consummation date, the information in this report relates to the consolidated entities of Natur, including Natur Holding B.V. and successor subsidiary and the former subsidiaries of Future Healthcare of America, the latter of which are currently in the process of being wound down and presented as discontinued operations.

On May 1, 2019, Natur Holding B.V. filed a Petition in the Netherlands Court for the District of Amsterdam ("Petition") for the liquidation of the company and the transfer of certain assets and retained liabilities to Natur BPS B.V., a wholly owned subsidiary of Natur International Corp., which operates under the trade name Natur Functionals. This court process allowed the historical business of the Company's beverage business to be continued and eliminates a substantial amount of the liabilities of the Company. The Petition permits the Company to focus on activities that will drive growth and future profits. As a result of the Petition the control of Natur International Corp. over Natur Holding B.V. is compromised for financial reporting purposes, and its investment in it will be deconsolidated as of May 1, 2019.

On June 30, 2019, the Company expressed its interest in pursuing a transaction with Share International Holding B.V. on a binding basis. The contemplated transaction would be an acquisition of Share International Holding B.V. ("SIH") and related assets for the operation of its business by the issuance of shares of Natur. The terms of this potential acquisition have yet to be negotiated and finalized, and the overall transaction is subject to conditions precedent at this time. At the same time as the Company entered into the letter of intent, it lent to SIH the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%. The repayment obligation under the Note will be cancelled if no business arrangement is concluded due to a breach by the Company of any agreement for the business arrangement that is concluded in the future, either party to the note experiences a material adverse change, or the business arrangement is not approved by the shareholders or owners of the respective parties to the extent that approval is required. The note also has other standard default provisions under which the Company may declare a default. Also, at the same time as the foregoing letter of intent and loan were concluded, the board of directors of the Company appointed Mr. Paul Bartley as the Chief Executive Officer of the Company; Mr. Bartley is a principal of SIH.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation. The Company prepares its financial statements using the accrual basis of accounting in accordance with United States generally accepted accounting principles ("US GAAP").

Cash and Cash Equivalents. Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable. Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for bad debts. The allowance for bad debts is recognized based on management's estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances.

Inventory. Inventory, consisting of raw materials, work in progress and finished goods, is valued at the lower of the inventory's costs or net realizable value, using the first in, first out method to determine the cost. Management compares the cost of inventory with its net realizable value and an allowance is made to write down inventory to net realizable value, if lower.

Category		Estimated Useful lives
Building and improvements		5 years
Machines and installations		5 years
Furniture and fixtures		7 years
Hardware and software		3 years

The Company's long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Long lived assets are evaluated on a yearly basis and no impairment losses were incurred during the six months ended June 30, 2019.

Related Party Transactions. The Board of Directors has adopted a Related Party Transaction Policy for the review of related person transactions. Under these policies and procedures, the management reviews related person transactions in which we are or will be a participant to determine if they are fair and beneficial to the Company. Financial transactions, arrangements, relationships or any series of similar transactions, arrangements or relationships in which a related person has or will have a material interest and that exceeds the lesser of: (i) $10,000, and (ii) one percent of the average of the Company's total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review. Any member of the board who is a related person with respect to a transaction under review may not participate in the deliberation or vote requesting approval or ratification of the transaction. Transactions that are subject to the policy include any transaction, arrangement or relationship (including indebtedness or guarantees of indebtedness) in which the Company is a participant with a related person. The related person may have a direct or indirect material interest in the transaction. It is Company policy that the board shall approve any related party transaction before the commencement of the transaction. However, if the transaction is not identified before commencement, it must still be presented to the board for their review and ratification.

Step 1: Identify the contract with the customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognize revenue when the company satisfies a performance obligation

The Company's performance obligations are satisfied at the point in time when products are received by the customer, which is when the customer has title and the significant risks and rewards of ownership. Therefore, the Company's contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of product.

The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon delivery to the customer. The Company's performance obligations are satisfied at that time.

	2019			2018
Expected dividend yield		0	%		-
Expected option term (years)		6			-
Expected volatility		382	%		-
Risk-free interest rate		3	%		-

The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company's common stock. The assumed discount rate was the default risk-free six-year interest rate in the Netherlands.

Revenues do not include sales or other taxes collected from customers.

The Company's products are sold and distributed through various channels, which include selling directly to retail stores and other outlets such as food markets, institutional accounts and independent outlets. The Company typically collects payment from customers within 30 days from the date of sale. The following table presents our continued revenues disaggregated by geographical region for the six-month period ended June 30, 2019:

	June 30, 2019		June 30, 2018
Netherlands		72,553		942,433
France		-		-
Iceland		-		-
Total		72,553		942,433

The Company sells its products and extends credit, generally without requiring collateral, based on an ongoing evaluation of the customer's business prospects and financial condition. The Company evaluates the collectability of its trade accounts receivable based on a number of factors, including the Company's historic collections pattern and changes to a specific customer's ability to meet its financial obligations. The Company has established an allowance for doubtful accounts to adjust the recorded receivable to the estimated amount the Company believes will ultimately be collected.

The nature of the Company's contracts does not give rise to variable consideration, such as prospective and retrospective rebates.

Recent Accounting Pronouncements

Leases: In February 2016, the FASB issued ASU No. 2016-02, "Leases (Topic 842)". This update requires the recognition of lease assets and lease liabilities on the balance sheet for leases classified as operating leases under previous guidance. The accounting for finance leases (capital leases) was substantially unchanged. The original guidance required application on a modified retrospective basis with adjustments to the earliest comparative period presented. In August 2018, the FASB issued ASU No. 2018-11, "Targeted Improvements to ASC 842," which included an option to not restate comparative periods in transition and elect to use the effective date of ASU No. 2016-02 as the date of initial application, which the Company elected. As a result, the consolidated balance sheet prior to January 1, 2019 was not restated, and continues to be reported under previous guidance that did not require the recognition of operating lease liabilities and corresponding lease assets on the consolidated balance sheet. As a result of the adoption of ASU No. 2016-02 on January 1, 2019, the Company recorded operating lease right-of-use assets of $580,310 and operating lease liabilities of $578,007.

Foreign Currency Translation. The Company follows Section 830-10-45 of the FASB Accounting Standards Codification ("Section 830-10-45") for foreign currency translation to translate the financial statements from the functional currency, generally the local currency, into U.S. Dollars. Section 830-10-45 sets out the guidance relating to how a reporting entity determines the functional currency of a foreign entity (including of a foreign entity in a highly inflationary economy), re-measures the books of record (if necessary), and characterizes transaction gains and losses. Pursuant to Section 830-10-45, the assets, liabilities, and operations of a foreign entity shall be measured using the functional currency of that entity. An entity's functional currency is the currency of the primary economic environment in which the entity operates; normally, that is the currency of the environment, or local currency, in which an entity primarily generates and expends cash.

The financial records of the Company are maintained in its local currency, the euro ("EUR"), which is the functional currency. Assets and liabilities are translated from the local currency into the reporting currency, U.S. dollars, at the exchange rate prevailing at the balance sheet date. Revenues and expenses are translated at weighted average exchange rates for the period to approximate translation at the exchange rates prevailing at the dates those elements are recognized in the consolidated financial statements. Foreign currency translation gain (loss) resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining accumulated other comprehensive income in the consolidated statement of stockholders' equity.

	June 30, 2019		December 31, 2018
Balance Sheets		0.8849		0.8734
Statements of operations and comprehensive income (loss)		0.8895		0.8464
Equity		0.9037		0.9037

Income Taxes. The Company is subject to US corporation tax. The US combined federal and state corporate tax rate is 23%. The company's United States net operating losses totaled $3,483,928 as of December 31, 2017 and begin to expire in tax years 2032 and following. Net losses from US operating totaled $157,386 for 2018 and may be carried forward indefinitely. The company is subject to US Internal Revenue Code rules limiting the use of US net operating losses after the merger with Future Health Care of America during 2018 (described in Note 17). This limitation has no effect on the Company's financial statements because the Company has recognized no deferred tax asset with respect to its net operating loss carryforwards. The NOLs are the cumulative NOL's per the Company's 2017 federal income tax return. The 382 limit will not be factored in until the company has income and the limit is therefore applicable.

The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.

Income /(Loss) Per Share - The Company computes income (loss) per share in accordance with Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 260 Earnings Per Share, which requires the Company to present basic earnings per share and diluted earnings per share when the effect is dilutive (see Note 12).

XML 19 R9.htm IDEA: XBRL DOCUMENT

Going Concern

6 Months Ended

Jun. 30, 2019

GOING CONCERN [Abstract]

GOING CONCERN

NOTE 3 – GOING CONCERN

XML 20 R10.htm IDEA: XBRL DOCUMENT

Fixed Assets

6 Months Ended

Jun. 30, 2019

Intangible Tangible Fixed Assets [Abstract]

FIXED ASSETS

NOTE 4 – FIXED ASSETS

Property, equipment and intangible assets at June 30, 2019, and December 31, 2018, consisted of the following:

	June 30,			December 31,
	2019			2018
Building and improvements		-			491,847
Machines and installations		-			65,886
Furniture and fixtures		60,117			200,508
Hardware and software		-			80,163
		60,117			838,404

Less: Accumulated Depreciation & Amortization		(1,432	)		(314,894	)
		58,685			523,510

XML 21 R11.htm IDEA: XBRL DOCUMENT

Other Current Assets

6 Months Ended

Jun. 30, 2019

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

OTHER CURRENT ASSETS

NOTE 5 – OTHER CURRENT ASSETS

Other current assets at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Value Added Tax receivable		34,878		67,388
Prepaid expenses		25,396		32,054
Other Receivables		-		93
		60,274		99,535

XML 22 R12.htm IDEA: XBRL DOCUMENT

Accrued Expenses & Other Contingent Liabilities

6 Months Ended

Jun. 30, 2019

Payables and Accruals [Abstract]

ACCRUED EXPENSES & OTHER CONTINGENT LIABILITIES

NOTE 6 – ACCRUED EXPENSES & OTHER CONTINGENT LIABILITIES

Accrued expenses & other contingent liabilities at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Taxes payable		21,628		352,423
Invoices to be received		26,018		3,972
Holiday Allowance Payable		2,558		24,642
Other accrued expenses & other contingent liabilities		56,183		202,124
		106,387		583,161

XML 23 R13.htm IDEA: XBRL DOCUMENT

Related Party Other Liabilities

6 Months Ended

Jun. 30, 2019

RELATED PARTY OTHER LIABILITIES

NOTE 7 – RELATED PARTY OTHER LIABILITIES

Related party other liabilities at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

NL Life Sciences B.V.		2,088,917		563,118
STB Family Offices SARL		227,323		200,234
STB Family Offices B.V.		-		661,432
Stichting Thank You Nature		-		16,913
Flare Media B.V.		-		25,458
AMC		193,632		325,382
Management & Board Fees		278,092		142,154
Yoomoo Limited		-		98,014
TriDutch Holding B.V.		21,975		-
		2,809,939		2,032,705

The other loans consist of the procurement of goods and consulting fees for the management team that have accrued from previous periods. No interest is being charged.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Related Party Other Notes

6 Months Ended

Jun. 30, 2019

RELATED PARTY OTHER NOTES

NOTE 8 – RELATED PARTY OTHER NOTES

Loan from other related parties at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Efficiency Life Fund		2,984,017		400,750
TriDutch Holding B.V.		-		672,099
		2,984,017		1,072,849

For the loan from TriDutch Holding B.V., in May 2019 the debt was fully transferred to NL Life Sciences B.V. as part of a debt restructuring.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Convertible Note Payable

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

CONVERTIBLE NOTE PAYABLE

NOTE 9 – CONVERTIBLE NOTE PAYABLE

Convertible loans payable at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Convertible loan 1		636,614		629,750
Convertible loan 2		-		970,960
Convertible loan 3		566,235		-
		1,202,849		1,600,710

Convertible Loan 1

Convertible Loan 2

Convertible Loan 3

XML 26 R16.htm IDEA: XBRL DOCUMENT

Related Party Convertible Note Payable

6 Months Ended

Jun. 30, 2019

RELATED PARTY CONVERTIBLE NOTE PAYABLE

NOTE 10 – RELATED PARTY CONVERTIBLE NOTE PAYABLE

Related party convertible note payable at June 30, 2019 and December 31, 2018 consisted of the following:

	June 30, 2019		December 31, 2018

Convertible loan Efficiency Life Fund		-		11,671,743

XML 27 R17.htm IDEA: XBRL DOCUMENT

Options & Warrants

6 Months Ended

Jun. 30, 2019

Warrants and Rights Note Disclosure [Abstract]

OPTIONS & WARRANTS

NOTE 11 – OPTIONS & WARRANTS

On November 13, 2018, the Company closed a subscription agreement and debt conversion agreement with Alpha Capital Anstalt wherein the Company granted the following warrants to purchase:

-	A total of 33,000,000 shares of common stock, at $0.0606060 per share, exercisable for four years.

-	A total of 6,000,000 shares of common stock, at $0.15 per share, exercisable for four years.

A summary of the status of the warrants granted is presented below for the three months ended:

	June 30, 2019				December 31, 2018
	Shares		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
Outstanding at beginning of period		39,000,000	$	0.074		-	$	-
Granted		-		-		39,000,000		0.074
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding at end of period		39,000,000	$	0.074		39,000,000	$	0.074

On January 16, 2019, the Company completed compensatory arrangements with three board members of Natur International Corp. with the following terms:

A summary of the status of the share options is presented below for the six months ended:

	June 30, 2019				December 31, 2018
	Shares		Weighted Average Fair Value		Shares		Weighted Average Fair Value
Outstanding at beginning of period		-	$	-		-	$	-
Vested		9,459,688		0.071		-		-
Unvested		18,298,275
Exercised		-		0.071		-		-
Expired		-		-		-		-
Outstanding at end of period		27,757,963	$	0.071		-	$	-

The fair value of all stock options outstanding at 30 June, 2019 is $1,970,813 at a weighted average fair value of $0.071 per option.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Loss Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

LOSS PER SHARE

NOTE 12 – LOSS PER SHARE

XML 29 R19.htm IDEA: XBRL DOCUMENT

Discontinued Operations and Assets/Liabilities Held for Disposal

6 Months Ended

Jun. 30, 2019

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS AND ASSETS/LIABILITIES HELD FOR DISPOSAL

NOTE 13 – DISCONTINUED OPERATIONS AND ASSETS/LIABILITIES HELD FOR DISPOSAL

Establish an asset transfer from Natur Holding B.V. to Natur CBD B.V., optimizing the proceeds for these assets and subsequently liquidate Natur Holding B.V.;

Expeditiously seek new funding in the form of (long-term) or convertible debt or equity. Discussions with Third parties are on-going.

NATUR INTERNATIONAL CORP

UNAUDITED BALANCE SHEET OF DISCONTINUED OPERATIONS

	For the Six Months		December 31, 2018
Current assets
Cash and cash equivalents		-		-
Related party receivable		-		201,907
Accounts receivable		-		124,016
Inventories		-		-
Other current assets		-		51,705
Total current assets		-		377,628

Fixed Assets
Tangible fixed assets		-		27,547
Financial Fixed Assets		-		23,618
Total fixed assets		-		51,165

TOTAL ASSETS		-		428,793

Short term debt
Accounts Payable		36,894		643,616
Accrued expenses & other contingent liabilities		133,575		243,510
Total short-term debt		170,469		887,126

NATUR INTERNATIONAL CORP

UNAUDITED INCOME STATEMENT OF DISCONTINUED OPERATIONS

	For the Three Months			For the Six Months
	For the Six Months			December 31, 2018

REVENUE		-			-

COST OF GOODS SOLD		-			-

GROSS MARGIN		-			-

OPERATING EXPENSES
Wages & Salaries		-			-
Selling, General & Administrative		(42,211	)		(81,621	)
Amortization & depreciation		-			-

Total operating expenses		(42,211	)		(81,621	)

LOSS FROM OPERATIONS		42,211			81,621

Interest expense		-			-

LOSS FROM DISCONTINUED OPERATIONS		42,211			81,621

XML 30 R20.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 14 – SUBSEQUENT EVENTS

On July 25, 2019 the Company entered into a Purchase and Recapitalization Agreement ("Recapitalization Agreement") with DRBG Holdco, LLC, a Delaware limited liability company, Temple Turmeric, Inc., a Delaware corporation, Daniel Sullivan, Tim Quick, and TQ Holdings LLC, a New Hampshire limited liability company to acquire the business of Temple. Under the Recapitalization Agreement the Company acquired 15,121,984 shares of Series A Preferred Stock of Temple from DRBG for a nominal amount and acquired from TQH a promissory note in the principal amount of $100,000, plus all accrued and unpaid interest. As part of the transaction Temple issued to DRBG a warrant to acquire a percentage of the Temple equity. The Temple board of directors will have three of the five directors appointed by the Company pursuant to the terms of the Series A Shares. The Series A Shares represent an approximate 52% of the equity of Temple, on a fully diluted basis.

XML 31 R21.htm IDEA: XBRL DOCUMENT

Recapitalization

6 Months Ended

Jun. 30, 2019

Recapitalization [Abstract]

RECAPITALIZATION

NOTE 15 – RECAPITALIZATION

-	115,759,999 shares of common stock were issued to the Natur shareholders.

-	2,023,562 shares of common stock were issued to two of the former management of the Company for their cancellation and release of accrued salaries

-	2,469,131 shares of Series A Preferred Stock were issued for a cash capital investment of $2,000,000 and debt forgiveness of $469,131. The shares of Series A Preferred Stock will convert at a ratio of 1 share to 33,000 common shares.

-	100,000 shares of Series B Preferred Stock were issued to the Natur Holding B.V. shareholders. These shares convert at a ratio of 1 share to 1,000 common shares.

XML 32 R22.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

STOCKHOLDERS' DEFICIT

NOTE 16 – STOCKHOLDERS' DEFICIT

On November 13, 2018, Future Healthcare of America completed a transactions pursuant to the Share Exchange Agreement discussed in Note 1. In connection with the Share Exchange Transaction, the Company issued the equivalent of 215,759,999 shares of the Common Stock to the former shareholders of Nature Holding B.V., which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the "Series B Preferred Stock") representing 100,000,000 shares of Common Stock upon conversion. The Series B Preferred Stock converted automatically into the Common Stock on June 26, 2019, when the Company increased its authorized capital in sufficient amount to permit the conversion of the Series B Preferred Stock. At closing the number of common shares, issued and outstanding was 322,230,038. Per the OTC listing the shares were officially converted on the July 2, 2019.

On September 21, 2018, Parent Company also executed a Securities Purchase Agreement (the "SPA") by which it agreed to privately issue and sell to Alpha Capital Anstalt (the "Alpha") 2,469.131 shares of non-voting, convertible Series A Preferred Stock, each share convertible into approximately 33,000 shares of Common Stock, based on a per common share conversion rate of $.030303. Alpha also purchased two warrants, one pursuant to the SPA that is exercisable for 33,000,000 shares of Common Stock at $.060606 per share and another one pursuant to a debt cancellation agreement exercisable for 6,000,000 shares of Common Stock at $.15 per share. The aggregate purchase price for the Series A Preferred Stock and the warrant for 33,333,000 shares of common stock was $2,000,000 in cash and conversion of $469,131 of outstanding debt. The other warrant was issued for conversion of outstanding interest due Alpha under a prior loan agreement to Future Healthcare of America. Prior to the acquisition of Natur Holding, B.V., Alpha also had cancelled approximately $651,000 of debt principle and interest due from the Company. These transactions eliminated $1,420,000 of debt principle and interest of the Company and improved its balance sheet. As part of the SPA transaction, Alpha has also agreed to reimburse up to $100,000 of the liabilities of Parent Company existing at the closing date, which has not yet been paid.

In June 2019, the Company has entered into a series of agreements under which it will be required to issue the following different series of preferred stock, subject to certain conditions precedent.

XML 33 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Basis of presentation

Basis of presentation. The Company prepares its financial statements using the accrual basis of accounting in accordance with United States generally accepted accounting principles ("US GAAP").

Consolidation

Use of Estimates in Financial Statement Preparation

Cash and Cash Equivalents

Cash and Cash Equivalents. Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable

Accounts Receivable. Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for bad debts. The allowance for bad debts is recognized based on management's estimate of likely losses per year, based on past experience and review of customer profiles and the aging of receivable balances.

Inventory

Property and Equipment

Category		Estimated Useful lives
Building and improvements		5 years
Machines and installations		5 years
Furniture and fixtures		7 years
Hardware and software		3 years

Intangible Assets, and Long-Lived Assets

Intangible Assets, and Long-Lived Assets. The Company recognizes an acquired intangible asset apart from goodwill whenever the intangible asset arises from contractual or other legal rights, or when it can be separated or divided from the acquired entity and sold, transferred, licensed, rented or exchanged, either individually or in combination with a related contract, asset or liability. Such intangibles are amortized over their useful lives. Impairment losses are recognized if the carrying amount of an intangible asset subject to amortization is not recoverable from expected future cash flows and its carrying amount exceeds its fair value.

Related Party Transactions

Related Party Transactions. The Board of Directors has adopted a Related Party Transaction Policy for the review of related person transactions. Under these policies and procedures, the management reviews related person transactions in which we are or will be a participant to determine if they are fair and beneficial to the Company. Financial transactions, arrangements, relationships or any series of similar transactions, arrangements or relationships in which a related person has or will have a material interest and that exceeds the lesser of: (i) $10,000, and (ii) one percent of the average of the Company's total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review. Any member of the board who is a related person with respect to a transaction under review may not participate in the deliberation or vote requesting approval or ratification of the transaction. Transactions that are subject to the policy include any transaction, arrangement or relationship (including indebtedness or guarantees of indebtedness) in which the Company is a participant with a related person. The related person may have a direct or indirect material interest in the transaction. It is Company policy that the board shall approve any related party transaction before the commencement of the transaction. However, if the transaction is not identified before commencement, it must still be presented to the board for their review and ratification.

Revenue Recognition

Step 1: Identify the contract with the customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognize revenue when the company satisfies a performance obligation

The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon delivery to the customer. The Company's performance obligations are satisfied at that time.

Share-Based Payment Arrangements

	2019			2018
Expected dividend yield		0	%		-
Expected option term (years)		6			-
Expected volatility		382	%		-
Risk-free interest rate		3	%		-

The expected term of options granted represents the period of time that options granted are expected to be outstanding. The expected volatility was based on the volatility in the trading of the Company's common stock. The assumed discount rate was the default risk-free six-year interest rate in the Netherlands.

Revenues do not include sales or other taxes collected from customers.

	June 30, 2019		June 30, 2018
Netherlands		72,553		942,433
France		-		-
Iceland		-		-
Total		72,553		942,433

The nature of the Company's contracts does not give rise to variable consideration, such as prospective and retrospective rebates.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Foreign Currency Translation

	June 30, 2019		December 31, 2018
Balance Sheets		0.8849		0.8734
Statements of operations and comprehensive income (loss)		0.8895		0.8464
Equity		0.9037		0.9037

Cost of Revenues

Employee Benefits

Income Taxes

Fair Value of Financial Instruments

The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.

Income /(Loss) Per Share

XML 34 R24.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2019

Summary Of Significant Accounting Policies [Abstract]

Schedule of the estimated useful lives of the assets

Category		Estimated Useful lives
Building and improvements		5 years
Machines and installations		5 years
Furniture and fixtures		7 years
Hardware and software		3 years

Schedule of share based payment arrangement

	2019			2018
Expected dividend yield		0	%		-
Expected option term (years)		6			-
Expected volatility		382	%		-
Risk-free interest rate		3	%		-

Schedule of revenues disaggregated by geographical region

	June 30, 2019		June 30, 2018
Netherlands		72,553		942,433
France		-		-
Iceland		-		-
Total		72,553		942,433

Schedule of foreign exchange rates

	June 30, 2019		December 31, 2018
Balance Sheets		0.8849		0.8734
Statements of operations and comprehensive income (loss)		0.8895		0.8464
Equity		0.9037		0.9037

XML 35 R25.htm IDEA: XBRL DOCUMENT

Fixed Assets (Tables)

6 Months Ended

Jun. 30, 2019

Fixed Assets

Schedule of property, equipment and intangible assets

	June 30,			December 31,
	2019			2018
Building and improvements		-			491,847
Machines and installations		-			65,886
Furniture and fixtures		60,117			200,508
Hardware and software		-			80,163
		60,117			838,404

Less: Accumulated Depreciation & Amortization		(1,432	)		(314,894	)
		58,685			523,510

XML 36 R26.htm IDEA: XBRL DOCUMENT

Other Current Assets (Tables)

6 Months Ended

Jun. 30, 2019

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of other current assets

	June 30, 2019		December 31, 2018

Value Added Tax receivable		34,878		67,388
Prepaid expenses		25,396		32,054
Other Receivables		-		93
		60,274		99,535

XML 37 R27.htm IDEA: XBRL DOCUMENT

Accrued Expenses & Other Contingent Liabilities (Tables)

6 Months Ended

Jun. 30, 2019

Payables and Accruals [Abstract]

Schedule of accrued expenses & other contingent liabilities

	June 30, 2019		December 31, 2018

Taxes payable		21,628		352,423
Invoices to be received		26,018		3,972
Holiday Allowance Payable		2,558		24,642
Other accrued expenses & other contingent liabilities		56,183		202,124
		106,387		583,161

XML 38 R28.htm IDEA: XBRL DOCUMENT

Related Party Other Liabilities (Tables)

6 Months Ended

Jun. 30, 2019

	June 30, 2019		December 31, 2018

NL Life Sciences B.V.		2,088,917		563,118
STB Family Offices SARL		227,323		200,234
STB Family Offices B.V.		-		661,432
Stichting Thank You Nature		-		16,913
Flare Media B.V.		-		25,458
AMC		193,632		325,382
Management & Board Fees		278,092		142,154
Yoomoo Limited		-		98,014
TriDutch Holding B.V.		21,975		-
		2,809,939		2,032,705

XML 39 R29.htm IDEA: XBRL DOCUMENT

Related Party Other Notes (Tables)

6 Months Ended

Jun. 30, 2019

Schedule of loans from other related parties

	June 30, 2019		December 31, 2018

Efficiency Life Fund		2,984,017		400,750
TriDutch Holding B.V.		-		672,099
		2,984,017		1,072,849

XML 40 R30.htm IDEA: XBRL DOCUMENT

Convertible Note Payable (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Schedule of convertible note payable

	June 30, 2019		December 31, 2018

Convertible loan 1		636,614		629,750
Convertible loan 2		-		970,960
Convertible loan 3		566,235		-
		1,202,849		1,600,710

XML 41 R31.htm IDEA: XBRL DOCUMENT

Related Party Convertible Note Payable (Tables)

6 Months Ended

Jun. 30, 2019

	June 30, 2019		December 31, 2018

Convertible loan Efficiency Life Fund		-		11,671,743

XML 42 R32.htm IDEA: XBRL DOCUMENT

Options & Warrants (Tables)

6 Months Ended

Jun. 30, 2019

Warrants and Rights Note Disclosure [Abstract]

Schedule of summary warrants granted

	June 30, 2019				December 31, 2018
	Shares		Weighted Average Exercise Price		Shares		Weighted Average Exercise Price
Outstanding at beginning of period		39,000,000	$	0.074		-	$	-
Granted		-		-		39,000,000		0.074
Exercised		-		-		-		-
Expired		-		-		-		-
Outstanding at end of period		39,000,000	$	0.074		39,000,000	$	0.074

Schedule of summary stock options

	June 30, 2019				December 31, 2018
	Shares		Weighted Average Fair Value		Shares		Weighted Average Fair Value
Outstanding at beginning of period		-	$	-		-	$	-
Vested		9,459,688		0.071		-		-
Unvested		18,298,275
Exercised		-		0.071		-		-
Expired		-		-		-		-
Outstanding at end of period		27,757,963	$	0.071		-	$	-

XML 43 R33.htm IDEA: XBRL DOCUMENT

Discontinued Operations and Assets/Liabilities Held For Disposal (Tables)

6 Months Ended

Jun. 30, 2019

Discontinued Operations and Disposal Groups [Abstract]

Schedule of the carrying amounts of the major classes of included in our discontinued operations

	For the Six Months		December 31, 2018
Current assets
Cash and cash equivalents		-		-
Related party receivable		-		201,907
Accounts receivable		-		124,016
Inventories		-		-
Other current assets		-		51,705
Total current assets		-		377,628

Fixed Assets
Tangible fixed assets		-		27,547
Financial Fixed Assets		-		23,618
Total fixed assets		-		51,165

TOTAL ASSETS		-		428,793

Short term debt
Accounts Payable		36,894		643,616
Accrued expenses & other contingent liabilities		133,575		243,510
Total short-term debt		170,469		887,126

	For the Three Months			For the Six Months
	For the Six Months			December 31, 2018

REVENUE		-			-

COST OF GOODS SOLD		-			-

GROSS MARGIN		-			-

OPERATING EXPENSES
Wages & Salaries		-			-
Selling, General & Administrative		(42,211	)		(81,621	)
Amortization & depreciation		-			-

Total operating expenses		(42,211	)		(81,621	)

LOSS FROM OPERATIONS		42,211			81,621

Interest expense		-			-

LOSS FROM DISCONTINUED OPERATIONS		42,211			81,621

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760

+ Details

XML 44 R34.htm IDEA: XBRL DOCUMENT

Organization and Nature of Business (Details) - USD ($)		1 Months Ended			6 Months Ended
Organization and Nature of Business (Details) - USD ($)	Nov. 13, 2018	Jun. 28, 2019	May 31, 2019	Apr. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Organization and Nature of Business (Textual)
Common stock shares issued	215,759,999
Issuance of common stock shares	115,760,000				65,621.283
Common stock voting, description	In part as 100,000 shares of voting.
Conversion of common stock shares
Common stock, shares outstanding					310,597,593	129,049,192
Common stock, shares authorized					750,000,000	200,000,000
Net cash received	$ 2,000,000
Costs incurred	$ 399,381
Securities purchase agreements, description					New funding through a series of securities purchase agreements that have been funded in the amount of $2,064,736 or are subject to signed commitments for funding in the amount of $3,283,904 that is expected to be completed during the third fiscal quarter of 2019. The securities to be sold will be a mix of several new series of preferred stock convertible into up to 96,289,473 shares of Common Stock and warrants exercisable for up to 177,404,377 shares of Common Stock.
Debt instrument, description					The fair value of all stock options outstanding at 30 June, 2019 is $1,970,813 at a weighted average fair value of $0.071 per option.
Series B Preferred Stock [Member]
Organization and Nature of Business (Textual)
Conversion of common stock shares	100,000,000
Preferred Class C [Member]
Organization and Nature of Business (Textual)
Conversion of common stock shares		78,832,399
Preferred Class C [Member] \| Preferred Stock [Member]
Organization and Nature of Business (Textual)
Common stock, shares outstanding					310,597,594
Common stock, shares authorized					750,000,000
Convertible Debt [Member]
Organization and Nature of Business (Textual)
Conversion of common stock shares					149,516,865
Convertible debt					$ 6,114,790
Debt instrument, description					The Company entered into the letter of intent, it lent to SIH the sum $250,000 under a promissory note, due January 4, 2020.
Interest rate					10.00%

XML 45 R35.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details)	6 Months Ended
Summary of Significant Accounting Policies (Details)	Jun. 30, 2019
BUILDING AND IMPROVEMENTS [Member]
Property and equipment, estimated useful lives	5 years
MACHINES AND INSTALLATIONS [Member]
Property and equipment, estimated useful lives	5 years
FURNITURE AND FIXTURES [Member]
Property and equipment, estimated useful lives	7 years
HARDWARE AND SOFTWARE [Member]
Property and equipment, estimated useful lives	3 years

XML 46 R36.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details 1)	6 Months Ended
Summary of Significant Accounting Policies (Details 1)	Jun. 30, 2019	Jun. 30, 2018
Accounting Policies [Abstract]
Expected dividend yield	0.00%	0.00%
Expected option term (years)	6 years	0 years
Expected volatility	382.00%	0.00%
Risk-free interest rate	3.00%	0.00%

XML 47 R37.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details 2) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Total revenues	$ 8,134	$ 414,716	$ 72,553	$ 942,433
Netherlands [Member]
Total revenues			72,553	942,433
France [Member]
Total revenues
Iceland [Member]
Total revenues

XML 48 R38.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details 3)	Jun. 30, 2019	Dec. 31, 2018
Equity [Member]
Translation of amounts from EUR into U.S. dollars	0.9037	0.9037
Statements of operations and comprehensive income (loss) [Member]
Translation of amounts from EUR into U.S. dollars	0.8895	0.8464
Balance Sheets [Member]
Translation of amounts from EUR into U.S. dollars	0.8849	0.8734

XML 49 R39.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Description of Summary of Significant Accounting Policies (Textual)
Corporate tax rate, description			The corporate tax rate for profits above $238,812 (or €200,000) amounts to 25%. Below that amount the rate is 20%. Future profits can be carried back to prior year losses for a maximum of 9 years for the full amount of losses incurred.
Federal income tax rate			23.00%
State corporate tax rate			23.00%
Net operating losses	$ (1,351,790)	$ (1,152,849)	$ (3,321,476)	$ (2,510,448)
Net operating losses expire date			Mar. 31, 2032
Related party transactions, description			(i) $10,000, and (ii) one percent of the average of the Company's total assets at year-end for the last two completed fiscal years, in the aggregate per year are subject to the boards review.
Expected option term (years)			6 years	0 years
Leases [Member]
Description of Summary of Significant Accounting Policies (Textual)
Operating lease right-of-use assets	580,310		$ 580,310
Operating lease liabilities	$ 578,007		$ 578,007
United States [Member]
Description of Summary of Significant Accounting Policies (Textual)
Net operating losses					$ 157,386	$ 3,483,928
Netherlands [Member]
Description of Summary of Significant Accounting Policies (Textual)
Expected option term (years)			6 years

XML 50 R40.htm IDEA: XBRL DOCUMENT

Fixed Assets (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Intangible Assets, Gross	$ 60,117	$ 838,404
Less: Accumulated Depreciation & Amortization	(1,432)	(314,894)
Intangible assets, net	58,685	523,510
Building and improvements [Member]
Intangible Assets, Gross		491,847
Hardware and software [Member]
Intangible Assets, Gross		80,163
Machines and installations [Member]
Intangible Assets, Gross		65,886
Furniture and Fixtures [Member]
Intangible Assets, Gross	$ 60,117	$ 200,508

XML 51 R41.htm IDEA: XBRL DOCUMENT

Other Current Assets (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Value Added Tax receivable	$ 34,878	$ 67,388
Prepaid expenses	25,396	32,054
Other Receivables		93
Other current assets	$ 60,274	$ 99,535

XML 52 R42.htm IDEA: XBRL DOCUMENT

Accrued Expenses & Other Contingent Liabilities (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Taxes payable	$ 21,628	$ 352,423
Invoices to be received	26,018	3,972
Holiday Allowance Payable	2,558	24,642
Other accrued expenses & other contingent liabilities	56,183	202,124
Total	$ 106,387	$ 583,161

XML 53 R43.htm IDEA: XBRL DOCUMENT

Related Party Other Liabilities (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Loans from other related parties	$ 2,809,939	$ 2,032,705
NL Life Sciences B.V. [Member]
Loans from other related parties	2,088,917	563,118
STB Family Offices SARL [Member]
Loans from other related parties	227,323	200,234
STB Family Offices B.V. [Member]
Loans from other related parties		661,432
Stichting Thank You Nature [Member]
Loans from other related parties		16,913
Flare Media B.V. [Member]
Loans from other related parties		25,458
AMC [Member]
Loans from other related parties	193,632	325,382
Management & Board Fees [Member]
Loans from other related parties	278,092	142,154
Yoomoo Limited [Member]
Loans from other related parties		98,014
TriDutch Holding B.V. [Member]
Loans from other related parties	$ 21,975

XML 54 R44.htm IDEA: XBRL DOCUMENT

Related Party Other Liabilities (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
NL Life Sciences B.V. [Member] \| STB Family Offices [Member]
Related Party Other Liabilities (Textual)
Total purchases relating to goods sold	$ 41,130	$ 797,770

XML 55 R45.htm IDEA: XBRL DOCUMENT

Related Party Other Notes (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Related party other notes	$ 2,984,017	$ 1,072,849
Efficiency Life Fund [Member]
Related party other notes	2,984,017	400,750
TriDutch Holding B.V. [Member]
Related party other notes		$ 672,099

XML 56 R46.htm IDEA: XBRL DOCUMENT

Related Party Other Notes (Details Textual)	6 Months Ended
Related Party Other Notes (Details Textual)	Jun. 30, 2019
Related Party Other Notes (Textual)
Bridge loan, description	For the loan from Efficiency Life Fund there is a repayment schedule in place to repay the loan in 10 installments from July 2019 to April 2022 and the debt therefore transferred from a related party liability to a loan.

XML 57 R47.htm IDEA: XBRL DOCUMENT

Convertible Note Payable (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Convertible note payable	$ 1,202,849	$ 1,600,710
Convertible loan 1 [Member]
Convertible note payable	636,614	629,750
Convertible loan 2 [Member]
Convertible note payable		970,960
Convertible loan 3 [Member]
Convertible note payable	$ 566,235

XML 58 R48.htm IDEA: XBRL DOCUMENT

Convertible Note Payable (Details Textual)	1 Months Ended				6 Months Ended		12 Months Ended
Convertible Note Payable (Details Textual)	May 31, 2019 shares	Apr. 30, 2019 shares	Oct. 20, 2017 USD ($)	Oct. 20, 2017 EUR (€)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2018 EUR (€)	Feb. 18, 2019 USD ($)	Dec. 31, 2018 EUR (€)
Convertible Note Payable (Textual)
Amount of advanced to loan agreement						$ 1,799,213
Conversion of common stock shares \| shares
Loan 2 [Member]
Convertible Note Payable (Textual)
Convertible interest rate			5.00%	5.00%
Convertible maturity date			Feb. 28, 2018	Feb. 28, 2018
Amount of advanced to loan agreement			$ 929,692
Loan 2 [Member] \| EUR [Member]
Convertible Note Payable (Textual)
Amount of advanced to loan agreement \| €				€ 800,000
Convertible loan 3 [Member]
Convertible Note Payable (Textual)
Principle amount									$ 560,915
Convertible loan 3 [Member] \| Three tranches [Member]
Convertible Note Payable (Textual)
Principle amount									560,915
Convertible loan 3 [Member] \| EUR [Member] \| Three tranches [Member]
Convertible Note Payable (Textual)
Principle amount									$ 500,000
Loan 1 [Member]
Convertible Note Payable (Textual)
Principle amount							$ 581,058
Convertible outstanding loan capital valuation							$ 17,400,000
Convertible interest rate							10.00%			10.00%
Convertible maturity date							Dec. 31, 2018	Dec. 31, 2018
Loan 1 [Member] \| EUR [Member]
Convertible Note Payable (Textual)
Principle amount \| €										€ 500,000
Convertible outstanding loan capital valuation \| €								€ 15,000,000

XML 59 R49.htm IDEA: XBRL DOCUMENT

Related Party Convertible Note Payable (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Related Party Convertible Note Payable [Abstract]
Convertible loan Efficiency Life Fund		$ 11,671,743

XML 60 R50.htm IDEA: XBRL DOCUMENT

Related Party Convertible Note Payable (Details Textual)	6 Months Ended
	Jun. 30, 2019 USD ($)
Related Party Convertible Note Payable (Textual)
Converted into Series Preferred C stock	$ 8,830,140

XML 61 R51.htm IDEA: XBRL DOCUMENT

Options & Warrants (Details) - $ / shares	6 Months Ended	12 Months Ended
Options & Warrants (Details) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Shares
Outstanding at beginning of period	39,000,000
Granted		39,000,000
Exercised
Expired
Outstanding at end of period	39,000,000	39,000,000
Weighted Average Exercise Price
Outstanding at beginning of period	$ 0.074
Granted		0.074
Exercised
Expired
Outstanding at end of period	$ 0.074	$ 0.074

XML 62 R52.htm IDEA: XBRL DOCUMENT

Options & Warrants (Details 1) - $ / shares	6 Months Ended	12 Months Ended
Options & Warrants (Details 1) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Shares
Outstanding at beginning of period
Vested	9,459,688
Unvested	18,298,275
Exercised
Expired
Outstanding at end of period	27,757,963
Weighted Average Fair Value
Outstanding at beginning of period
Vested	0.071
Unvested
Exercised	0.071
Expired
Outstanding at end of period	$ 0.071

XML 63 R53.htm IDEA: XBRL DOCUMENT

Options & Warrants (Details Textual) - $ / shares		1 Months Ended	6 Months Ended
Options & Warrants (Details Textual) - $ / shares	Nov. 13, 2018	Jan. 16, 2019	Jun. 30, 2019	Dec. 31, 2018	Dec. 31, 2017
Warrants (Textual)
Stock option, description			The fair value of all stock options outstanding at 30 June, 2019 is $1,970,813 at a weighted average fair value of $0.071 per option.
Weighted average fair value			$ 0.071
Stock Option [Member] \| Mr. Anthony Joel Bay [Member]
Warrants (Textual)
Stock option, description		Through La Bay Ventures Inc., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary.
Stock Option [Member] \| Mr. Rudolf Derk Huisman [Member]
Warrants (Textual)
Stock option, description		Through Pas Beheer B.V., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of the Company. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary.
Stock Option [Member] \| Mr. Robert A. Paladino [Member]
Warrants (Textual)
Stock option, description		Through Cavalier Aire LLC., will be issued a six-year option to purchase an aggregate of 7,319,321 shares of common stock of NTRU. The option granted by the Company provides for equal quarterly vesting of the shares commencing March 31, 2019, over three years ending December 31, 2021, with the right to exercise vested shares at $.030303 per share at any time until March 31, 2025, the sixth-year anniversary.
Stock Option [Member] \| Ms. Ellen Berkers [Member]
Warrants (Textual)
Stock option, description		Through Montrose Executive Management, will be issued an aggregate of 5,800,000 share of options to purchase common stock of the Company as part of her termination arrangement dated May 30, 2019. The option granted by the Company provides for the right to exercise the shares at $.030303 per share at any time from April 1, 2022 until March 31, 2025.
Warrant [Member]
Warrants (Textual)
Shares of common stock	33,000,000
Exercise price per share	$ 0.0606060
Exercisable period	4 years
Warrant One [Member]
Warrants (Textual)
Shares of common stock	6,000,000
Exercise price per share	$ 0.15
Exercisable period	4 years

XML 64 R54.htm IDEA: XBRL DOCUMENT

Loss Per Share (Details) - $ / shares	6 Months Ended
Loss Per Share (Details) - $ / shares	Jun. 30, 2018	Jun. 30, 2019	Dec. 31, 2018	Nov. 13, 2018
Loss Per Share (Textual)
Common stock shares issued		310,597,593	129,049,192	2,023,562
Common stock shares outstanding		310,597,593	129,049,192
Nominal value		$ 0.001	$ 0.001
Description of loss per share	Alpha Capital Anstalt has two outstanding warrants issued on November 13, 2018, each with 4-year terms. The first warrant has an exercise price of $0.060606 for 36,000,000 shares and the second warrant is exercisable for 6,000,000 shares at a $0.15 exercise price. The Company has reserved 16,240,000 shares of Common Stock for management incentive awards.

XML 65 R55.htm IDEA: XBRL DOCUMENT

Discontinued Operations and Assets/Liabilities Held For Disposal (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents
Related party receivable		201,907
Accounts receivable		124,016
Inventories
Other current assets		51,705
Total current assets	5,000	377,628
Fixed Assets
Tangible fixed assets		27,547
Financial Fixed Assets		23,618
Total fixed assets		51,165
TOTAL ASSETS		428,793
Short term debt
Accounts Payable	36,894	643,616
Accrued expenses & other contingent liabilities	133,575	243,510
Total short-term debt	$ 170,469	$ 887,126

XML 66 R56.htm IDEA: XBRL DOCUMENT

Discontinued Operations and Assets/Liabilities Held For Disposal (Details 1) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Discontinued Operations and Disposal Groups [Abstract]
REVENUE
COST OF GOODS SOLD
GROSS MARGIN
OPERATING EXPENSES
Wages & Salaries
Selling, General & Administrative	$ (42,211)	(81,621)
Amortization & depreciation
Total operating expenses	(42,211)	(81,621)
LOSS FROM OPERATIONS	42,211	81,621
Interest expense
LOSS FROM DISCONTINUED OPERATIONS	$ 42,211	$ 81,621

XML 67 R57.htm IDEA: XBRL DOCUMENT

Discontinued Operations and Assets/Liabilities Held For Disposal (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2019	Nov. 13, 2018
Discontinued Operations And Assets/Liabilities Held For Disposal (Textual)
Issuance of common stock shares	65,621.283	115,760,000
Preferred shares value	$ 2,064,756
Conversion of common stock shares	6,754,575

XML 68 R58.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details) - Subsequent Event [Member]		1 Months Ended
Subsequent Events (Details) - Subsequent Event [Member]	Jul. 09, 2019	Jul. 31, 2019	Jul. 29, 2019	Jul. 24, 2019
Subsequent Events (Textual)
Purchase and recapitalization agreement, description				The Company entered into a Purchase and Recapitalization Agreement ("Recapitalization Agreement") with DRBG Holdco, LLC, a Delaware limited liability company, Temple Turmeric, Inc., a Delaware corporation, Daniel Sullivan, Tim Quick, and TQ Holdings LLC, a New Hampshire limited liability company to acquire the business of Temple. Under the Recapitalization Agreement the Company acquired 15,121,984 shares of Series A Preferred Stock of Temple from DRBG for a nominal amount and acquired from TQH a promissory note in the principal amount of $100,000, plus all accrued and unpaid interest. As part of the transaction Temple issued to DRBG a warrant to acquire a percentage of the Temple equity. The Temple board of directors will have three of the five directors appointed by the Company pursuant to the terms of the Series A Shares. The Series A Shares represent an approximate 52% of the equity of Temple, on a fully diluted basis. Under the Recapitalization Agreement the Company will provide working capital to Temple in the amount of not less than $150,000 but up to $250,000. The Company will acquire additional equity ownership of Temple for this investment based on a valuation of Temple of $1,000,000. This further investment will increase the controlling position of the Company in combination with its ownership of the Series A Shares. The Temple warrant is exercisable for the greater of 1,493,735 shares of common stock of Temple or 2.5% of the equity of Temple on a fully diluted basis. The exercise price per share is the par value of the common stock to be acquired upon exercise of the Temple warrant. The exercise period is ten years, but not later than the earlier of the consummation of the initial public offering by Temple or a sale transaction of Temple, as defined in the Warrant. The Temple warrant has a cashless conversion right and has typical anti-dilution rights for dividends, reverse splits and changes in the capitalization of Temple.
Debt instrument, interest rate terms, description	The Company lent to Share International Holding B.V. a company of which Mr. Bartley is a principal, the sum $250,000 under a promissory note, due January 4, 2020. The note bears interest at the rate of 10%.
Outstanding loan facility, description			$639,784 of an outstanding loan facility in the principle amount of $581,058 or €500,000 plus accrued interest, at an interest rate of 10% per annum, was converted to common stock of the company. On this date the debt was converted and 11,632,445 of common stock was issued to the borrower.
non-US private investors [Member]
Subsequent Events (Textual)
Investment agreement, description		The Company reached agreement with certain non-US private investors to invest in total $1,765,605 to acquire 46,947.368 of the Series G Preferred Stock.

XML 69 R59.htm IDEA: XBRL DOCUMENT

Recapitalization (Details) - USD ($)	Nov. 13, 2018	Jun. 30, 2019	Dec. 31, 2018
Recapitalization (Textual)
Common stock, shares issued	2,023,562	310,597,593	129,049,192
Description of convert at a ratio	The shares of Series A Preferred Stock will convert at a ratio of 1 share to 33,000 common shares.
Post merger, description	The historical number of common shares of Nature Holding B.V. presented in our financial statements were converted to post-acquisition shares on a 1 to 112 basis.
Preferred Class A [Member]
Recapitalization (Textual)
Preferred stock, shares issued	2,469,131	2,397,131	2,469,131
Capital investment	$ 2,000,000
Debt forgiveness	$ 469,131
Preferred Class B [Member]
Recapitalization (Textual)
Preferred stock, shares issued	100,000		100,000
Description of convert at a ratio	These shares convert at a ratio of 1 share to 1,000 common shares.
Natur Shareholders [Member]
Recapitalization (Textual)
Common stock, shares issued	115,759,999

XML 70 R60.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit (Details) - shares		1 Months Ended			6 Months Ended
Stockholders' Deficit (Details) - shares	Nov. 13, 2018	Jun. 26, 2019	Mar. 19, 2019	Sep. 21, 2018	Jun. 30, 2019	Dec. 31, 2018
Stockholders' Deficit (Textual)
Common stock shares issued	2,023,562				310,597,593	129,049,192
Common stock shares outstanding					310,597,593	129,049,192
Series A Preferred Stock, conversion description			The holder of the Series A Preferred Stock converted 72 of such shares with a stated value of $72,000 for 2,376,002 shares of common stock. The applicable conversion price per common share was $0.030303. The Company did not receive any payment on this conversion, having received the consideration for the Series A Preferred Shares on November 12, 2018. There are remaining an aggregate of 2,397.131 shares of Series A Preferred Stock issued and outstanding. The shares of common stock issued on conversion are registered for resale by the holder.
Shares of Class C preferred stock		78,832,399
Preferred stock class, description					· Series Preferred Stock D: 15,789.473 preferred shares, conversion to common shares at a ratio of 1:1,000. price per share of $31.70, no voting rights and a warrant reflecting the right to buy 20,000,000 shares at an exercise price of $0.06 · Series Preferred Stock E: 56,443.551 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $30,40, no voting rights and a warrant reflecting the right to buy 56,443,551 shares at an exercise price of $0.0304 · Series Preferred Sock F: 49,342.105 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share $0.0304, registration rights, and warrant reflecting the right to buy 740,130,158 shares at an exercise price of $0.0304. · Series Preferred Sock G: 46,947.368 preferred shares, conversion to common shares at a ratio of 1:1,000, price per share of $0.038, registration rights and a warrant reflecting the right to buy 46,947,368 shares at an exercise price of $0.076.
Alpha Capital Anstalt [Member]
Stockholders' Deficit (Textual)
Description of shares of non-voting convertible series				Parent Company also executed a Securities Purchase Agreement (the "SPA") by which it agreed to privately issue and sell to Alpha Capital Anstalt (the "Alpha") 2,469.131 shares of non-voting, convertible Series A Preferred Stock, each share convertible into approximately 33,000 shares of Common Stock, based on a per common share conversion rate of $.030303. Alpha also purchased two warrants, one pursuant to the SPA that is exercisable for 33,000,000 shares of Common Stock at $.060606 per share and another one pursuant to a debt cancellation agreement exercisable for 6,000,000 shares of Common Stock at $.15 per share. The aggregate purchase price for the Series A Preferred Stock and the warrant for 33,333,000 shares of common stock was $2,000,000 in cash and conversion of $469,131 of outstanding debt. The other warrant was issued for conversion of outstanding interest due Alpha under a prior loan agreement to Future Healthcare of America. Prior to the acquisition of Natur Holding, B.V., Alpha also had cancelled approximately $651,000 of debt principle and interest due from the Company.
Description debt principle				Transactions eliminated $1,420,000 of debt principle and interest of the Company and improved its balance sheet. As part of the SPA transaction, Alpha has also agreed to reimburse up to $100,000 of the liabilities of Parent Company existing at the closing date, which has not yet been paid.
Parent Company [Member]
Stockholders' Deficit (Textual)
Description of common stock	In connection with the Share Exchange Transaction, the Company issued the equivalent of 215,759,999 shares of the Common Stock to the former shareholders of Nature Holding B.V., which was issued in part as 115,760,000 shares of Common Stock and in part as 100,000 shares of voting, convertible Series B Preferred Stock (the "Series B Preferred Stock") representing 100,000,000 shares of Common Stock upon conversion. The Series B Preferred Stock converted automatically into the Common Stock on June 26, 2019, when the Company increased its authorized capital in sufficient amount to permit the conversion of the Series B Preferred Stock.

EXCEL 71 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 73 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 166 352 1 false 54 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://futurehealthcareofamerica.com/role/futu-daei Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://futurehealthcareofamerica.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://futurehealthcareofamerica.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Unaudited Consolidated Statements of Operations Sheet http://futurehealthcareofamerica.com/role/UnauditedConsolidatedStatementsOfOperations Unaudited Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Unaudited Consolidated Statements of Shareholders??? Deficit Sheet http://futurehealthcareofamerica.com/role/UnauditedConsolidatedStatementsOfShareholdersDeficit Unaudited Consolidated Statements of Shareholders??? Deficit Statements 5 false false R6.htm 00000006 - Statement - Unaudited Consolidated Statements of Cash Flows Sheet http://futurehealthcareofamerica.com/role/UnauditedConsolidatedStatementsOfCashFlows Unaudited Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Nature of Business Sheet http://futurehealthcareofamerica.com/role/OrganizationAndNatureOfBusiness Organization and Nature of Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://futurehealthcareofamerica.com/role/DescriptionOfBusinessAndSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://futurehealthcareofamerica.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Fixed Assets Sheet http://futurehealthcareofamerica.com/role/FixedAssets Fixed Assets Notes 10 false false R11.htm 00000011 - Disclosure - Other Current Assets Sheet http://futurehealthcareofamerica.com/role/OtherCurrentAssets Other Current Assets Notes 11 false false R12.htm 00000012 - Disclosure - Accrued Expenses & Other Contingent Liabilities Sheet http://futurehealthcareofamerica.com/role/AccruedExpensesOtherContingentLiabilities Accrued Expenses & Other Contingent Liabilities Notes 12 false false R13.htm 00000013 - Disclosure - Related Party Other Liabilities Sheet http://futurehealthcareofamerica.com/role/RelatedPartyOtherLiabilities Related Party Other Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Related Party Other Notes Notes http://futurehealthcareofamerica.com/role/RelatedPartyOtherNotes Related Party Other Notes Notes 14 false false R15.htm 00000015 - Disclosure - Convertible Note Payable Sheet http://futurehealthcareofamerica.com/role/ConvertibleNotePayable Convertible Note Payable Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Convertible Note Payable Sheet http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayable Related Party Convertible Note Payable Notes 16 false false R17.htm 00000017 - Disclosure - Options & Warrants Sheet http://futurehealthcareofamerica.com/role/OptionsWarrants Options & Warrants Notes 17 false false R18.htm 00000018 - Disclosure - Loss Per Share Sheet http://futurehealthcareofamerica.com/role/LossPerShare Loss Per Share Notes 18 false false R19.htm 00000019 - Disclosure - Discontinued Operations and Assets/Liabilities Held for Disposal Sheet http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposal Discontinued Operations and Assets/Liabilities Held for Disposal Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://futurehealthcareofamerica.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Recapitalization Sheet http://futurehealthcareofamerica.com/role/Recapitalization Recapitalization Notes 21 false false R22.htm 00000022 - Disclosure - Stockholders' Deficit Sheet http://futurehealthcareofamerica.com/role/StockholdersDeficit Stockholders' Deficit Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://futurehealthcareofamerica.com/role/DescriptionOfBusinessAndSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://futurehealthcareofamerica.com/role/DescriptionOfBusinessAndSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Fixed Assets (Tables) Sheet http://futurehealthcareofamerica.com/role/FixedAssetsTables Fixed Assets (Tables) Tables http://futurehealthcareofamerica.com/role/FixedAssets 25 false false R26.htm 00000026 - Disclosure - Other Current Assets (Tables) Sheet http://futurehealthcareofamerica.com/role/OtherCurrentAssetsTables Other Current Assets (Tables) Tables http://futurehealthcareofamerica.com/role/OtherCurrentAssets 26 false false R27.htm 00000027 - Disclosure - Accrued Expenses & Other Contingent Liabilities (Tables) Sheet http://futurehealthcareofamerica.com/role/AccruedExpensesOtherContingentLiabilitiesTables Accrued Expenses & Other Contingent Liabilities (Tables) Tables http://futurehealthcareofamerica.com/role/AccruedExpensesOtherContingentLiabilities 27 false false R28.htm 00000028 - Disclosure - Related Party Other Liabilities (Tables) Sheet http://futurehealthcareofamerica.com/role/RelatedParty Related Party Other Liabilities (Tables) Tables http://futurehealthcareofamerica.com/role/RelatedPartyOtherLiabilities 28 false false R29.htm 00000029 - Disclosure - Related Party Other Notes (Tables) Notes http://futurehealthcareofamerica.com/role/RelatedPartyOtherNotesTables Related Party Other Notes (Tables) Tables http://futurehealthcareofamerica.com/role/RelatedPartyOtherLiabilities 29 false false R30.htm 00000030 - Disclosure - Convertible Note Payable (Tables) Sheet http://futurehealthcareofamerica.com/role/ConvertibleNotePayableTables Convertible Note Payable (Tables) Tables http://futurehealthcareofamerica.com/role/ConvertibleNotePayable 30 false false R31.htm 00000031 - Disclosure - Related Party Convertible Note Payable (Tables) Sheet http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayableTables Related Party Convertible Note Payable (Tables) Tables http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayable 31 false false R32.htm 00000032 - Disclosure - Options & Warrants (Tables) Sheet http://futurehealthcareofamerica.com/role/OptionsWarrantsTables Options & Warrants (Tables) Tables http://futurehealthcareofamerica.com/role/OptionsWarrants 32 false false R33.htm 00000033 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Tables) Sheet http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalTables Discontinued Operations and Assets/Liabilities Held For Disposal (Tables) Tables http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposal 33 false false R34.htm 00000034 - Disclosure - Organization and Nature of Business (Details) Sheet http://futurehealthcareofamerica.com/role/OrganizationAndNatureOfBusinessDetails Organization and Nature of Business (Details) Details http://futurehealthcareofamerica.com/role/OrganizationAndNatureOfBusiness 34 false false R35.htm 00000035 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 00000036 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 00000037 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) Details http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesTables 37 false false R38.htm 00000038 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) Details http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesTables 38 false false R39.htm 00000039 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://futurehealthcareofamerica.com/role/SummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - Fixed Assets (Details) Sheet http://futurehealthcareofamerica.com/role/FixedAssetsDetails Fixed Assets (Details) Details http://futurehealthcareofamerica.com/role/FixedAssetsTables 40 false false R41.htm 00000041 - Disclosure - Other Current Assets (Details) Sheet http://futurehealthcareofamerica.com/role/OtherCurrentAssetsDetails Other Current Assets (Details) Details http://futurehealthcareofamerica.com/role/OtherCurrentAssetsTables 41 false false R42.htm 00000042 - Disclosure - Accrued Expenses & Other Contingent Liabilities (Details) Sheet http://futurehealthcareofamerica.com/role/AccruedExpensesOtherContingentLiabilitiesDetails Accrued Expenses & Other Contingent Liabilities (Details) Details http://futurehealthcareofamerica.com/role/AccruedExpensesOtherContingentLiabilitiesTables 42 false false R43.htm 00000043 - Disclosure - Related Party Other Liabilities (Details) Sheet http://futurehealthcareofamerica.com/role/RelatedPartyOtherLiabilitiesDetails Related Party Other Liabilities (Details) Details http://futurehealthcareofamerica.com/role/RelatedParty 43 false false R44.htm 00000044 - Disclosure - Related Party Other Liabilities (Details Textual) Sheet http://futurehealthcareofamerica.com/role/RelatedPartyOtherLiabilitiesDetailsTextual Related Party Other Liabilities (Details Textual) Details http://futurehealthcareofamerica.com/role/RelatedParty 44 false false R45.htm 00000045 - Disclosure - Related Party Other Notes (Details) Notes http://futurehealthcareofamerica.com/role/RelatedPartyOtherNotesDetails Related Party Other Notes (Details) Details http://futurehealthcareofamerica.com/role/RelatedParty 45 false false R46.htm 00000046 - Disclosure - Related Party Other Notes (Details Textual) Notes http://futurehealthcareofamerica.com/role/RelatedPartyOtherNotesDetailsTextual Related Party Other Notes (Details Textual) Details http://futurehealthcareofamerica.com/role/RelatedParty 46 false false R47.htm 00000047 - Disclosure - Convertible Note Payable (Details) Sheet http://futurehealthcareofamerica.com/role/ConvertibleNotePayableDetails Convertible Note Payable (Details) Details http://futurehealthcareofamerica.com/role/ConvertibleNotePayableTables 47 false false R48.htm 00000048 - Disclosure - Convertible Note Payable (Details Textual) Sheet http://futurehealthcareofamerica.com/role/ConvertibleNotePayableDetailsTextual Convertible Note Payable (Details Textual) Details http://futurehealthcareofamerica.com/role/ConvertibleNotePayableTables 48 false false R49.htm 00000049 - Disclosure - Related Party Convertible Note Payable (Details) Sheet http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayableDetails Related Party Convertible Note Payable (Details) Details http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayableTables 49 false false R50.htm 00000050 - Disclosure - Related Party Convertible Note Payable (Details Textual) Sheet http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayableDetailsTextual Related Party Convertible Note Payable (Details Textual) Details http://futurehealthcareofamerica.com/role/RelatedPartyConvertibleNotePayableTables 50 false false R51.htm 00000051 - Disclosure - Options & Warrants (Details) Sheet http://futurehealthcareofamerica.com/role/OptionsWarrantsDetails Options & Warrants (Details) Details http://futurehealthcareofamerica.com/role/OptionsWarrantsTables 51 false false R52.htm 00000052 - Disclosure - Options & Warrants (Details 1) Sheet http://futurehealthcareofamerica.com/role/OptionsWarrantsDetails1 Options & Warrants (Details 1) Details http://futurehealthcareofamerica.com/role/OptionsWarrantsTables 52 false false R53.htm 00000053 - Disclosure - Options & Warrants (Details Textual) Sheet http://futurehealthcareofamerica.com/role/OptionsWarrantsDetailsTextual Options & Warrants (Details Textual) Details http://futurehealthcareofamerica.com/role/OptionsWarrantsTables 53 false false R54.htm 00000054 - Disclosure - Loss Per Share (Details) Sheet http://futurehealthcareofamerica.com/role/LossPerShareDetails Loss Per Share (Details) Details http://futurehealthcareofamerica.com/role/LossPerShare 54 false false R55.htm 00000055 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Details) Sheet http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalDetails Discontinued Operations and Assets/Liabilities Held For Disposal (Details) Details http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalTables 55 false false R56.htm 00000056 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Details 1) Sheet http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalDetails1 Discontinued Operations and Assets/Liabilities Held For Disposal (Details 1) Details http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalTables 56 false false R57.htm 00000057 - Disclosure - Discontinued Operations and Assets/Liabilities Held For Disposal (Details Textual) Sheet http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalDetailsTextual Discontinued Operations and Assets/Liabilities Held For Disposal (Details Textual) Details http://futurehealthcareofamerica.com/role/DiscontinuedOperationsAndAssetsliabilitiesHeldForDisposalTables 57 false false R58.htm 00000058 - Disclosure - Subsequent Events (Details) Sheet http://futurehealthcareofamerica.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://futurehealthcareofamerica.com/role/SubsequentEvents 58 false false R59.htm 00000059 - Disclosure - Recapitalization (Details) Sheet http://futurehealthcareofamerica.com/role/RecapitalizationDetails Recapitalization (Details) Details http://futurehealthcareofamerica.com/role/Recapitalization 59 false false R60.htm 00000060 - Disclosure - Stockholders' Deficit (Details) Sheet http://futurehealthcareofamerica.com/role/StockholdersDeficitDetails Stockholders' Deficit (Details) Details http://futurehealthcareofamerica.com/role/StockholdersDeficit 60 false false All Reports Book All Reports ntru-20190630.xml ntru-20190630.xsd ntru-20190630_cal.xml ntru-20190630_def.xml ntru-20190630_lab.xml ntru-20190630_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/currency/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 76 0001213900-19-015722-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-19-015722-xbrl.zip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
@7?CW#W1:4$:@QNN"?[Z65_SB W MZ8160IB)P4"1K+K+@@20?$"KE8;5:G2L3JA7)OJ?OHR0!?;3ABJPD M&K*V)3-*K#J>)!J,,P.K(G,B?%/!F9O,!]*9,[/B633?*$\_?>]'5&)$'5\' M+__*Y'&4FEH)%![Q(Z[B8/81GO#@4VK?PX5H6^D3(-+-/+V5FD9#FG9F#I/5 MQ)&/5VRXM[J/9+F?1;ROKA35IF;-#R/I31F#V((T(!,0##KR ^??\%'=8+4* M$\9X6W+(=LD,&O5?&8R=2"OF^FZ=M1[-K*$DNI% IJ059>#'MWP-T\R2L&6I M;4^NV(8<(:JH5:M6%6Y+Y5J[E)[Q*Z4<7MX<"U?=O^B"PUL ?!9/'JZ%$)=$5H )V,+GQHN(FZ5Z,A 6O]./ B305 M)JX@P^O#)^&J"T0/2B:?5* $4I0'?#4B=YZKN >=QA#T<_RMZTY&MCA6MMJN M![OJZC'IMX-/-'$5>R^7*K6*<7[08_C$P9WQD8#"C7H]6]#,%^C$ X@+16 M,PZKOCZ;!\HR;;>H3)@$FS$O*:7C0ZEVJM BZ\$4 MKV?F<]5-KA;3ADH&^4DV&"$43?S'L"62D<-C17UZ7ILU&W6ALI."*>DM:!J* MYE) 5!HI ,SJ[#L8\@YQI7&BC)[ZFC6[JP8[QC7@0]K:I_!1RVSC7!WL0S4! M&(WA=CBBP;(\[ ,0GX7$!W^;K >14R(P< F,0@V"(:P0FNR YB")>HH74*:- MU.CBP*ND)*<8AVV942 TA2HEH@1(PC>5("#S;^H 8)N&$K(62UF3*$?VP+A" M9\_%AV:#'!)D@T/22)3UA#=GUD,.1D/(:*][1JN1Z&7U;.0X'RI6O5J>/X/( MC#YKJF/Y-%877I1AM[9+1J1P).6L#Y(.DZ'L*!R0I1CQD'*P0#KCVQBOWLHO MI#4(-9+V#CLIKYCBJXG]SU8R4@D]O$%8BFGBQ'AG?Y21N)42]15G4-JS"^FV M5P-B[YL-#&7*D,Q*YXQW:TIB:#^:4@M:57R!S(M:A4 =VD;[!OZ>N&$^M(BK MT,&O6K46,L7J BZDV-]DXL+!I0;2*:<@#LC&DFD)0[RKG,@4TS\Y< 9$1X'L M2S3CX'>)\4S=7--)+'2%(RFJQP>)W\89J* S@F Q']8N;=^\[+#:U";(4,@$ M:%D:VXY'A\ S^#U>'JQ:IS4EW9_D]XJQ3JF"C(8%S%Z]DM&R%5@8YD-!+[A& M>!<=3\KZQW22$Y/3AL])%\C-95O^M,MAZ) H@&I M/?W]$>-.R#;>)_N2#,C M35ED2,UKM:UV#>FMLTA!F;XI@3!=Z1XQQ32V=9?(%SF=:R3.D!)*.3/(#-DG M4P*:"+66PSMJVH6=*+'O:X,SA072E8)M"J[K/Y!0=="EC.PN'=D(\V,B"^/; M?\D^J5,Z!!$VC8,Y0GR\+P"HO^VT'Y@#Z'$[NO M/T_5F"R75ZHRR9 <1O[D,UJ.U4<=?EU.4S>>S@"!]Y_*\E# E4M):N@+RH+R MV_-R0'"YAZ'S;\EK?LZ4V7L7NJXL'3?//D,T8@ MMMJ=4KU5FXF0M4P):IC*F1NBS5V0WD"F]L\5CEV:CF!!+:E6*;7*%N@JROZF MPRSH1IIK_IL_9 MZ6?1:%KU>JW4:%1>?,Y6@R$]E-;\0UFVZJL>RM4@R)Q@7K^%ZU_B!-?*]67. M\*+C:Y[<94]!KD]I(37S(37Q,)]]%O6.5:M72Y5R8QU"<_9\JB-@B3FI*9S4 ML(S0;,'YKL QKS3:2YZYTOH%YUXFS9+ ^CK@I)O=* MOO77GY;@)L!X_OK3C]O =3[C?^'C_P]02P,$% @ D&0.3V&KE4SL$P MP_4 !$ !N=')U+3(P,3DP-C,P+GAS9.U=6W/;.)9^WJW:_\#UULSVUI8B MRX[3B3N9*_3,$D)*%" 0I VM+\^@5 4B(!$"1EI<&98AY2 M,LZ%YYP/UT,0>/_7U2+TGB!EB. /!X-7AP<>Q#X)$)Y]./@\Z0TG9]?7!]Y? M__(?_^[Q?^__L]?S+A$,@U/OG/B]:SPE/WF?P *>>A\AAA1$A/[D_0+"6)20 M7T?W-_S/1/^I=_+J\-'W>KT:VGZ!."#T\_WU1ML\BI:G_?[S\_,K3)[ ,Z%? MV2N?U%,W(3'UX487CFC\IZ/SH\/!N\,WQX>O5E-N]3F(.$F4<=+A6_[?X/CA M\-WIX,WIR>O?:SXG E',-L\Y7!VF_^J)WR+F;X3_]]OR=_;CZA[].H/X;3P$ M5ZO;+^#CY=_\<; Z^?T?9[^%HZBL?W1X..C_>GLSD7P'">/I*D3XJXE] M\.[=N[ZD9JP:Y^J1AIGJX[X@/P(&-YHY%5GX$681P'Z!/X@V GGFDWY"++ B M(^N;A!5EK %4^!CT7\W(4Y\3^J(.] X'O>-!QAZSW@R Y49D"MBC5)T2S"*4 MA) 9923%(,1HI//S0C-K+UHO30_8D QBF& <+\SQ#R+:%W)]SM3C7) B?R-7 M+504X%Z6F)=13-;QAKD5B*.8PCD$833W 85D"N03 &_VBW[6>'F/%<(%Q-$E MH8MS. 5QR&/X+08AFB(8''@1H#,8B0;&EL"'3=5GS19@3'CKYAU96B+*EDO$ MFR\O^+?WHIZ?"EP?N&^>^,%[KYH/$]R2I1< R.LH"CX<;/\4ZOG#Y ,".$48 M22O2GF7@]40_$HL0Y'\"''@7.$+1VA-=#%U(V]_W534YY3&#P1C_1?Y>4LBX M&BETPPM2P92E1,@'H1^'S62VIAA%TH(LL/L)]0B$HHN9S"&,6!+N8I$]Y$<\ MSJ*GAVG,SPAF)$0!+PF\5)&7:.KBK<7[CO/@: XCSA(:@E^DVY$XKH^$]T-! M\?]TR AD/F,0!XA'*Q^Y3439>#I>BED=MREM)TT$[-B]5K#;:"ZBN-7MD:FW MU=[A5PN_R9P+SDD8\$DX'QV1CZ*:0)HD[8B>[()H_C%__J^W1X,?^50\>5P' M<2V(SP";7X;DN6X+W?+;X7RS"YQ"N2>U=^@)],9T!C#ZAS1TB(-/0$B,IZ.8 M(0Q9"ED5DQVG'\6TCZ\<0\*X&/\CKT[. Q.% IY,90>. .<<,I^BI7CH-MH< M@ F:8;YZ\ &.AKY/8CZ-QK,[7N-]!%/(=A.U _E6!7(2+Q: KF4WN=7K;15[ MF>8.3X'G1\)CPCLG'U*NEPEV 18 OT0H&0\8VRZ9\@36\ M@T,UO%+42V2[Z,JQ@B].Z%E,Q3(E'V1#N3W6 VU$$!J\5$47\US,>5]*8QA< MK)80,\B24!/9N7*?;Q!X1"$W*>OVZ[/;$3I2$4H5>YEF[\]@L?PI V[S!"_W MB Y > ]#,4TE"_NH[6,EH:9E<,.T[$*4ZK+D\I2=#I(JB#Y1*)2,!*:'8;7 M=6"0BCH ! "\OWB"-$*/(111N0-KP'\F )30[ "ZF>+OYJ [!A M48//CLL;>\/H4+).M^3JC7T!E/)553;74@KM\=>7WHEX.GIG6KIXBWC?$,;N M()4)OR38A1)[I+6UL9#UN'"20.PB+/,9/$!RJLAGDMM,^1"G*[1P.U&Y@F%P M22@76!*6O8;97=R.G;:RSC\HE]*7N:KD6?WXF"+MC)D.Z#)8I F.95LP%<*;4'6UN7J_)= MK&7%CHC_U?3.RD2P1UQ;9^=5_'?WHJG8G\AL\WAJS6$7T^ -9>Q@::OM^OEO M[X?L5_=BOP&8#V(UT C*5,(.I+9>;P)D\H0.1C7AGL=*+[8#HJW?\\GW+N05 M6?A\Y$NI=@"TA;HI(]\!L5MJ/H]/4R$[;-KZ?H=+:]?F+T92790M!2".KI#ZGN#K0&>:,"=LU$[!!JB8HFF:,. MR9V1'.P Y: "2RWGL0.6WJ!#LSF:1SN@>52!II8*V07-HP[-YF@>[X#F<06: M+_C48(OF<8=FBPV/%53 &BQE)VY/;QS40';/VO)PI8UF&TP]?T M6XH.JL90%>86#?CMP-7Z^L($7#>-J/'VS=[*"BQVF+34B>7]6]>R:@-C;U,F M3CM,%9]LF&#JVE&-]Z6%=F1GL0.D)3K*7[MUS:@V+H5F5(O3CI*6P*A$J6M% M#5]PEXY,+VE=%;M$NK:V9_1*AZ^7M\$3+9W1$,NN1=KV+12S'6::'1\]U5&R MQXZ+E)*IPZ7JLLB]Z"]V5B6!' M0DLR%+_O[?JH/6VO*L#T8BUV3+6,Q,LW6'6U8)^U8+"?:E U^FDIC[W5@VZ< MW%--*(RH^U)FKQ5:GF5_M:(;I6WG!"B;]\Q$.W:&[2/*J0%=5VT_/T!)KIB) M=A ,J92BF@Z#RG,%BFVAG&Y%XHU^B(;IE(%_13C$?^)VEWLX]>2M,*?B:H\/ M!PPMEN*4JZ1L3N'TPX&XW*.7W:OQ=^[:J]4BS%B$:LNM,!(_-1KI@S,5@/J: M%NW6&JZ$+$56"K)^9GRF($*1$+_+/<83S^'5H[\/ET/PV-1E+@+#[^CKC="_ M5R=Y[6OJI%)AOY.K9]NG[-5AWG2:.EQL;=_)W_/-0_+NIC?7]+=7UZ1_J]?; MO.>.$QIY6+LXQW9G4W+;U WQI2J+B/BKE\GU1%%O<-0['KQ:L6!K:1,CMF%H M9D0FMX,1YLNH:CX^$Q#//6GTQ+*[JDP/9F5"XD=O*UW7 .O-5R6>R^<;!?LP MY+/ZM.2%UNAW2NUNCM2U@STUKM.J4SORDI\205%+WHG:.7CS0F-V,V1G*PJ5 M3VXYIFL1[!\;U=J\8/9';ZME-V/DED]_W;P-%20W?[VD_JIWO-6JNIE04FW% MK6\OLV#7)J3;4=%^TAO;Y*1;#*9_O\9/!/F0/9 1'PI]B)[$S6W"V@\')304 MAN)EXH<#+B^&/G&MX"D?$A$)'N3(G0PN449Z3&Z#^G#@4QB( \62\3TA+@CF M4W.ZOH[@0DASQ_F"E@^DL7#[(R7Q,F-%G,7FRA41%Z.LAV%(GL4#-P>^)MZ4 MD]OJ4.XU[CB.A GB>M ; O!9LMH4]U6F9^(E/C:2J'0[B&G*J_@=P,<_QFUA M^<54K.%$,[]!4W@9X\#@;2EC6[$MW&*2.C*,[D6\,_?L+ W0R[O (LIKQ#Y0 M"@%CXVGZHFY,[]%L'N4JW1HC!N_X6+9IDB_441_;) )\ M*!5D^5KK>T7@8K5$O.;L['T]^<;@_Q&N?Y1O;*_QG;1CYP@T4M/*0$@,DQ1Z MYD8UYAK_K@U<>,:^GVM)_.LZIG.WTJUBG6M0/=OJT+9*-:I_+W4J*]W' )F^ M6Y)"U]@/8S$B&%^0I1]4,KEW>X@#,1E@R815./$)1H/-F+IOK3O/+[[O'*J! MGU]XM\HFW"PJSY9M'"=5OJW3RCO"HEM(9Y#F)E:9OV5$U[.L#(>9$$(9#D$. M!Y+A(+;M7%*RR-\;6P1S5R6[(_J=)]'Y7;4/O$-CP) MHB9Z7$]/&Z-\MI_*HJGY%ZHLC4+41(_KRI++Z!E=M-!=#]UE$PQYQ,M:[(L; MA3E/ZK,W3W$0+ ;B*-.QCRKJSV$0AY!,+[B"A;#\,X/3.+Q!3Y#=)6_$UP ' M%]]BM!2RFTJYBV2;7!Y/:QXQJT'\(@VM"(&E0\GW)Y\QBEB=7L@DY+K+N8NI M/P<,\A6^NHMO.*-0:PMF*6\ZRXAM?1>V[2AECDWF'\1A#+EN,Y>:JLW=ABXTW^/E MYBO%>E?%Y+JR77/S6"3*;#UB)9?K#G#;3S/Y&,. MTI_YXQLWF_& :#,J+K7J?& M2LRV4J\6:0,RZ:?TO-5DG]'+[+]\DVEI;\W%6N%L<9_;)?#%9XIK0YVLQ>FZ M@IX!-L_V6HJ137S>M]T%5AP$-L-$,YFVOE;(C6A)_D!\WPH?(]/\I@9G6]TL MXJ$[9Z'_L[DTQB5K4I7EG\VQAV=2Y5C"TE;'1&N1:>?$=M%KW-^I9Y4^D+1, MSC^4),.+-+0U+!/HQU1:OLGO96M9TZ:"^NRNAQ7KD;3E4X+F8FV8$BA-4NR$ M,&5PJ[A<8W:.*/0C0L6,;"SVMO..Y1KS@(N6< L7CY!N5P]U6'?%)B +@/:Q MIR^K/>L2-RQTY[8/%W(WX,,<1%](' 97X F.(,3W4'S? X.B)[6YG?MU,9WR MJL/&T^%R&:YYS?T$GS_&*-#1J<7IW)]1,E(,F1F8WTN#!MC94UNH;?-]H=G8K4]3W=N^\7G>R65ERMP M;UU,E5@62IS;]^GFYUCTI??R#%%UG##2G-NLGX6CY7++Z,YM?Z#H/([\^161 MZ4YU:"XG.[=<;"O1.C6UL"U6WA&$]2ZXC-@JJ[7.MXS8+JOG%%JB722WRO)+ MHJ:92JGMLAL]60)>H+;*[@E:E9N=)[;":F-K;%TK+&E]+6QUTJ3RWME,;IGE MYCIA)+?-L%KI[VR/$VR5?2#_, ?[Z&XGE&V1E[*AB^GB69["=FYY?>\M[A@$8C@#01,W=U12G5NM[1' MR9H5BIQ;N#W227SI=:;F*,Q$YU9_(OCS)/T (#E@Q[!IT\;BW(-;=A&&$(]X M/Z%-14IHSFT^)WXL#S+BDVD_1IH0NDM/='IG<];@9YFOQ@O17YI/SCPL_ M$JZ'C_,^I)I+9EKK7-B>#V,X'$;UJ29SZYPTGP6C>E?%U6JWS(>JV%RLDFBA MN\H1D9IS9?36N3*)%PM U^/I!,W$BLSG4^[TJ@QQV*CF*&,&3R9*H8A*K/3:5:YW;A K;,[*'( M;MIJKSD8^]'5NA!9ZW5ZZ7JCMJ#)M,YEVYD8)> W$FF_PYOCZ.JX:F9NG9-" M?#P]2R^4':[0YG16$^4/-C^(3@.T$-\4)E=KU7?D7"Z)S*YDM)<[\QTSE,HQ M>X8:5Y.Y=36.S_D(#:"\5RPY+B0W&]0I;3TRJ7I>GG;I-3J,9O(M1+3.29$[ MQ:#]SB>G56LS?J6T=6;;;L!2G:G'VSX7T],\TSJDU;YR>NM<$9_2WZ47C)5U M*':>UKF4GAZ 9Q>K)1_A(1M/&UR^J#6XO:EK7:!*#,;IPB'<3JFO8"A/!$W] M+EN1[4U?ZT(E#H"%WV)>=B%VLI2UE$JVUCF6+";(YO/RB7@7)H];5'VKP]DZ M]TP7$!BG"Q5LK7-,'K&8;C^S[SYW !^,__!U!+ P04 M " "09 Y/@-/!%>40 J[@ %0 &YTABB44T#-3^S(E; 54XTAI MV88POWXEQR&V)%$,< !"@N'G'4QV?OK77__BL7^?_C88>&<( MAL&A=T+\P06>D8_>%9C#0^\<8DA!3.A'[Q<0)OP3\MOQS27[<_6X0V]_=^_> M]P8##6V_0!P0^O7FXE7;8QPO#H?#Y^?G74R>P#.A?T2[/M%3=TL2ZL-773BF MR=_')^.]T<'>^\G>[G+&K#X!,?N*?\:^VOO ?HPF=WL'AZ/WA_OO_J/YG!C$ M2?3ZG+WE7O9O)?XI1/B/0_[C'D308US@Z' 9H<\[.73/DUU"'X;CO;W1\+=_ M7][ZCW .!@AS3GRXLY;B6F1RHX.#@V'Z[;JH4')Y3\/U,R;#M3FOFMFW2%$^ M9TF$#J/4O$OB@SBM4K6/\2I+\+\&ZV(#_M%@-!Y,1KO+*-A9.S_U("4AO($S MC__/ZLCK4V=)G%#X"$$8/_J 0C)CK%#D U91YD->.BTR" !$S/Q4UR.%,U;) M68T8;.I#%'PG%(Q?%JPU1&B^"!GV85L&'8.0>_/V$<(XJC-*6K@/PZY9&1P_ MPI@5"8VLE$IV9/)7#)( Q3#X0G!$0A2P)AWP-@GGS(9H.ILN>!_%*FJMIQNH ML@7J]I$)/I(P8/WL"9PA'\5;HU/HM 7S"X@>ST+RO#UU@J:.($WI \#HS[26 M'.'@"G")Z>PXB1"&42T.3?&.C#^!D4_1@C]\\TQFQBUZP(A5"(#C(]\G"8Y9 M['#-W.PC6 MI*Z4= 3TG[%FLJOB0XCK[964[,NL,+6%P%$4:HX*D:%9>N9UNU1$O-C-;7T-7?4C:_4>_ DI9=U_?@>D8H$UB0J#Y4WUIQ1X!OD_L(?DM81WOZ!#5J M257YSIJA#Q8H!F$6GM4W.GGYKKP7$_\/LQF!0J0SBN=S0%_87$,5_.E&ELVT M685VQSO;EH 5=74?DNK97BG06WBJ9V>=G.U050]%0W4]1"HF,8F5L%3/P3JR MO8:H>F;KR%H+5\T];Q%.*1;5[%Q40J[%BWJ06E)O9]GM!,8 A=NNOI6T6 TD M-!$U4N8"L%&KR$8N01NW"FWL$K1)J] F+D&[@\LXJ9]<;Z.S^Q!>L]>HEN@M MB-?ML>L$;8?QFCB:ZK.P_JR)R$"%/1":C=I<4Z\SF::,R(1M&-Z4!86.7J=D MFO[7$K9AN*;_3718FULV: LV>=&VHT$;<8"OTCQ8=U!72O5J:NTTI$:L5V,U MZXB6< ][;9JU02'BVDJ*)J*V]#L*O[;-M/8 1QV@V0Y;?DQ/N[+:"T]*L9[V M:+6C :58?SNVNLZME529[(/03\(4Z"7[NR#!JA3$ 0S6>KBA6Z5:QRCF&K*4 M^)$WX/GS"4_*S/\*<."=LJ80OW@\M9[.LQWS_@R79UD7C!\SBU]32MGO^513 M+Y/W,@69W6O+0^(7K UY[CRA19XS8],$^1F([M,L^20:/ "P&'+^AS",H_4G M:8T8[(VR9/GOLH]_7W4>V9+(^@$AN(=A^MC?LW*E8D-[!O/,W&H[5]^6SX2REO!YYW5< -0O\"^>.\A*#".^7,?5#!#C=2T_HV2N\E;F&2*Q-.\T M]I =[QFBA\/:VE%17(^&L54:E$@=Y&4S7[MCX7@$ M_'0 2N 9 W]'9+OD,KI,M.BQ.+',HKE?G"/W O/0A] 75A&KR2N6TB/GG55R M9+B<9H-;@BV-L&D69HQ>HB<87. 8X >^L+JR\G29 M<7).2/",PE#5VYMJC.\94;!+5&>%<"X%HV),"<<[[!T*3?]6^EU(T NI;<%ASG M7&6H:X1F[:_K$4T9=#6*H^STZDH<;Z#6Y')I:B-^65F;%7Z5V!=E6^OU$Y:* M\K8;1#4%Y4JE!.QBLVS4GJ+K;3)JD& MLIL4I1EWNKU=M83M&,V,) 5HYU@JY7QIUMS>Q@8N M/XZD,74RU6-[&52;UV8.:I%G,0N#?_+[-?L2LF<&:4Y&Z3:-'#^\<$59/0Y^ MM,B!PGA'VU,.4[M[#ELKUF/[@_T6UY(+7:X:6C0[-3VKY\IU]^=SU_CZLBJO M05;6:G UGQ.<&I5>]JH*I\HE;=>A:K<+ 90'3D M^\D\26/JTC50LE2S>EG;TWMMXO0=X1R'.5.SP\+S!4]QQA%Z@BQ (W/(#\Y< MP7@ZNP-+Y8*GF2+;2P'ZS;*9BYRC.A?<\6MS#>*G>DG;88DNMNIXU^TMNH;X M% 65,#\-RR@OV=]V#E'(+X$OG*B8Z)^H\'XHZ/MGGV=#FMP+7\#YKH3S56$1 M\4:E1V9>3JG-*4_$>L<;^ 2Q>KY3*-;F MM*-<\:BVY9@ZA)B.57(=E]KX-H\*N?&^W/*3SQ3,E/%X85"5N<2J;L5 M2VF;$K;;GL2QPH2@B,;-H*(>A[PIB& &EO>45T,Z383!:+V@S)P3VA M+*#+>N?,)D4@7E'>=HNH)* <;ROQ.M>#WL(PY*GFZ>O)0GZB/I@CC**8@WV" MM73IRMON"'3I,_.'0#9O]U%V-'\1PNQ^SJ,YH7'I=G5)-K&6M.W%1ETJ M37SA')&O(#>K+QH]?KZP,QVFB*!$E&R0=C*:T(=474>=BRPV6/AYX=5-B@FS M?#.I/H8S0K-EP#NPA-'IDG6'S-L( _IRP3R6)D\S2>;,,'5/#"F,E"=Y.WRH M[9K?@T>KJIND8KK6LZVAU(860D';S;]_7BM\]18[D6WZ@K?0I"L9[+[.N-?" M,RQ9M3UFP;1RA:92P/T6KZ2]T@7N-> K&.M$FJ5BMINEU&KC%NAL0SH'"$\I M-WV*;T$(I[-TM^L"\ROC4(!8_Z!8]M01MMW = @T\()S#!8KG_P:P_K$ S,M MMN?GYHU2SR_.D2O)DJCG4BEDNS_50%0^;" EVS6FMLO[:3/9I\L]/5/NVDOU ML9Q,L=7[V@OI!_M-T@_RVK__[L-X].-'3\CP<\ +XHO="]C?-\'.=7HKI5:# M5V['-25/B#GP^.5KQ*_5>5T5.?)C]+1*^3>:F6ZK]__QO'GHT *1;W*(RN]6 M--JP:;A/TVELWSZ9&FYRCMIT?#@&$>^9YWPYH(;5JO(.!/;M$ZIVCG-FR? M(.BI*N@X\RU4BO5UO\H#LS5BMN\9Z(ERB:O> L/B6Q1-B)9)V[[3H">^JQWW M%F@OW>;59(0WO,2BNVL->A[>7;__0FIYZ5(P0[X%:3W*#_X'**]PW!M@G<4@ MA9V#+:=MNP]M,;9![A06C4P0JQMEZ; MEX* EW05_XX<^=\21&'EE>;5\$UT.+JV;%@%RM>-&#O1O;;!3/8A#-*=^%7# M;E(33)0XNC*]954P=Z-S8V.%8\X0!MAOOYO4UNM(Z[B!BZR]3V,W"KW0,8I-TNBT1] MBM*7=O/N-W\5F(3(]*"[D0I'=^ :$FJ._PVTXOSMMWJ-MRCAZ.9;>VU6YB"G M&4T[EMM'0N,[2.?ZG;),SM']M/;8K7:6BOA9_FP]0TL8E-+K\J:. M]LJFIA)>.1FQA\91G0]8,'@DM Z>#(Y/M#4'IK7WDAMX!@OXP@)YQ:[@G+WOU28 +FO9H.%Z!-TV$Q^A50 M"G!5AR8.\"NIK-UOA/NSFR=U7?-E8_:UW&AAJ.8B'I/Q,J$> Q!I0,C/ J9# M0;CI6'Z&87!&Z/J%;')DPMB=UY^[63X-O5:/&.8Z+X\_Q)L1ZFT>TY\O^&X= M_):PX>'T"5;5N+$PYF_$O+5."=7U 6-A M<,]+_L/&I0!92#V=*>-S99P^%@9T_3C=^V']6Z^OH=!#?TPK%X>/N%O7 PK/""$)QJKQ-X/ MF4H'0S$E6"%H,8G%G,<\DH,6(IT&H+V1N[#'+$J==2@1:NS!VD&A/O)0 MV]B6R>&WEZ]0NG:!1UK"J?S::XJ,E%A,SDCOR\^,K 4E+6P[(;@!7:4\"H4/ MNC^!ZY8*J9(LE&&+ M::Z%G1!- YYJ@O!.*Q-#AM+*K$"^B*RD45CA4*PB.T%@'I*2NIJL#1DR*Z3) M%Y.5I E+%=7KQS8X4R)2J58U%6/B%4J4-DH[+E,^&4-4T( M28H)<79J6./--B54(3C9?K?M+3JGHJ$* 4YKWNFY26_K'V7C%V*E]KQDHYLH MYUTJVX]D;Z>4?FDKIBAF5"I!2**EHK2EG58Q,U,%X[V8"BM+T"QCR58'^(][ M$$'VR7\!4$L#!!0 ( )!D#D]EM#&5FR4 '"= @ 5 ;G1R=2TR,#$Y M,#8S,%]D968N>&UL[5U9<^,XDG[?B/T/W)K8.1YU-URVPW9U MS^R+ R8ABU$4H09)E]6_?@&2DB@2"8 418 >SD-/V4:"F?GA2&0F$G__Q_,L M<)XPC7P2_OQJ]/K@E8-#EWA^^/CSJV^W>^/;X_/S5TX4H]!# 0GQSZ]"\NH? M__.?_^&P__W]O_;VG#,?!]YGYX2X>^?AA/SD7*(9_NQ\P2&F*";T)^=7%"3\ M-^2?1S<7[,?L9\U=LTCN>?]_=__/CQ.B1/ MZ >AWZ/7+M'K[I8DU,6KOL*8)O]]>')X,/IT\/[-P>OG">/Z!,7L3_QW[$\' M']E_1F_N#CY]'KW__.[M_VE^)T9Q$JV^<_!\D/\O(_][X(??/_/_/* (.PR+ M,/K\'/D_ORI(]^/-:T(?]P\/#D;[__QZ<>M.\0SM^2''Q,6OEE2\%Q'=Z-.G M3_OI7Y=-*RV?'VBP_,:;_24[JY[97[UX15!L_&X_^V.QJ2_INL!TY'^.4DDN MB(OB=/0I.7+ %ORGO66S/?ZKO='AWIO1Z^?(>[7$*54V)0&^P1.'_S\;3JNO M3I(XH7B*41!/740QF3 J>\B-J9F^[QUVF3/0]AG[*=]32F>L/G !L_>>NA$ MWI\J#>/%G$V'V/OF(01"7R/S7Z/3U\\8SQ$5Y.K.5_.V$!5:KI!5Z:$NITR MPBD)/+8DG^")[_KQUM))^C0EYC&*IF=B32%7U$H?]'.DK&H7>) M.,75Y"B)_!!'2CDTR7?$_ F.7.K/^N2)(R9F7'- MU.SZ6"G25IWN2- OA'V+#147TU#%OZCMCM@Z\Y^Q-XXBC5U!T'17(YHMY/0X MH7Q)U^,-IM@1BVS\T 1[I\]S'$8XRKY/T@'%6+CPT8,?^+'&6*W=T8X$NL$! M7\#8/AHO4B9JR*!#VQ7;ER1NP/ &U8Y89:BRTU/L/P28?^X:+= #_X"<53E5 M!UIMQK9^#[M:0]+E/_H-4_4"(FZ^(^8N2!1=8YJ:/RK.1&UWM1G[D9LN M/6Q!6AN>;./,EM1@/:M_84?8,T(9P9Q$:E-]ZXYW)/!M\A#AWQ.VT)X^88U1 M K7?V31TT=R/49";9^I))VZ_*^W%Q/U>[T0@(=D9Q+,9H@MVUI 9?[J69;/> MC(IVQQ?;E@3;[&OW)JD>[R!!9^:I'I\J.M.FJIX4#;OKP%*I8Y,8,4OU%*Q# MVZF)JL>V#JTQ<[6^Y@V*4[)%-1<7&9%M]J*>2"UU;\;M=H)CY ?;>M]*O1@U M)#0E:M29#8*-6I5L9)-HAZV*=FB3:&]:%>V-3:+=X>^KT)-,4$1&Q"<:;HB#I MH],CF:;^M8A-,*ZI_SI]&#M;-I@+)G'1YJ/!'+$ K](Y6'=3EU)URJKR&*(@ MZY19S3&B1=Q!K$US-$A(;/.D:$K45O^6BJ^<,ZU]P%(%:,[#EC_34516V_$D M)>LH1JMM#4C)NHO8ZBI722EC&5%WR;6HV:_] MT.?KW 7[<8-OMJ/@T,/>DG/>X58W+6(_YCWDEV=&SAZ_:9/PG.SB/U'H.:=L M)XP7#K^$0V=YPDQG?(OO6&SP?L@87B64LW\7$\V=G-[).\C97C(>$'>#VX#? MG"%4.#Q26"DBQ3:*]1X3F^WSUW\=!'"U_D^X'>P>C_*K,G_)?WZ\X9"K" MY^R?*VD"]("#]-OW>6-1VWT+6+\K)B1*V,[;E5E>#Y,Q73*?SPW-!2B;D)^Y M<<8&UFF0?HU-:OS(_['D;$+)3*G/7'=$*D%1P8R15PZA;&?_^=7H8,U+0"+L M_?R*F0("D4V@=!R@B%\:X:;(^-G7&6=5DE:Q$YH0*JPV(0!P@F050&84G"*? M)[E% J$B:MLJ'%7C2(4%J&:BY!S"X_"@QX#?\TM9@@Z8?-[T=C;#KU-^QU 1C(]B";7X&PRN[QM,GQ4 M#Y6\^?W;7J%2Y!I"Y:U95&Z9+8VCXQ7?J8@J;"1$]^\M1TC%.X33>[,X95[% M\4,44^3&,#2;[>X_F4%#VY@6L L!8'9/R1A=YJIHPE!J;@H-6,DB,$1,6VHP MHV@JL?R-T 4;C3!^ MQ58]P:?",J3_=T;UGV:J;8@&HU!MVQ,L ,9!2]@"0^QJL@RG?Z$D8:/)#1)> M/4T8E5/>.E \-$"""Y)Z-8[&%4I^G$V OB& MP/EDV';(]81,M,@ &9]&S4LHK(.8,"VZ+0_ &\K)#@@S'I4]%'N+W3U\##K 5$MCC:L MB[H:E^O9K*>C<"F2E_J$U[W1ZL#TK5$@2$TZR;I""#=M *IC$% M61,D0"QK!;8,NS:RF@-1?NM/[>,0MK< -7V/!RP!B)%AWT=VZ;\JK!0F,4G/ MD)(( 8)EUA=2OO>OY\SO-U R$DM.^X%XBV*"@X/:SPL=1#O-XA: MN%CC*M$"Q (DMG>&R $QZ_UHXGRTS]VX/5P-/8^'9OTBQV0V(V'*>_K^HNPL ML-G2G&.X/C9"WD%$S#H_-@TI!2B"QGW"!6(?@L;P5<6QYZ4Z1,$U\KWS\#BK M9"-Q(8H)^@213 00)K/>CAM>GR?$WBFB(;- H['K)K,D/1>6GEX1)=>K:/L$ MGJ8T((YF/1\%;O,BO;,Y+RX21OX39@<,,L.\8-TECJ\F=^A9ZLFOTU&?$&XB M&@BWV5R.JOAU#,@^@09P#^)BC:-$:!HWSS'HK[&O)1F(9\&S\??]DM 7[$ E1D M'+0B[ +G*HFC&(4\?Z<&0@6J'L)4X1ZTP^TP^!KN6GKT]N-71P[02K0(2?WM M2T[7-^3J;6)F:6ZQT-=N0J@LI?T;C?]]"E'@^VS.+@;R5X.S@OWXJ31P0 M?%L*"*XZW P-KKMTR,0I=MK9JS-*4=/9LOG.EUCF=TUD+O;^YS]]/!Q]^,E9 M?L6"P%5EC ^1T2$RVB9*658$3TXB(9\3FM%1,5E/(J0RF6USSY1X5<7E@.:& M8Z52A1,= 2P-F;:!3B\"I]LB:'/\M& =JB)!E:;W9FQ@^2P!_6EKGNU<[+)B M=ZN\]CRC706*C,I4!+4.0$K^+8VEEG/853B)V]\;.D;604C".>@/,_S.C3K[ M7 67=A>F8N!U$*PGC*5!\2&=46JH&P[5#>F,=MGF0SKCOW$Z8_OH=9'.*$/% M<(7M5M(9^Y5D6N0:7.->6#JC:.[;A)"*=W!-,VVY]?,&I;8GO-8U.\-8Z,>= MJX%:ZY$0.GH$8ZW;@_7@UA($]/#9C68Q*6P;3#?ZZ3^R57% 9Y^U"_5: MP*O)-Z;YALMSI1OKT:TO#02N!97YJG)D8W-[=(%^^@JO3!P(WZ:U^X"<2=V! MMSJ7'NFD5F[9J[UXMB4ZVE_C6DP[T$#1U00,(&)1M.C7')R/L.3$$*$)FFKIRV-KSC MG6QXQ_U?$&L)!\+;\NL']1?O;?#5[K:7 ->3#D38K'-(5J+R#CU?$YH"$,?4 M?TABE-ZJX2]W$*88$C!V'L_#&#,]J-X8:N4;]HZ3W8@*#AI;ZA4J+_$D[6#Y=JW5-G,IW@R*7^/$X7K^7W>?5,_S'T)ZQI&.?O M"O)%CZ'A%MYXV)3T8UG2VV0V0W217K5:=^>L^W/6'78F\!?"/LQ&EHMI*);C M4UF.E,19T73&ZIG_C+W-QWLW.!T=E#E-*9PE27<3(UWR\J=-)/R.*G.!$SHY M9?=\Y^\PGC[S0 Z.\I4['9KI0E]YU&13G,.R.'E_SK)#Y\]H-O]I*>6J8V>C MY\ZD+;S"M2@_;"@6\$U9P+P+)^TCE\L28=+WQL1BO-41(Z?O3(#2VW>E5\@V M!7A7%J! G#+NK,B- %!'EO=R,"R0["K=#:/?$*5LNP+&5'5;SZCR*;\F[HQM M;E^6*\UL\ES9H#F)PVB6+8=_Q)D0ZJP_TYDJ;I.'"/^>\'MV3Q@:;H>5G7Y-YBSI M.ISZ;G9/*;=BQ2Q7-OLJ67=*+B2IR>H('%:V]"+E7U;5 ;H<'JD-?361&N12 MP_RPLHWK&^;.7Y?_^IMU0J=72 "1*UM^'9&SCKL4N&#IRZ2JV %%>]\$WU7# M7\9^9>L7F?\FQ- ^!\BDJU@$#4X#)H0O&G)BR2IV@^(88%J*]7E AE?%: !/ M!2;D$9O4$GG>5$P$R)0V#4]]T02FA,Z9PY?!8SU"2ZN66I)H2&M]A M.N,YO'?L:XJ;[>+FEM]JE\EHWT6I$K.J6]0@@:&[[5)E*X"Q_')[6]A8?_QLON=>L%@YT^K24X+FALI/J69+N0 5P+FER]Y0966HLC)461FJK+SH*BM9 M(86C)I4CA$36/U6FXAW"Z:4]6&:HW%XK%3XL+K@W%%36+JALM@+"4%#99G-B M**BLB:#-MD6]S4JXTG^TOZ0HR#>$RL>6[V@IPA!W;%PF*!@_1#%%KNA>!N^E M7B?W(T.%]?1NZ#01!D++[!1:9>&[;$1&J6ZSL;F\%Y*7L+BBZ?5!'D9-N +S MYU*4CU^UTW_WPV%+E,G.E&"I+TMK,+P@2/6!L>9ASU\)3P*Z\1^GLE(? $'/ MX9)*U?;Y0?H>6G9SL_+V*+!K2FGZBHFF8*"CQ*9HBG88KL,8EDIJ5^'SW'N*Z@$.1MEQ_#;D+3]-;K MA+I3%.'Q(\59G8/"U7S %-6D[BMTM44$#^)F'3K<.EM7(97#FM. )'W%4D\N M$$"SKI1-KI<>HANV9*2^2>\:4Y?] 3U*$HSU^WA1$*L%!3$O>&F,%KC1NXTH MS?RO7-RKD4 M->2W+S^:4 M/&6'*U7J!DQCZ&)"G5E7]@W(1+%SU?V*W"FS!^BB**D*,PF1J5<3FZ.F$L;2 ML^190IE*V2F L7WF/_-_*><:3&/J6<7FL"ED ;=%P\D49!+_8,?#$_R$ Z(U MV4 24P\M-L=,+@JXJ5EJEWZ+\"0)+OR)Y#2H06PJF[[.HW1:,D#X'?31_[)Z M[FK3 5,I/=3 >.,[*N!E;-V*):Z4I*HB=2'@^-I<#SUQ?$4T;B $/NIC [[ MU1J9+Y@\4C2?LED0 "XFUE[2W%*GDISI3@XT>D!D([#((NABX#+!S3MV$6DI MF.@PWHT;J%,TK'3QM(78[MPXT5(#$79?/Y*G_71/I@L.W(?E#QRW#P7<\E_? M7UX(0,K_>'G1M4=&:\@3 9.[6)JVTNO9#:S7LYO.G28-%)MSN1-OR%:J/;^% M57M^V[ECHX%JB+.JZ^$1_S,3C&.+_AGN)ZE:0(PA:7'."7?=H:F1/RJ(LBEG'M M=$?:> H >.)6NE'I=V J'TEO$I'&(NW$#[?]++RCB&? C=W8?_+CA4[6M83$ M[HU-*:MM9>N$#*L62"F1F2U-K7@-H"S?SMK&RN:MK$4\;>%IVU_D^3 ?NM% M#NRW'>; [C(C_KW]JLVYA%3[WNQYY9B$O(Q7%ONZ\:/O1XLC'+K3&:**%Q/5 ME);NS]K\VQE&JO*]Y%KY>)^2TLPI4QL)%8!B15AWWMP=@E9N_KM%V>;3YRT* M<)3?>KC$ZE(3HN;&7OO3G5U$4P8((\.O_EU@7HR64AY^65;1D&]\,(7=&YY* MTBHT9M^#$/&K6B!E-&8V-Z76U2!9OIVUBY/-6UAK6'::[I>R(F>PN@RD*EZW5-Y7'H22/?>J_XM=&UO3= 6Y70SLC?53S%]#R< M$#I+;:9K3&.F.R;+'KV8'G8.\"^Q(8\D[\9_7#R%.)IBG:^$5 MNSR5YP:S'<;U S_+#8_/,&,5!7RZ)(R1Q49C29QQ^\Y?X*!I2RMV>GETI$N7 M7:;/"\9&H+7$;-/KO^D0DJK#SH-3?I&_&&J:T3C19K?RR3@ M=XW4;T-I4+XD#.N(#![ZS/I\^0."#^QXFMXBPXS[#(35R?9HL6YRC1;\5V,^ M/,^03W]%08+'493,4C'YB&4;%/;N,)U)LN)W]\V7-+:Z418T*LT^,KA>%+GG M)'VB^6KR+>*B8,E+NU*R%S@VU/)"\#9]4' 7\%[XZ(&9K_%"%]@5P8N'=%-2 MT)%DR]6:,_\9>^G@DSY,]O:@?'$F)70RRN'IL>%*S,N_$C,\/38\/38\/69! M.'AX>NS?^.DQW>?&^OKLD8!_Q;[ I9 %=8H91XPK%%_X3]L[#&(6//K.NLR/S%RJ-F:DHNW_ZO>Y)3T\" M"#BSMH:$]['K)K,D#1^,9X3&_A$B*VH]0#TU6MLI3+9>3B42',IG+2K7%"Q=!;X>P=7]>"JW@5*4(+#T:+X%[G'NDX?=CNNZVO#-A.ER*?* MP2EJ:\8[W4#O,'"6^Z2W0\AFC_,.4.STCBZ.A)>D])W-A0 M?2;)\"]E@$*OKT[.D,S/UA<328^8^$6T4"J9)C E+M>3],*OEMWTVOJ M6S&DH>;W;_NDZPVN(4V_;5O3L>].^1'I;HK"[_\BR27B)QFYNF4TIOSEFCI7 MLMZZ=QQ0_%D0(/YAST>*T2UH:S[NL/?D4ARA)]04VS9N56]R-K-S^06U#K;>]Y_R)D1LB%/_,9I]+Q*VAY M/[)ZJP,Y!K7;]CYWL@C97NO^DGKH% NNL.W]R.J-3<(SJ&/# =^3!)\Q85/_ M94%(7W;W$J:Y/[0]&*'B72-0:#00H>' ECU,\/9M4S_V\!K!X,\>_-F#/WOP M9P_^;&L0&OS9@S_;?G_V3O>F1IM1CW@ MMC#KX;;4%-=.MZ1RL*96/,J:+0F>&Y*XE'IW:KKT:11Z*3L:].I UNC!U+4< MO7*/=071\"$9*N%]-;F-B?O]F)FAOI<_$WZ#7""I;/M*+S)Z25;ZE3F.DQAYG0ET;4,E*JHUIVGVL/&YE/4UOAU>FXZ MY6<([N=:<)?761+*4QN@YH;.3LHI0/18;WLM Y1]1_V3)':GOY"TOH+"<0JT MWL'8;UW7,M9!75M0V3XU6/-G9?,;>?#B!%&8>EU"V\Z2,M[KLXHTO^%]_2/+ M.K.ANWN([$SYA&G,;$R9G*(I(>Q#V7)"GVD$CEY+\-9;#B+O?RSV.V4T)@7 MJUV^)BX_C@'-[3Z1266T[5!6859E]X,$9HYDIQW="8KL7#W@]31]:JYJ5-98![<$X\^E%T\@V@=B.9V][_;ILP\!9LL5 .G947HX M_EC["#ED_0]'R1=_E#Q]YI>1$S^:<@&N)GP5EY\F80J[#Y0J26T[4XKXU3F^ MJ.C,G#"5VE>#U8.SYFXPL_GDV2JN-M=&OR#AX](F5E4%KK8U=%+5G$9$@_M. M%DFMJ_^9O>I"5]%8D\T6EFY+%3[!-6T+#4=+62+LOGXD3_MN_LE,S M_OY^' 0YD_R.+;2*+9L+6W>\WT!J)1JL[F17,0Z!E=M'J#FB[ !GB6M:<-8:XEO5QK<:QEG>]<_QOL ZI M^YW%L19#!>W:B;5T6=R.,WDU41S"TAQ)04-+]V:(74BG;W>I4G =KW)I:'=5 MJ M4ZLYVU-WHU?L41=_;) MCTP;C2Q=C$6L@A:%#2I7&=ZE9F:.0B)U"A5N^;&GBL5]6BA@P0)#;=-#U#+A[/2"++78,HND>J&0"RJZ5E:4#W M]LYFT5421S$*^5W "X+"8S3W8Q3\BH($>KJRI 5%!SU#J8EPH+UAT40[9WL[ M92O_#5MD3B<3[,;^$[YF=B_[&WJ4)+G5ZJ9G8#<7T4^)B[$6\I/P- MGJ,%'RE1EF,$3Q095<\@TY8(=!CMPASAA]*K"3MPS$B8EO!*3R&0CUY*TS,\ M-.6!T/A@R16'XOW_!E?E/\F+ &A\.MI381 V$JWE:#_LW M1"D*Y0]JOZL^J)T1Y^],+_LP@J!8CI%8D,K+V0I!G)%Y4:0CK_(PMDJ@X4;1 M<*/HI=\H.@Y0Q,R??/!?T1O_<:JX4B0AL3M&I935MDM%0H95L10ID9EHEEKQ M&D!9'NEJ&RN;HV MXFESA"SG5Q4!VVAFJ@J SI0A"K;!F=6R)W[)I**.2+F9 MJ=+K-50+L@V.<-/E::G_A+BS=^T^O/&C[ZJ"P3(JNVT '8GMBVHL>6:GX]2A MHI- +J^@9WQX;LSZY\;,!FF'Y\:&Y\9LW\7Z_-S85SH.XRD)%_]+<'"$%M)S ME;BQJ=VI]GMC$O;!#:KEA,RO]";Q2#!A.^OW7Q(_FB'8&LA8!MJ;JLW>0.DR M"< @;?MZ)^R;\?@:!"^CCWG,4976#36_'YDJ_*J5R2UG&]*UA8[]RX1K MXVIRBUV>:^?CZ)B)@[VCQ5+$O&'=.)I^Q]U#K8V@AO>_KIP]"M"=/K/SGA_A M:^J[>/7'E3RCFB-"U5V_QX&>=&W[9:&7GN5N&NRF^8#U/LC9\P18]X8V&1>&F[8: WHZA3?4!CLI J;S2Y]X)$$5OM M4H&E29]ORZF%G-)AI$Y*:R39D_-#PM@/$\S R1^%CL:A-XXB'$?!^JGI7W#@ MG1'*".8D0H%4TLI#R\7/..OO.&P,.-F7]@NO6CO\6P[[F+/\6B]U Z3,5IYT M:TTYW2;7;JL>:1INY76X]I1D(#7\-GF(\.\)6P5/G[ J-[SRJL&:VLG(AQ?Q MAJ3CEY]T7)HTY5*! K@@ KLCM0HY;?-F"-A55JF$20S5$%6H7 F0Y5'9-C&R M.1K;$HY6YQ)M,JW,)Q(U-_6FGG+>2/&Q\9V".VZI74W.V='UR??XY57PP0*@ MJ:5[$/PE,_?D=.64GA!BN"BF24M5)]V\=R(&0 *:G MCUWO5M9B:>5.MCN\.\TMNB3AM]OK-(44GX=/.&*$\DP "477^]46@,E:\7"M?0(?YMK,& .UGN*?N[D>*L3JPQ*GD1)WKOJ9*22U! MVC;E !RN$^I.483'H7>#W:PVF?]'%J70!Z9F+SU"JHEDG1B"6T9QBR7*> 5^ MZ?TT*6%/P*PA3-M1>&#JE0H#GB&7^^07ZMFF)NP))C6$T8BW&RYH>!LSSU; >(S5O+ M]J#9'#:_9GUA2K&7LCU6A477A+QV@0 M--WT"?N,Z\>R..C[RN,EQ0[^XN1=#,'0(1CZ\H.A*]Y/?T]\_B+0;$Y" MGD:AZ7$6D_7$ZRR3V;;C38E7E:\3:&[8_RQ5.-$1P%(W=!OH],(9O2V"5OND MF7FAOL%5;&7* RV?'$3.KZ6^Y\T42=7;!=6V=N\YL'2VN64V.;UDUK:ZXCU$ M8>I] E#7,E"JHEJWS;2'C9]4CW^(1P,SZBFI1FU"J"VT7OGX-?'M*5JEV6A[?3\M9: TC=<97+8>7:N M<%RX9E@#KP)5_T$K"].V,0I5 <^"QCXSEU-FTGNVRUAR)%Y$T[+9*KK^(*(O M#H2)V;+2FP?3,RP)(E::]@=REP )A&!0 5 ;G1R=2TR M,#$Y,#8S,%]L86(N>&UL[;W[D^,XDA_^NR/\/\!S]NU,1/5KYAZ>V5M?2%6J M'MG54IVD[MGUAF.")4)5]%"DEJ2JJ^ZO-P ^1!)/4B20FO,WOK[M*64F,X$/ M$HE7YK_\Z\L^1,\X28,X^M,W']Z^_P;A:!O[0?3XIV\^K]],UM?S^3S2MI M3UEV^.G=NZ]?O[Z-XF?O:YS\EK[=QF;BUO$QV>)*5I0EQ__V_?!2C$A?1.E/+VGPIV]JUGW]X6V^]-$-$^V>)O2BXJ1<3WX<(6;F3]GK@< T#?:'D"K%_O:4X)U8F3!)WE'^=Q%^)#WNTP_]2#_T MX9_HA_ZN^/.=]X##;Q"E)"B4VO5C0U;!],ZVLOT%[M?B)S[[+4UF$]ROI6N8=W=-9\A\,L+?_RAO[ES?L/A?O^N^+/O][@AVQ.)I#DN,=1-GD)TO(K MS,0_?:,B?-?6F[),DE)Y+]EJ6J"@>+>-R?QUR-Z$>5OG[+LDWJN_7[11K*+Z M-7RH).:M23XJ4;U!EN"4!2F=.K.NO[8!"]7V(2&EX1Z.WGQ>?_,_*"$Z4:*_ M4MK_\R_O3D+[P(6&6&]. 18=#.0OOT["PY-W[1T"XO0F-) (LT]X_X"3EA4Z M8AM0,%.8PD%-Z1P21NJU8<'H4<& "@[TUYSG;'@,XTUHN(TI:&=_.P;9ZW6\ M/Y E2Y2E"L>BX;'I8XS4K[L;)8-SF'71LHVVG!2=: =R0\/@C*BUCZ-U%F]_ M$WHK!9U-/$G5K&.((P*#&YEF;:SD=(@1PL#'"F=>$&%_YB51$#VF2I#(B&TB M1:UP'2YB2C"84:K7!DY)C$IJ] Y-MMOC_AC2]0&ZP;M@&V0P,%53;)D]X82Z MQ@0_X2@-GO$\VL9[K(19!WZ;R.ML5AV,QLQ@\-E5XS9D&1-J<*&B'=$EP_8;* +?8"%3&8G-PF%'5*UY$GHP4#-(V";5P5Y(C1HY)AW+5? M747Q%"DGL[;>4RA9K?0$-,YQH%%,V?\IL&5=[N"J982!0U%RV/0I!JK7W8J" MW#FBS'5L@ZN8H"H62_YE>: 'D.0SZ23R!1,MG2[E;J<+MS5OU-VDRDF9LSI' M6C]]N5"I$H"\R$?;1LP4Y)#\-B12O@/F[C:)1\_?)]LL> ZRU^GKAGQ1X>P4 M]#9=G5;MNJ.3$CL'GZF&;;@5]*AD0--71%E ;5SEVVK*=6*3Q": 1,K5,5/_ M'0Q,!$I)]C)A.9D59HO0>R_)7@ETH]3;,E\Y?:W_HO Z7038W\N4 M&PP".ZO,;X/EVUV,;MR0;'%W%^SP>AM@TH_I]%D>?LDHK85::E6KL$I,YAP< M>MW:*%C<(4J-2G(T??OE[6!.2W;\N]\JCGM//]H[WFTK=#K.+7^!T;=M=;CC MVD_7X\XX:9+59AOR7^V9AOSIUT]>Y#VR-9^PF\4D-CI;I1SMH52[ M^T]DP.*.]5.<9!N<[.DU$\W"1D)K]4A>I6[C*%Y$Z!PQ)MJUH<-HWV2$&%'J MJR%7,9)IX#J.GG&2!0\AII]<1N*C+ VMM4E"IVXU9\@(G>/"1#O^F+TB1V'L M1>C#V-%!2\'-U]@8%C5:5[#@U)7!HB($"8NV=EI8?#\V+*@_6NZNCTE" E71 M$E5*90T*WX46GA7B'2M)QIXC9,5&,_OJOUCJ95ZGJW--/ M,#J5TX?;HR($8X_;V8Y>IZ%0H0O-VV/D*SI42FNO>S7JGCI;0@BDZ]7:<4"H MR//M ,HPEA]/@IMCMGWZ.0[ISKEJ-TA*:L^CJY4]N74Q'0PLJ)7C3S1R:E20 M6]D16F^FM]X^"%^7%(@X77M)*,>%BMH:-/0J5^B0D\( B%8_;K&XF:*< Q4L M:#U9W=E&BO.BWO\3' MA9<=$\6&@H;!'DA,%#\A144-!"X&*G*8*7D08T*$"^5L8^/F-@P]JIP?>"IO M(B2SAA&%DA4R!#0P\"!7K(V"6TJ(&"4-.L;N^K_$\3Z.[X)]D&'%FD1(9JWK M%4I672^@@='U6.[H\ISB_DY%:OU6B4 M;ERQD= Z1Y&A@MQJMD%.=ZO8ZV9(5[+N8C)!%B3OS8;R0\*U>'&[N<5 ML$B.O:.<^'Y KTIZ89'60CG_JEELSL0FRM=G!16]"_PW\ZA, M30(#7]5;I^O02]/ECB4G,,E"PM,[R4 B4UN8?:1-# 93.@VY>8:2T54"(P2U M3%CC),#I])Z(Q&0R]/7)1Y0<5D&E5[T!*SDY'&!I=>0V-AD'FJ**IP29\TNZ MU2CYB./'Q#L\!5LOE,2S"EI;P:U6W3+2E1(ZAY&)=FT U$=KYI[\Z[VE.E7:W M?H[8/B=#PW#O[F7/;^A)ROK)2_!3'/HX43Q_EI+:>X"C5O;T D=,Y[SK#93C MWN!0:E0G![9LJB8O%BE-E/&'A-9FY*%4MQYS" F=(\A$NS:$3N%%'LQ.0"-H MV@%!4_<(FIHB: H:0=-.")I"0Q#QCI+W9&(2JW@1*-> 2>UW..C@E>) P4A8 MXC$O@O:6_3Z)#SC)7N^)RMDD\NF#^P,-K;6I,XPX[?H;8U.:WD?+!@=MQKKR MGBGGO$*,EZ5UJ;@'?:8@AP,Q/0Z\F^T M"PXTJ3NRG <8UFZ/2130:YA$U=O@A?Y+[\#C0Y-1B<:57D+E.6 M# QF)0LP?*WC7?:5Q)@W^!F'L=Z3*>BM'FWHU&X<;,B(P6!+IR%WJ%'0HQK# MH, Z:W=Z<2?9C*4_V-R=/BE2WYU>W#GO=TX5;D,2TR-V\B=_6(=Q5K_>KB1F MT!]L]NM)D7J_WJ[ ]&NE"C?M@^S/VPNQ)]5!&0FCM^$BI:'5X)*1RWME:U;B:73DMRHF' M?:@[:K[)[@DFP624[)A"$M0>G%Y'=9+(&L^X=W+;3T[-G_DZ?^1K^,07DLM1 MZF;PO-=R/BA";)XHK$'M+"<4K[(T*]2)% 8XM/II,T/] &Q.*FZ%_N(EQ)UE MRV05/#ZIWO,IZ*V6==.IW2CO)B-V#BI3#:67= L.%">(\8 Z^RF44VYBM6AL M8DBH7ATW#0(P6!%IU<9'"8N1)Z,2KZIQ2BM9'Q,Z M8'/*%YS2=XJ*6:1!87/,"U2KC_C:S\ZQ(->IC82" I3O9Q D M>"9&T0I+9?7W59"JGJVI66R"TD3Y.@95]& @9Z DMQ-8L: 3#RSO2)\]+0]T M\*@]($]G]RFD1,WF$\@6$1CHR#3C$V[11V@YX=@A\Z=D$F5/8L*!,C)K>;:TBC= MR+@EH76.*$,%N>Q;E!S5Z&U4H&$?E;N7QL_67(I J4*92<8\@@ MP>#O"$/KXT.*_W8D4^'L61_!2*FM^B:UR@V_)":%XY.4^G'[*14U8N3P7B6V M[%'/=6):ATA2S&\B0J@H4N_)M3'D/D?4)LA"O-S-(S]X#ORC-#^4A,Y6;BBE MFF5>*"&1<4H850F$5.3VD@CI ME3XE$I+3.D>'H8)MD$0Q_5]TR'E04#(!"W#*U]9&C^-=/HC7/X('@A>E6M+' M[HXSG0_X*AQ5NHW[S2)",.Y7I9WJNKQQW8ES3M?261CB:(J3WY29 M(,5T]L[5%&J>#M4$1,Y!H-.,<_?I6\2(44$]^EO.>,NN!]$I*[>)D MG]]K>TBSQ-MF(IO,^.R]].Q@QNGAIP$3# 1UT)2[#%:PYIFR&#.J<9/U8L$_ MS@MP'P?Y!$7^T9Z7R)]^S35:X<> :A%E"V^/6RT@)[,!+YV2%$TR&N?@T2C& MU>C(X7&B1938(2ZN"7 3+YQ'/G[Y7_A5:AU'9Q<9$C6;T&@1 <*&6#,). IB MQ*@1(7<"CPEQ:3YU:[>A]R@PK/6[+3@(U2IAT/@11/>+-&IW>T6#*)&3SLY+ M/V6W0;KUPK]@+YE%_HV7B>8).:DM".B4+=$@HP,!#(URXMI[ MXX5JMA'0( (%!9%F4DSDQ#"\0.Z6DSI$;#3U9Q.U]YR>T5D%H&CU39%G(X.DBPD2DGP\P+.C$4JV.7BYUXOX\C]J"& M9<-)E\48@V$WKO)S" M=>S+;QQIN&S#RL"$-KH4+*! IM=3BK4::UY$'17,B'+#N'O-]&('JMY#V,:; MC,ANKC.1@LU$9W4*Y^!1JL6G."N(T%\9&9 ;^95:=T&$Y^2?T@?= D(GZ. 4 M%2*DHH*'DK9J"J104L1H7;VQ.;-X/;B7-6HUY3D94I:A< *B%SH7@ ?>"VTU M=;TP==0+ Z:Z =K990X)"L?0S0@1':Q\8$G5Y?+0(@<%$K)WLXF[. P,UUU[Z)#$M_\GJ M&]2:,HTGI^3O8'J\I@S7P>0G]O)K2_^!_W8,GKV0]#B0OE[A+28:D059NL"9 M>'-/0VNW"J!"W6;]/P$A&+RHM./FDRVK.IJBI&*" AUA^<*;([XE?;:)Z[]+ MVZ&+" #E)I7&&=2?%/(#@F5GI645*@^L0B4TR-)\/1&1_4I&G:0-FB0V(2=2 MK@ZI^N]@("-0BJN)7)"0]14,%"QI.?5&D"8Q3D1H$Q%R1>NXX*G H$.J6ALC MC!!MBV#8 Q0,Y]HO=S=!>HA3+_R8Q,?#/-J&1WHN3_Y*^C$+HB/VEP><'X&H M076.0/N+L7,,YU=L?:2! ?/9)LC6?CG:SV 51D.&[X!G[\R@C6M-$7+F2LY?"TWZ,8_]K$,HCTJYB[ ;Y_8QL M+@2ZR0 S@_94G%]0E'SYU D#OO=)3*;][/6>Z)K5\TO*UYIJ%KLU!_3*-\]9 MY?1@X&:@))=%,GC!/JCU1VT)I5]D.5N>:M:E8"#!ZR1>B0+R*QV6&^U 0-(( M9TFT6D[V?-,;U6;[BP,#X/-M$(6#VPM:B6KA[1:S)D!TBB[#5:D6-_G"%.IB M0CECNI@LY?.D@RG2$ .RGE]N)G<(TCV7N\![",(@"W!*XCQV=^LI#GVV0>^^5'K-KMNDE MQ%;G0:7"C7E12 D&0TKUI)=X"FHPX$G(BH$?#7*39?26(:16NX4B,3&X77R- MH@)(47J$7PXXHB5]_][;'_Z(XOPDG:T&'ZG+"J&Y++;#8HPY*;7UG2XSO$E( MP;@MM7[JZUPYMF ":A%GV&P6E)-;AY1":0Y3 EI8H)(K:(*JB'+#P%.M!I Y MJG1,CNHV&2),S0$&9T9JJDHZ4901V &*P>IVU.[7UE8FD:_=\NPJQ"88^QE8 M!VFD-Y29T#1( 0L-)3'G+63)1A8Z'RZ">4\L]L)Y@6< M678^I:PS_ 'E+#! 5^&]%_CSZ-H[!"3@9[6;,,#6DF2=#QP4&=\:JBA>7+*E[%?SY.0<,#-8L82=YM"@& MT15'*9FB:7;?/;Z+4YJJ9KG;>"_R"PS=I%B^,]+'Q-9-DBXBP."VG]Z"ZR:E ME.J.24T."N-ABC*-L4 V7K^Y7A";+81A;:1(]1/OI\S^[?-\\Y=WWQ8W<[^# M@1G=]6/])I*$#=*%<R-C S*KFNJJW>*J]'7 @S*L03:K=)'U#\!R.0"=3 M70*V-CE$D$ET5(.+VQ$$"K(YVU(T;822VBFXFBHK@963P@550S\C0.5;P$#! M)"^'9\;B%%:24G@F]' !IB^#)T19/&S]NZ$/"3H&::;,[HX2NH1J9IQ@(-E) M7#&*2X3F24/K331I::P\:=.I6;QIDA,Z!8J*=ZJ56%M,#IFI1 ,,GY:=E58%"S<5+*;7=A*-* ME9MY186DSJ%DIA^?)912HUHUR9(!2.G1%7[&T5%ZH_OTL]U;'$VEFGH-6L[O)9G:#[B>KS5]&!PO55&U,3N$ $G75 M!"B@/T/K^)I.^KZ&X?USY0O7)=U(;=#8W9@6J-?4@&1UQ,HG*"*FP1F*TC-CJA3:EPHUK;$)*: L5I99M%/WB/59)W=9>Z,&I MG[?&84BK=."(C(N0V#/Q]T$4T#%!WW2I<67*;/4B;B>#FC7N33BAX;"3UMPC MUISY"A7L!42;(F ]08?$KP-6 H)\N\0L[3XQ-Q]G&3!O[._2YK(C-5J,80. MQC2J'ACP00-H!YVY=PHU$G2%_)HD]APUV!^$*$;@C PR@47ID&(XY#.*)2# MM0*0J2=^KQ67U%6&56" .3W=T=E;IW0"&EY5(6Q.9- KI:? M4+$,6"Z A/_S*,.D>3)U?,91V3VL$JK8/*1JD(!9)(KU$I2N8U2E3X&"C!+4 MM,[[=9Y^BX"]RK^53O$N3HK'@AOO!:>S%Q+IQ8D?1%[R.L_PGA6,(9RDH4(V M3G)#E4=Y(WW1_O'JJ$W'']&.\CE8<_7XALH=]_5RL9DO/M,-G),/1]/9[7(U M0_/%]?+3#&TF?X:RK5,U0>%ZIF1=)M\WEE+;'S52E7G$#AF'KM>ML(' MNO(GJSO"H$V*-$WW(%]P&:2CXT!/@+,:0]O67O0U267&PI$-/IVL=S,T(K8\/:> '))Z2':J:<%H]G38WI7%JK6<# M UYS7;D#;L*)OJ696KY#<52E1J9Y^]**%P8DNXS0 08Y7.]]KF.&MI/60W=N MI4:8$6W1NDLE&/;KWI9F.8HC,-O\Q"3M?FV+QFJ1#I%ZC1H<=0)8(;%(-:[( M]6R#[E?+V_D&?4L7^M^AR9?)_&XRO9N]FVPVJ_GT,YF0-\LR-0P,T)29YLKW MJ5,O#;:25I#0V@214MTZF(2$T!R52LDVO-AO"!<<[XHIECBG_($33#3=!.$Q MDS[6E%*[1%1+916F"E(P49M:/W[AP'Z%#BE!*L%JV:1>?QMQ6L[$86I**R&' MC@V:8S-7F;\T_>E^-?MYMEC/OY0[X2H@P@E8OH?6"6+UN+ %9RB_LDS"%NH M8 S[,Y+$PLL,VS<=[$7E@#TC\>M2D.PU8,PPP*AP9]T=()@YI^-< VM%IE=4 M/;,T5FJ.)A@&^U/R^")G_"=6RD+J#B3T\*8?(VW%GJ!#%OT1NZ>=C%W>,6)* M>%VBT9,O#)J3FV22'[$?#)*+R[O&F!E>;W577950?7D]=]1_O7.0V^T1LNX- M8G^=>4FFZA6%GOR6#?G/+9 8QC2[D>-\1D89C-SF+#(%BF'"H@(E5WGU#B!7 M=O(5H>(@H4Y@-]]56[%F:JOR5S#+(DZE"UF YP>^+%G;S3$A\+UGL&?)+,O- M:NS3.8E,2.R C+U^5GG-/M*L%\OH;S(WFW47!0:UY^G/O>>C'&\>* M;Y9<\ M,)!^@Q^R/"U82NM YPG"L#^/TBPYLBQ0^_@891\D367.;OCFL_YS'C! MH+6CPMQ)"&%'%1=-"U?DBE[#20NG-;&>DK,W5%M"0 %6:& GV#8D7 YX16IW M@S"LV%(UMYP:8KG[' 59GWA"( -*%"$USS1VX 2 @7$?K<7).2D=O6MURN0Z M@>F3)2;G8^U,)$N% ("RQD #+$LD0 >S6NW>:![*/4LR IJ.S$K#J39]\=DB MK>4<',CX*DGAF?*<(WQ (TSQ/AW:>W?#.3]HSP=Z!YFND=[9?!W4C06"QGI7 M*WJ#?63G3BVCV\\%,0UM.T)N;+2!I0H]GKX*+8MTO7< MWM7X_E'L]>7,[!V-,)W8K\%&L;V!WD&F:Z1W-O^,*/:"L-[5BMY@A[6#K+IJ MO/%>[NGS^3AJOJKOE#MJR ] N6C>KV%,KZ-WD^Y\4(UFDNH*7BRXYO[H!5'Q M\NK2KN?]X.#6U2SR.U[.^Z'_Y3QXU]QZ3^#GP ML3]]_9S2@_XJ\^MDFP7/01:PD([+NJ6!Y5#"+>>$&+!!6F\S!Y ,9E ,:@ZW M"IBL?T:W=\M?&DF%%Q_1Y'HS_S+?S-5I*,?%1YTO#A2&\J!U$M0;]7?0C&8*V7K^A>;@1, ME9&.Q45EA4DSR)1;HP:B3P?-+?90>'#%-1ENK'$_W:HY)0D(\XZ91"W$+41,#U6!528 /6P/M>0 7U.A R%\O M ,7SZ)F8$].8Q+AA&CQN,2I07PW)&@-\!/+*\H"KT4#%6'XDGP^<29IBZ
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